Mass spectrometric analysis of pilus assembly,

amyloid fibril formation, and membrane proteins in their native state by Leney, Aneika Corrine
I 
 
 
Mass Spectrometric Analysis of Pilus Assembly, 
Amyloid Fibril Formation, and Membrane 
Proteins in their Native State 
 
 
 
 
 
 
 
 
Aneika Corrine Leney 
 
 
Submitted in accordance with the requirements for the degree of PhD 
 
The University of Leeds 
 
Astbury Centre for Structural Molecular Biology 
 
October 2012 
 
 
The candidate confirms that the submitted work is her own, except where work which 
has formed part of jointly-authored publications has been included. The contribution of 
the candidate and the other authors to this work has been explicitly indicated overleaf. 
The candidate confirms the appropriate credit has been given within the thesis where 
reference has been made to the work of others. This copy has been supplied on the 
understanding that it is copyright material and that no quotation from this thesis may be 
published without proper acknowledgement.   
II 
 
Publications 
 
 
 
Chapter 2 includes work from the following publications:  
(i) Leney A. C., Phan, G., Allen, W., Verger, D., Waksman G., Radford, S. E., Ashcroft, 
A. E. Second Order Rate Constants of Donor-Strand Exchange Reveal Individual 
Amino Acid Residues Important in Determining the Subunit Specificity of Pilus 
Biogenesis. J. Am. Soc. Mass Spectrom. 2011 (22) 1214-1223.  
In this publication, all the mass spectrometry data were acquired and analysed by 
myself. Protein purification was equally performed by a combination of G. Phan, W. 
Allen, D. Verger and myself. S.E. Radford, A.E. Ashcroft and G. Waksman helped with 
the scientific input in the paper and provided help writing the manuscript.  
 
(ii) Morrissey B., Leney A. C., Toste Rego, A., Phan, G., Allen, W. J., Verger, D., 
Waksman, G., Ashcroft, A. E., Radford, S. E. The Role of Chaperone-subunit Usher 
Domain Interactions in the Mechanism of Bacterial Pilus Biogenesis Revealed by ESI-
MS. Mol. Cell. Prot. 2012 (11) M111.015289 1-10.   
In this publication, the protein purification was performed by myself in combination 
with A. Toste Rego, G. Phan, W. J. Allen and D. Verger. All the mass spectrometry 
analysis was carried out by B. Morrissey. The manuscript was written by B. Morrissey 
with help from G. Waksman, S. E. Radford, A. E. Ashcroft and myself.  
 
Chapter 4 includes work from the following publication:  
Leney A. C., McMorran L. M., Radford S. E., Ashcroft A. E. Amphipathic Polymers 
Enable the Study of Functional Membrane Proteins in the Gas Phase. Anal. Chem. 2012 
(22) 9841-9847. 
In this publication, all the experimental work was performed by myself. L. M. 
McMorran provided the plasmids for the OmpT expression and purification and helped 
interpret the data. S. E. Radford and A. E. Ashcroft helped with the scientific input in 
the paper and provided help writing the manuscript.  
III 
 
Acknowledgements 
 
 
Firstly, I would like to thank my supervisors Alison Ashcroft and Sheena Radford for 
their constant support and advice throughout my PhD studies. I would also like to thank 
the BBSRC for funding and Dr. R Bateman, Dr. J. Hoyes, Dr. M. Morris and Dr. K. 
Gilles from Waters for their advice and funding throughout my PhD studies. The pilus 
chapter was carried out with help from the Waksman group (Birkbeck College, 
London). I would also like to thank team Amyloid for useful discussions and Lindsay 
McMorran, Bethny Morrissey, Alice Bartlett and Gerard Huysmans for help with the 
membrane protein project.  
I would like to thank all current and past members of the Radford lab. It is a brilliant 
group to be a part of and none of this work could have been done without them. In 
particular, I would like to thanks my office friends: Bethny for being my pilus best 
friend (pbf), Claire for among other things providing skittles and chocolate at crucial 
stages of writing, and Maya for her entertainment with jelly, fire at Astbury retreats, 
honest comments and elastic bands wars. 
I would also like to thank the mass spectrometry lab for help and entertainment. 
Charlotte Scarff, in particular, has been a great help both scientifically and as a close 
friend. I would like to thank Lucy Woods for putting up with me as a housemate      
Finally I would like to thank my family for all their support; my mum for trying to 
understand what I do and my dad for learning the word Biochemistry although I am still 
trying to persuade him that Academia is not an island somewhere near Greece. I would 
like to thank Richard for support and encouragement throughout my PhD especially 
throughout the toughest parts during my shoulder injury.  
 
 
 
IV 
 
Abstract 
Structural analysis of proteins and their complexes is crucial to understanding protein 
function. This thesis demonstrates the application of mass spectrometry (MS) to the 
study of pilus assembly on Gram-negative bacteria and amyloid formation in dialysis-
related amyloidosis. In addition, it also tackles the challenging area of membrane protein 
analysis by MS.    
Pili are hair-like appendages located on the outer membrane of bacteria that are involved 
in the transmission of infection. A periplasmic chaperone and an outer membrane usher 
protein coordinate pilin subunit assembly. Electrospray ionisation (ESI)-MS was used to 
elucidate the mechanism of subunit assembly. Experiments revealed the specific amino 
acids on the N-terminal extension of the pilus subunits that are important in catalysing 
the subunit assembly process. Further MS/MS analysis indicated differences in the 
stability of the chaperone-subunit-usher ternary complexes formed, providing new 
insights into the role of the usher in orchestrating pilus biogenesis.  
Ion mobility spectrometry (IMS)-MS was next used to characterise oligomeric 
intermediates formed during beta-2 microglobulin (β2m) assembly into amyloid fibrils. 
Analysis of the oligomers formed by a range of β2m point mutants that affect the 
kinetics of amyloid fibril formation highlighted the complexity of this fibril-forming 
process. Further detailed characterisation of the β2m mutant H51A revealed subtle 
differences in the subunit exchange dynamics of the oligomers involved in fibril 
formation.  
Finally, this thesis shows a novel method for solubilising membrane proteins for MS 
analysis. Amphipathic polymers, termed amphipols, were used to fold and enhance the 
stability of two bacterial outer membrane proteins, OmpT and PagP. The utility of 
amphipols to study the structural and functional properties of membrane proteins by 
ESI-IMS-MS was then developed. Together these data show the power of ESI-IMS-MS 
in separating conformationally-distinct populations of amphipathic polymers from the 
amphipol-membrane complex whilst maintaining a ‘native-like’ membrane protein 
structure in the gas phase.  
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1. Introduction 
Mass Spectrometry 
 
1.1 Biophysical Analysis of Proteins 
Proteins are essential in maintaining both the structure and function of living cells. 
They rarely function alone and form partners with other molecular species to fulfil 
their specific roles within the cell; there are a variety of such species, including small 
molecules, metal ions, oligonucleotides and peptides, in addition to other proteins. 
Biophysical techniques for the analysis of proteins have developed significantly over 
recent years. Spectroscopic approaches (such as circular dichroism (CD), light 
scattering, fluorescence), isothermal titration calorimetry (ITC), surface plasmon 
resonance (SPR), analytical ultracentrifugation (AUC), electron microscopy (EM), 
X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy and mass 
spectrometry (MS) are all commonly used for protein analysis; each method having 
its own strengths and weaknesses. 
Traditional chromatography and electrophoresis based methods, such as size 
exclusion chromatography (SEC) and gel electrophoresis, can be used to determine 
the purity of the protein sample of interest in addition to the molecular weight and 
subunit stoichiometry of protein complexes. Careful consideration is needed due to 
the sensitivity of the elution and mobility times to the shape and physical properties 
of the protein of interest. By use of a calibration obtained with protein standards 
most relevant to the protein of interest low resolution molecular weight 
determination and stoichiometry information can be determined. AUC is another low 
resolution technique commonly used to determine the molecular mass, shape and 
equilibrium constants of proteins and their complexes, the development of which 
was awarded the Nobel prize in 1926 (Svedberg et al. 1926). AUC does not give as 
accurate molecular weights as other biochemical techniques such as MS, but it is still 
very powerful at providing sub-stoichiometric information on protein complexes. 
X-ray crystallography and NMR spectroscopy are commonly used to provide high 
resolution structural information on proteins and their interactions with various 
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binding partners.  X-ray crystallography provides a three-dimensional image, in 
some cases, at sub-atomic resolution (<1 Å) (Petrova et al. 2004). NMR 
spectroscopy, in addition to structural information, can provide dynamic information 
from a range of experiments including multi-dimensional and heteronuclear 
experiments, relaxation measurements, and hydrogen-deuterium exchange (Shortle 
1996; Dempsey 2001; Dominguez et al. 2011; Zhao 2012). Due to the high 
complexity in NMR spectral analysis, the structure of proteins with molecular mass 
above ~50 kDa is extremely difficult to determine (Clore et al. 1998). A minor 
disadvantage of both X-ray crystallography and NMR spectroscopy is the use of high 
sample concentrations that they require which can lead to non-specific aggregation. 
Another common biophysical technique, SPR, can be used to study non-covalent 
interactions in solution. SPR assumes that immobilising a molecule does not affect 
its interactions with other molecules in solution, and that the interaction measured 
reflects that in bulk solution, even though measurements are taken very close to a 
surface (Li et al. 2009).  
Mass spectrometry (MS) is the technique used throughout this thesis. MS analysis 
has several advantages over other techniques including low sample consumption, no 
upper mass limit, and the ability to distinguish multiple species in solution by their 
unique molecular weight. MS does have several disadvantages in that samples in 
volatile buffers are required, the ions analysed are in the gas phase, and samples 
cannot be re-used (since it is a destructive technique). A brief history of MS and 
current MS techniques will be discussed further in this chapter followed by its 
application to protein structure analysis.  
 
1.2. Mass Spectrometry 
The first mass spectrometry experiment was performed by Joseph John Thomson in 
1897. In this work cathode rays were deflected by an electromagnetic field in an 
evacuated tube which led to the discovery of the electron (Thomson 1899). 
Subsequent to this, Thomson and his student at the time, Francis W. Aston, refined 
these magnetic sector instruments to enable separation of isotopes of neon (Thomson 
1911) and many other elements (Aston 1919). These experiments awarded them with 
the Nobel prize for physics in 1922.  
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Since the initial discovery of electrons by mass spectrometry, the field of mass 
spectrometry has been transformed more than could have been predicted. By the 
1940s, industrial chemists were using commercially available mass spectrometers to 
quantify levels of known substances and by the 1950s these were used further for 
routine identification of unknown compounds (Griffiths 2008). Over the last 60 
years, advances in ionisation methods and separation techniques, such as 
chromatography and ion mobility, that have been coupled to mass spectrometers 
have led to a great expansion in the application range of MS. MS has been used for 
applications as wide as the analysis of the chemical composition on planet Mars 
(Fenselau et al. 2003) in addition to the drug testing of athletes at the Olympic games 
(Hemmersbach 2008). 
 
1.3. Overview of Mass Spectrometry Instrumentation 
MS is an analytical technique for determining the molecular weight of gaseous ions 
based on their unique mass to charge ratios (m/z).  There are three fundamental parts 
to the mass spectrometer, the ionisation source, the analyser and the detector (Figure 
1.1).   
 
 
Figure 1.1 – Schematic representation of a modern mass spectrometer. 
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1.3.1 Ionisation 
For mass spectrometry analysis, the analyte of interest must first be ionised and 
transmitted into the gas phase in order for it to be detected. There are many different 
methods of sample ionisation. Electron impact (EI) ionisation (Dempster 1918; 
Beynon 1956) and chemical ionisation (CI) (Munson et al. 1966) are suitable for 
small, vaporised organic compounds, whereas atmospheric pressure chemical 
ionisation (APCI) (Carroll et al. 1975) and electrospray ionisation (ESI) (Fenn et al. 
1989) are useful for analysing samples from solution. This advance in MS ionisation 
methods led to a dramatic increase in the number of applications of MS to study 
biological systems, in particular protein analysis.  
 
1.3.1.1 Matrix Assisted Laser Desorption/Ionisation 
It was not until the 1980s that ‘soft’ ionisation techniques such as matrix-assisted 
laser desorption ionisation (MALDI) and ESI were developed (Karas et al. 1987; 
Fenn et al. 1989). In MALDI, the sample in solution and the matrix are often added 
sequentially to the MALDI plate. In the majority of cases, the matrix consists of 3,5-
dimethoxy-4-hydroxycinnamic acid or α-cyano-4-hydroxycinnamic acid for protein 
and peptide analysis, respectively (Cohen et al. 1996). Typically the sample is 
spotted onto a MALDI plate, air-dried, and a laser fired at the analyte-matrix mixture 
to transfer the sample into the mass spectrometer. Upon laser ablation, protons are 
transferred to the analyte of interest either during or after the desorption process 
generating singly-charged ions (Figure 1.2A). This is disadvantageous since the 
organic matrix does not provide native conditions for proteins. ESI is the preferable 
ionisation method for protein structural analysis since, using this method of 
ionisation, it is possible to ionise samples from purely aqueous solution (Loo 1997; 
Ashcroft 2005; Benesch et al. 2006; Heck 2008; Bich et al. 2009). Electrospray 
ionisation is favoured over MALDI for non-covalent protein analysis since it can 
report on protein conformation due to multiply charged ions being produced in the 
ionisation process (Section 1.6, Figure 1.8). 
5 
 
 
Figure 1.2 - A) Matrix assisted laser desorption/ionisation (MALDI) showing the analyte and matrix 
in red and white respectively. B) Electrospray ionisation (ESI) showing the solution containing the 
analyte of interest (red) being sprayed from an electrically charged capillary. The solvent (blue) 
evaporates until coulombic fission occurs resulting in positively charged ions. The differences 
between the ion evaporation model (IEM) (Dole et al. 1968) and the charge residue model (CRM) 
(Iribarne 1976) are highlighted. 
 
1.3.1.2 Electrospray Ionisation 
Electrospray ionisation is a gentle ionisation technique which takes place under 
atmospheric conditions (Fenn et al. 1989). During ESI, sample solution is passed 
through a charged capillary and drawn into a filament before it forms a mist of 
charged droplets around the end of the capillary (Figure 1.2B). The droplets reduce 
in size as they travel down a potential and pressure gradient through the inlet of the 
mass spectrometer towards the analyser. As the solvent evaporates from the solution, 
the droplets increase in charge density until the Rayleigh limit (the point at which the 
charge repulsion between the ions exceeds the surface tension) is reached. At this 
point either the solvent evaporates and Coulombic fission occurs until the droplets 
are of a certain radius to enter the mass spectrometer (ion evaporation model) (Dole 
et al. 1968) or the evaporation/fission cycles continue until all the solvent has 
evaporated and only the charged analyte molecule remains (charge residue model) 
(Figure 1.2b) (Iribarne 1976).  
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ESI can be used under aqueous conditions; however, the extra energy needed for ion 
desolvation from aqueous solvent (compared with volatile organic solvents) can 
damage native interactions. Nano-ESI, a low flow-rate modification of ESI, produces 
smaller initial droplets than ESI (diameter of 0.15 μm compared with 1.5 μm) (Wilm 
et al. 1996), reducing the energy needed for desolvation and fission events 
(Juraschek et al. 1999). Nano-ESI is, therefore, widely used in analysis of non-
covalent native protein complexes (Sharon et al. 2007), and is the ionisation method 
used in this thesis. 
There are two commonly used nanoESI methods for introducing samples into the 
mass spectrometer; coated capillaries and the automated NanoMate system. The 
NanoMate Triversa developed by Advion, uses a microfluidic chip consisting of an 
array of nanoESI nozzles. A voltage is applied to the surface of the chip while the 
sample of interest is sprayed through the nanoESI nozzle. The NanoMate offers a 
very efficient and stable spray due to the precise field strength created by the 
nanoESI nozzles. The NanoMate Triversa has been used to analyse a variety of non-
covalent biological complexes including the interactions of peptide ligands with the 
vascular endothelial growth factor protein (Dyachenko et al. 2010), the interaction of 
tRNA with a tRNA-modifying enzyme, tRNA-guanine transglycosylase (Ritschel et 
al. 2009), and the self-assembly of the protein, beta-2 microglobulin during amyloid 
fibril formation (Smith et al. 2010; Smith et al. 2011).  
Borosilicate glass capillaries are also commonly used to analyse large non-covalent 
complexes (Kirshenbaum et al. 2010). The capillaries used to spray the biological 
complexes used in this thesis were pulled in-house and coated in a gold/platinum 
mixture. Due to the ability to optimise the capillary diameter at the end of the 
electrospray tip, the coated capillaries produce mass spectra with increased signal to 
noise compared with the nanomate source. Poor reproducibility makes the nanomate 
system advantageous when performing multiple repetitive experiments. 
 
1.3.2 Analyser 
Once the sample has been ionised, the analytes must be separated according to their 
unique m/z ratios. A variety of different mass analysers are available. The first mass 
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spectrometers used magnets to deflect ions according to their mass to charge ratio. 
Since then, other analysers such as quadrupole, ion trap, time-of-flight (TOF) and 
ion cyclotron resonance instruments have been developed to achieve ion separation. 
Mass analysers aim to maximise resolution, mass range and mass accuracy.  
 
 
Figure 1.3 – Definition of resolution between two peaks of mass (m) and (m+∆m) in a mass spectrum. 
Peaks are resolved if the valley between them is at x % of the smallest peak intensity. 
 
In mass spectrometry, resolution is defined as the smallest mass distance between 
two fully resolved peaks. Peak are considered resolved if the valley between them is 
at x %, where x is usually 10 or 50 %. The equation for resolution is shown in Figure 
1.3. Resolution can also be defined by the peak width at half height for a single peak, 
termed the full width at half-maximum (FWHM). Resolution in mass spectrometry is 
highly dependent on the type of mass analyser used. The mass spectrometers used 
for Aston’s early work had a resolution of 130 Da (Aston 1919), whereas the more 
recent Fourier transform instruments described by Marshall and co-workers had a 
resolution of 8, 000, 000 Da (Shi et al. 1998). Quadrupole and time-of-flight 
analysers were used in this thesis and are explained in more detail below.   
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Quadrupole Mass Analysers 
Quadrupole mass analysers detect ions of each m/z sequentially. They consist of four 
rods arranged in pairs, parallel to one another (Figure 1.4). A direct current potential, 
U, and a radio-frequency oscillating potential, V, are applied to the rods. The 
potential on the rods (Φ0) is described in Equations 1.1 and 1.2 where U is the 
magnitude of the direct potential, V is the amplitude of the oscillating potential, ω is 
the frequency, and t is time. 
 
                                 Φ           ω                          Equation 1.1 
 
                                 Φ           ω                        Equation 1.2 
 
The ions traversing the quadrupole will have a particular trajectory depending on 
their m/z. Due to the potentials applied to the rods, the ions will oscillate in the x and 
y direction until they reach the detector. If the trajectory of an ion through the 
quadrupole is stable, then the ion will reach the detector. Alternatively, if the 
potentials applied cause an unstable ion trajectory, then the ion will hit the walls of 
the quadrupoles, thus not being detected (de Hoffmann 2002).  
 
 
Figure 1.4 - Schematic of a quadrupole analyser showing an ion with a stable trajectory path (red) 
being transmitted to the detector whilst another ion with a different m/z ratio (blue) hits the walls of 
the quadrupole and is thus not detected. 
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Time-of-Flight (Tof) Mass Analysers 
Time-of-flight (Tof) analysers were also used for the work in this thesis. Tof 
analysers have the advantage of having no theoretical upper mass limit. In Tof 
analysers, ions exiting the ionisation source are accelerated initially by a potential 
(V), giving each analyte ion a fixed amount of kinetic energy (EK). Ions with the 
same kinetic energy then traverse a field-free region of fixed distance (d). The 
velocity (v) an ion has in this field-free region is inversely proportional to the square 
root of its mass (m) (Equation 1.3) (de Hoffmann 2002). For a fixed kinetic energy, 
the analyte ions velocity is determined by its mass and total charge (ze), where z is 
the number of charges on the analyte ion and e the charge on an electron (Equation 
1.3). 
 
                
   
 
   
     
 
                             Equation 1.3 
 
Since the time (t) an ion takes to traverse the field-free region is proportional to the 
length of the flight tube (d) and inversely proportional to its velocity (v), the time for 
ions to reach the detector can be related to the ion’s m/z according to the following 
equation (Equation 1.4).   
 
                       
 
    
                                        Equation 1.4              
 
Unfortunately ions of the same m/z can have different initial kinetic energies causing 
them to reach the detector at different times. This can lead to peak broadening and 
decreased resolution (de Hoffmann 2002). Delayed pulse extraction was a technique 
developed to reduce the spread of kinetic energies between ions of the same m/z and 
is now used in all commercial Tof instruments to improve resolution (Vestal et al. 
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1995). This extraction pulse provides ions that have moved a small distance into the 
flight tube (i.e. whose kinetic energy is too low) with more kinetic energy thus 
allowing both ions to hit the detector simultaneously. Another method developed to 
increase the mass resolution in Tof instruments was the addition of a reflectron 
(Mamyrin et al. 1973) (Figure 1.5). Reflectrons consist of a ring of stacked 
electrodes, creating a retarding field, which acts as an ion mirror. Reflectrons 
compensate for differences in kinetic energies of analyte ions since ions with more 
kinetic energy will traverse further into the reflectron and as a result take longer to 
be reflected back than ions with less kinetic energy. The mass resolution is also 
increased by addition of the reflectron by effectively doubling the length of the flight 
tube. Another major advantage of the reflectron is that the instrument dimensions 
and the vacuum system can remain constant while the advantages of doubling the 
flight path in terms of resolution are realised.  
 
 
Figure 1.5 - Schematic of a Tof analyser showing two ions of same m/z but different kinetic energies 
(blue and red) being deflected to different extents by the reflectron and thus reaching the detector 
simultaneously. 
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1.3.3 Tandem Mass Spectrometry 
Tandem mass spectrometry (MS/MS) involves the combined use of two or more 
mass analysers. MS/MS can be carried out on tandem instruments whereby two of 
the same analyser (for example, tandem quadrupole) or of two different analysers 
(hybrid) (for example, quadrupole-time-of-flight (Q-Tof)) are separated by a 
collision cell in which ions can be fragmented. Q-Tof instruments have been used 
throughout this thesis not only to characterise non-covalent complexes but also to 
perform structural characterisation of proteins through tandem mass spectrometry 
experiments. During MS/MS, a single precursor ion is selected in the first mass 
analyser (i.e. the quadrupole in the case of a Q-Tof), subjected to fragmentation, and 
the subsequent product ions detected in the second (Tof) mass analyser. 
Collision-induced dissociation (CID) is the most commonly used fragmentation 
method. During CID, an ion of interest is subjected to collisions with an inert buffer 
gas (for example, argon) resulting in its fragmentation. In peptides, this results in 
predominantly but not exclusively b and y fragment ions (Roepstorff et al. 1984; 
Biemann 1992) which can be used to sequence the peptide of interest (Figure 1.6). 
Although CID is a relatively simple, straight forward fragmentation technique, the 
energy required to fragment a peptide bond between different amino acid residues 
varies and acidic residues are cleaved preferentially (Summerfield et al. 1997). This 
can limit full sequence coverage by CID and has led to development of the more 
novel fragmentation methods, electron capture dissociation (ECD) and electron 
transfer dissociation (ETD). ECD was first described by the McLafferty group and is 
based on ion-electron reactions in which the positive analyte ion captures electrons 
resulting in its fragmentation (Zubarev et al. 1998). In peptides this leads to the 
cleavage between the α-carbon and nitrogen atoms yielding predominantly c and z 
fragment ions (Figure 1.6). ECD generally allows full sequencing of peptides; 
however the production of high populations of electrons needed to induce 
fragmentation in Q-Tof instruments is challenging. ETD is comparable to ECD but 
instead of electrons, uses a small singly charged molecule, for example anthracene, 
to transfer electrons to the peptide precursor ion (Syka et al. 2004). Thus ETD avoids 
problems associated with high density electron production.  
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Figure 1.6 - Peptide ion nomenclature where a and x, b and y, and c and z represent fragments ions 
(Roepstorff et al. 1984; Biemann 1992). CID and ECD/ETD produce b and y, and c and z ions 
respectively. 
 
CID, ECD and ETD have been used to reveal structural details of proteins and their 
complexes (Griffiths et al. 2001; Sobott et al. 2002; McCammon et al. 2005; 
Bakhtiar et al. 2006; Wu et al. 2007; Esteban et al. 2008; Gordiyenko et al. 2010; 
Morrissey et al. 2012) (see Section 1.9, Figure 1.10).  
 
1.3.4 Detection 
Ions exiting mass analysers are typically detected by electron multipliers which 
amplify the charge induced or the current produced when an ion hits its surface 
(Koppenaal et al. 2005). Tof instruments typically use multi-channel plates (MCP) 
of high resistive material that allow simultaneous detection of multiple ions 
(Koppenaal et al. 2005). By correlating the detection of ions with time in a Tof 
instrument, information in terms of a mass-to-charge (m/z) versus intensity plot can 
be obtained. Tof instruments are very sensitive as they have the ability to monitor all 
ions produced continuously (magnetic and quadrupole instruments can only detect 
one m/z at any one time i.e. they ‘scan’ the m/z range).    
 
Over the last five years, a commercial instrument in which an additional separation 
technique called ion mobility spectrometry (IMS) has been inserted has aided the 
analysis of complex mixtures by MS and the structural analysis of proteins. The 
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development of IMS will be discussed in more detail below and examples of its 
application in protein structure analysis discussed further in Section 1.6.3.   
 
1.4 Ion Mobility Spectrometry 
Ion mobility spectrometry (IMS) can be used as an additional tool together with MS 
to separate ions based on their shape and/or charge (McDaniel 1973; Karasek 1974). 
During IMS, gas-phase ions are separated based on their mobility through a drift 
tube containing a buffer gas (Karasek 1974). Larger ions will take longer to traverse 
through the drift tube compared to smaller ions as they will experience more 
collisions with the buffer gas than smaller ions. Due to the electric field applied 
across the drift tube, differently charged ions of the same shape can also be separated 
with more highly-charged ions taking less time to traverse the drift tube than ions 
with less charge. Rotationally-averaged collision cross-section measurements can be 
calculated based on drift time measurements from IMS data. Using conventional 
IMS coupled with MS, collision cross-section measurements can be calculated 
directly from an ion’s mobility (K) (Revercomb et al. 1975). Under these conditions, 
the mobility of an ion is equal to its velocity through the drift tube (VD) divided by 
the electric field strength (E) (Equation 1.5) (Creaser et al. 2004). This can also be 
shown in terms of drift time (tD), whereby the velocity through the drift tube (VD) is 
related to the time it takes for a gas phase ion to travel the length (L) of the drift tube 
(Equation 1.6).   
                             
             K  =  VD      Equation 1.5 
          E 
 
                                                
 
  E
                                            
 
As the ion’s mobility through the drift cell depends on the buffer gas density, the 
mobility of an ion is normally reported in terms of its reduced mobility (K0) 
(Equation 1.7), where T is the temperature in Kelvin and P the pressure in Torr.  
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With conventional IMS, the mobility of an ion can be related to its collision cross-
section (Ω) by the following equation (Equation 1.8), where z is the number of 
charges on the ion, e is the charge on an electron, kB is the Boltzmann constant, and 
N the buffer gas number density. 
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The term [1/mI + 1/mN] refers to the reduced mass of the buffer gas (mN) and the 
analyte ion (mI). Rearranging equation 1.8 for collision cross-section and substituting 
in reduced mobility (K0) for mobility (K) from Equation 1.7 gives 
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          Equation 1.9 
 
where the collision cross-section is proportional to the drift time (tD) of an analyte 
ion of molecular mass (mI) and charge z. 
 
These home built, IMS instruments can suffer from poor sensitivity due to radial 
losses during IMS separation and duty cycle limitations. As such, detecting low-
level, low-energy analytes such as macromolecular non-covalent protein complexes 
is challenging. The launch of the first commercially available travelling wave IMS-
MS instrument, the Synapt HDMS, in 2007 (Pringle et al. 2007) was accompanied 
with a dramatic increase in the number of structural studies on proteins and 
macromolecular complexes by IMS-MS. 
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Figure 1.7 – Schematic representation of the Synapt HDMS instrument highlighting the quadrupole 
(used for isolating ions in CID-MS experiments) and the ion mobility cell (IMS). The Figure was 
adapted from Pringle et al. (Pringle et al. 2007).  
 
In contrast to drift-cell ion mobility in which a constant low electric field is applied 
to the mobility cell (described above), travelling wave ion mobility uses a travelling 
wave of electric potential created by a series of stacked ring ion guides throughout 
the drift tube (Giles et al. 2004). The travelling wave ion guide can be used to 
separate ions of different mobility since the ability of the analyte ion to surf along 
the wave of electric potential through an inert gas depends on its mobility. Higher 
mobility ions are carried by the wave and reach the detector faster than lower 
mobility ions that roll over the top of the wave, thus taking longer to reach the 
detector (Figure 1.8) (Giles et al. 2004). 
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Figure 1.8 – Schematic of travelling wave ion mobility separation. Ions with a higher mobility (red) 
exit the drift cell before ions of lower mobility (yellow). 
 
The travelling wave device in commercial instruments complicates the relationship 
between the collision cross-section and the drift time of the analyte through the drift 
cell. The cross-sections in travelling wave ion mobility, therefore, are calculated 
relative to the drift time of ions of known collision cross-section (i.e. that have been 
measured previously by use of conventional IMS-MS). The equation for the collision 
cross-section (Equation 1.9) can be adapted to contain constants, A and B, to account 
for the travelling wave characteristics. 
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           Equation 1.10 
 
where A corrects for the electric field parameters (E and L in conventional IMS, 
Equation 1.9) and B for the non-linear effect of the travelling wave device 
(Wildgoose 2006). 
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The collision cross-section is often quoted as a charge and mass independent 
quantity in Å
2
Da
-1
C
-1
 termed Ω’ (Equation 1.11). Equation 1.11 can be further 
simplified to equation 1.12 by combining most of the parameters into a single 
constant A’, where A’ incorporates the correction for temperature, pressure and the 
electric field parameters. 
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               Equation 1.11 
 
                            Ω       
                       Equation 1.12 
 
Altogether, based on Equations 1.10, 1.11 and 1.12, the collision cross-section can 
be expressed as follows (Equation 1.13): 
 
                      
 
  
  
 
  
 
 
 
    
 
                  Equation 1.13 
                         
 
  
  
 
  
 
 
 
         
 
A universal cross-section calibration method for travelling wave IMS is still in the 
process of being developed and different research groups tend to use different 
approaches for calibration. The calibrations used in this thesis are based on the use of 
denatured protein calibrants (Smith et al. 2009), that have had their absolute cross-
sections measured by Clemmer et al. (Liu et al. 1997; Shelimov et al. 1997; 
Valentine et al. 1997a; Valentine et al. 1997b) (Amyloid Materials and Methods 
Section 3.4.10.2). The T-wave height, wave velocity and buffer gas pressure can all 
be optimised to separate the analyte of ions of interest in the ion mobility cell. For 
18 
 
the cross-section calibration to be valid, the ion mobility calibrants must be 
measured under the same experimental conditions as the analyte of interest 
(Shvartsburg et al. 2008; Leary et al. 2009). Where possible calibrants should be 
chosen to reflect mass, the mobility space covered and compound class.  
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1.5 Protein Analysis by MS 
 
1.5.1 Protein Structure by ESI-MS 
Mass spectrometry has often been applied within the field of proteomics, aiming to 
identify the primary structure of proteins along with their expression levels, post-
translational modifications, protein-protein interactions and their function within the 
cell (Aebersold et al. 2003). MS over the last 20 years has expanded to the study of 
native quaternary structure of proteins and their complexes (Ganem et al. 2003; 
Chait 2011; Hilton et al. 2012), and it is this aspect of MS that will be covered 
throughout the rest of this thesis.  
One major assumption throughout this thesis is that protein structure in solution is 
preserved on transition into the gas phase. There is significant evidence that the 
structure of non-covalent complexes is preserved on transition into the gas phase 
(Benesch et al. 2007; Sharon et al. 2007; Heck 2008; Wang et al. 2010). Initially 
there was concern as to whether all solution structures could be preserved into the 
gas phase since it is known that electrostatic interactions are increased and 
hydrophobic interactions weakened in the gas phase (Robinson et al. 1996; Loo 
2000). As such, if protein complexes are maintained by predominantly hydrophobic 
interactions then preserving these structures in the gas phase was thought not to be 
possible (Hernandez et al. 2007). Recent studies have now shown that hydrophobic 
interactions can be maintained in the gas phase if the correct conditions are used (Liu 
et al. 2009; Liu et al. 2011). Indeed the binding affinities of these hydrophobic 
complexes as measured by ESI-MS closely match those observed in solution (Liu et 
al. 2011). With the launch of IMS-MS, evidence has increased for the maintenance 
of solution-phase structure into the gas phase (Ruotolo et al. 2005; Benesch et al. 
2010). As such, it is now widely accepted that under controlled experimental 
conditions and short time-scales MS can be used to report accurately on solution-
phase structures. 
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1.5.2 Protein Conformation by ESI-MS 
Providing native protein structure is preserved on transition into the gas phase, the 
charge state distribution of proteins in the m/z spectrum can be related to the 
conformation of proteins in solution. During positive ESI, protons attach to the 
exposed, basic sites of proteins producing multiply charged ions. As such, a folded 
protein in solution will pick up less charge than its unfolded counterpart resulting in 
a narrower charge state distribution (Figure 1.9). This technique of determining 
protein conformation in solution has been widely accepted by the mass spectrometry 
community. Thus, ESI-MS is frequently used to probe protein conformational 
changes during pH titrations and temperature ramping and to observe conformational 
changes on protein/ligand binding.    
 
 
Figure 1.9 – Schematic of a mass spectrum of A) a folded and B) an unfolded protein in solution. The 
inserts represent the folded and unfolded protein picking up a different number of charges during the 
electrospray ionisation process. 
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More recently, the combination of IMS with MS has revealed more detailed 
information on protein conformations in solution (Kanu et al. 2008). IMS-MS can 
reveal conformational changes within proteins on folding/unfolding. Albert Heck 
and colleagues have used IMS-MS to look at substrate folding by the chaperonin 
complex GroEL-GroES. In these studies, the collision cross-sections were identical 
between the GroEL-GroES complex and the GroEL-GroES-substrate complex 
confirming that substrate folding occurs within the GroEL-GroES cavity (Van Duijn 
et al. 2009).  
In addition to protein conformation, MS can also be used to determine the subunit 
stoichiometry (Section 1.5.3) and subunit dynamics of protein complexes in solution 
(Section 1.5.4). Additional advances in MS techniques have allowed quantification 
of protein complexes in solution (Section 1.5.5) leading to the determination of 
binding affinities by MS, for example with protein-ligand complexes. This, in 
combination with IMS-MS can reveal additional possible structural changes that can 
occur on ligand binding (Sharon et al. 2007). For example, a subtle conformational 
change was observed by IMS-MS on binding of ABT-737 (a small molecule 
inhibitor) to the Bcl-xL protein involved in cell survival (Atmanene et al. 2012). 
IMS-MS in combination with molecular modelling is very powerful in refining 
structural details of proteins and their complexes in solution. This is discussed in 
more detail in Section 1.5.7.   
 
1.5.3 Subunit Stoichiometry by MS 
In addition to the molecular weight of macromolecular protein complexes, MS can 
be used to determine the subunit stoichiometry of protein complexes in solution 
(McCammon et al. 2005). Tandem MS (in particular CID-MS) can be used to 
increase the internal energy of the complex once transmitted into the gas phase. This 
increase in energy causes the complex to dissociate into its individual components 
which can then be identified in the mass spectrum. For example, the dissociation 
pathway of part of the yeast nuclear-cytoplasmic exosome protein complex (a 
hexameric ring bound to proteins Rrp4, Rrp40 and a large exoribonuclease, Dis3) 
was analysed by increasing the collision energy applied to the exosome complex 
(Figure 1.10). On increasing collision energy, the Rrp40 dissociated first followed by 
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the Rrp4 protein with the hexameric ring remaining intact and bound to the Dis 
exoribonuclease protein throughout. These data indicate that the core hexameric ring 
is stable in the gas phase and is likely to be simply decorated in solution with the 
weakly bound proteins, Rrp4 and Rrp40.  
 
 
Figure 1.10 - MS/MS spectra of the exosome subcomplex. The exosome subcomplex, consisting of 
the ring proteins Rrp4 (4), Rrp40 (40) and Dis3 (Dis), with 40 + charges (○) was selected as the 
precursor ion and a collision voltage of 50 V (top), 100 V (middle) and 150-175 V (bottom) applied to 
it. On increasing collision voltage from 50 V to 100 V, two charge distributions were observed 
corresponding to the Rrp40 being released from the complex. On further increasing collision voltage 
to 150-175 V, the Rrp4 subunit was further released from the complex. This Figure was adapted from 
Synowsky et al. (Synowsky et al. 2009).     
 
Tandem MS has also been used to probe the subunit interactions within the human 
eukaryotic initiation factor 3 (eIF3) (Zhou et al. 2008). Human eIF3 is an 800 kDa 
protein complex made up of 13 different subunits, the interactions between which 
were previously unknown. To create an interaction map of the protein subunits that 
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make up the eIF3 complex, ESI-MS was used initially to transfer eIF3 in its native 
state into the gas phase. Subsequent CID-MS experiments and in solution 
dissociation experiments (involving increasing ionic strength to dissociate the 
complex) allowed 27 subcomplexes of eIF3 to be identified. These data along with 
previously obtained data on the yeast eIF3 complex (Hinnebusch 2006), allowed a 
comprehensive interaction map to be proposed for the human eIF3 complex (Zhou et 
al. 2008). 
IMS in combination with tandem MS has also been used to determine structural 
information on intermediates involved in the formation of large macromolecular 
complexes, for example virus capsids (Knapman et al. 2010). Two transient on-
pathway intermediates were identified by ESI-MS during MS2 virus capid 
formation. On further analysis, by ESI-IMS-MS and CID-MS/MS, the mass, 
stoichiometry and cross-section of these intermediates were identified revealing 
information on the building blocks and thus the assembly mechanism of the MS2 
virus capsid (Knapman et al. 2010).  
Tandem MS has also been proposed as a tool to determine the nature of protein-
protein interfaces based on the charge state distributions of the gas phase dissociated 
product ions in the MS/MS spectrum (Dodds et al. 2011) (see Amyloid Chapter). 
Additionally, it has only been with the high collision energies provided by CID-MS 
that membrane complexes have been able to be released from their complexes with 
detergent in solution and thus be detected by ESI-MS (Barrera et al. 2011) (see 
Membrane Protein Chapter).  
 
1.5.4 Subunit Exchange by MS 
Complex biological molecules rarely remain as static entities in solution and are 
constantly undergoing conformational changes whether it is through ligand binding, 
enzymatic function or movement throughout the cell (Kaltashov et al. 2002). 
Studying the folding and dynamics of protein complexes and their subunit exchange 
events is of utmost importance in understanding protein function. This subunit 
exchange within protein complexes can be detected by MS simply by a change in 
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mass if hetero-oligomers (subunits with different masses) or homo-oligomers 
(identical subunits with 
13
C or 
15
N labelling) are used (Keetch et al. 2005). 
The oligomerisation of transthyretin (TTR), a tetrameric protein associated with 
amyloid disease, has previously been studied by subunit exchange MS analysis 
(Keetch et al. 2005). In this study, the differences in the subunit exchange kinetics 
were monitored between WT TTR and a more amyloidogenic TTR mutant, L55P. 
Interestingly, subunit exchange between the L55P mutant reached equilibrium in less 
than 20 minutes as opposed to WT TTR that took over 9 hours to reach equilibrium. 
These experiments highlight how subunit exchange can reveal differences in the 
subunit dynamics between structurally similar oligomeric complexes, revealing 
novel information, in this case, about the mechanism of amyloid fibril formation. 
Subunit exchange by MS has more recently been applied to look at the structural 
dynamics of the protein, β2-microglobulin, whose oligomers also result in amyloid 
fibril formation (see Amyloid Chapter) (Smith et al. 2010) and virus capsid assembly 
intermediates (Stockley et al. 2007). 
 
1.5.5 Quantification by MS 
MS can be used as a quantitative tool to analyse protein complexes in solution. To 
determine kinetic and thermodynamic parameters of protein complexes by MS, the 
mass spectrum needs to reflect accurately the distribution of all molecules in 
solution. The intensity of ions in the m/z spectrum has been shown to be comparable 
for similar protein species that are present in equal concentrations in solution 
(Benesch et al. 2011); however there is an m/z dependence in current mass analysers 
(Liu et al. 2011) and detectors (Fraser 2002) that needs to be resolved to obtain 
absolute quantification of different species in solution based on signal intensity 
alone. Efforts have been made to enable quantification of proteins in complex with 
lipids in solution. Indeed, work by the Klassen group has developed methods to 
account for non-specific binding (reporter molecule method) (Sun et al. 2009), in-
source dissociation (reference ligand method) (El-Hawiet et al. 2010) and 
interactions difficult to detect by ESI-MS alone (proxy protein method) (El-Hawiet 
et al. 2012). 
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1.5.6 Kinetic Analysis by MS 
Dynamic processes can span a wide range of timescales from femtoseconds to days 
(Kandt et al. 2010). Although MS is limited by speed of sample introduction and the 
mass analyser, MS can measure structural kinetics on the millisecond timescale 
(Simmons et al. 2002; Pan et al. 2010; Stocks et al. 2010). The simplest method of 
kinetic analysis by MS is to monitor the reaction of interest continuously in real 
time. Prolonged spraying in ESI can cause electrochemical changes in the solutions 
which may affect the reaction kinetics (Van Berkel 2000). Thus, more commonly 
manual sampling methods are used at different time points to monitor the reaction 
over the required time course. Indeed MS has been used for kinetic analysis of 
proteins in pilus assembly, by monitoring changes in mass spectra as a function of 
time (Rose et al. 2008) (see Pilus Chapter 2.1). MS has also been used to monitor the 
assembly of the heterohexameric MtGimC chaperone complex (Fandrich et al. 
2000), revealing information about its assembly mechanism in addition to the 
reaction kinetics.  
 
1.5.7 Molecular Modelling of Protein Complexes 
The combination of collision cross-section measurements from IMS with coarse-
grain modelling is very powerful in elucidating structures of proteins and protein-
protein complexes. Several methods have been proposed to calculate the cross-
section of an ion based on a three-dimensional model of its structure. The projection 
approximation model is the first model, described in a preliminary, pre-computer 
state, by Mack in 1925 (Mack 1925), and further developed by Bowers et al. (Von 
Helden et al. 1991; Von Helden et al. 1993). This model assumes each atom is a 
hard sphere and calculates the cross-section by averaging the projected shadow of 
the analyte ion over all possible orientations. The projection approximation model 
underestimates the collision cross-section of proteins as interactions with the buffer 
gas are not taken into consideration (Jarrold 1999). More recent extensions to this 
model have been made to take these problems into account (Mesleh et al. 1996; 
Shvartsburg et al. 1996).  
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A modification of the projection approximation algorithm has also been developed 
by Dr. T. W. Knapman and Dr. J. T. Berryman et al. (formerly University of Leeds), 
termed the Leeds algorithm and is used in Chapter 2 and 3 of this thesis (Smith et al. 
2009; Knapman et al. 2010). The Leeds algorithm assigns atomic radii based on a 
PDB structure of the protein or protein complex of interest and a snapshot of the 
protein taken based on its projection in the x-y plane. An appropriately sized box is 
then drawn around the projected structure and the area of the structure that would 
theoretically collide with the buffer gas in the drift cell of the mass spectrometer 
calculated based on the ratio of hits to misses, where a hit represents an area of 
protein structure that can collide with the buffer gas and a miss an area where the 
projected structure is absent. The structure is then rotated and the procedure repeated 
until the cross-section over all possible orientations is calculated. This method has 
been used successfully for collision cross-sectional area calculations of the amyloid 
forming proteins, β2-microglobulin (Smith et al. 2010; Smith et al. 2011; Woods et 
al. 2011), in addition to virus capsids (Knapman et al. 2010; Shepherd et al. 2011).  
Molecular dynamics simulations in combination with collision cross-sections can 
provide additional structural information on the protein-protein interaction of 
interest. Indeed molecular dynamics simulations on the human amyloid forming 
protein, islet amyloid polypeptide (IAPP) showed that it adopts an expanded β-
hairpin conformation in contrast to the non-amyloid forming rat IAPP whose cross-
section matches more of an α-helical conformation (Dupuis et al. 2009). Molecular 
dynamics on large protein complexes is challenging and too computationally 
expensive for an atomistic approach. Therefore, molecular dynamics on large 
complexes is typically carried out by dividing each complex into its individual 
subunit components.   
 
MS is a good technique to study proteins and their complexes in solution. In 
particular, recent advances in IMS-MS have allowed structural information to be 
obtained on a large number of protein complexes in addition to information on 
subunit stoichiometry, binding affinity and subunit dynamics which were not 
possible by other biochemical techniques. 
 
27 
 
1.6 Thesis Overview 
 
There are three main objectives of the work presented in this thesis. Firstly, to use 
mass spectrometry to determine the mechanism of pilus assembly in Gram-negative 
bacteria. Secondly, to determine details of oligomeric intermediates of amyloid fibril 
formation for the protein beta-2 microglobulin. Thirdly, to combine a novel method 
for membrane protein solubilisation for structural analysis of membrane proteins by 
mass spectrometry.      
 
An introduction to the proteins of interest and current relevant mass spectrometry 
methods for analysis of these proteins is given at the start of each chapter. A 
description of all methods employed in this study and the material used, along with 
the references, are given at the end of each chapter. Chapter 2 includes the 
development of a mass spectrometry method to determine second order rate 
constants and its application to revealing insight into pilus assembly. In contrast to 
the carefully orchestrated pilus assembly process, Chapter 3 shows the application of 
IMS-MS to the study of the protein, beta-2 microglobulin, which assembles 
spontaneously into amyloid fibrils resulting in the disease, dialysis related 
amyloidosis. Chapter 4 includes the analysis of membrane proteins by mass 
spectrometry. All results are discussed together along with the future applications of 
mass spectrometry to protein analysis in the final remarks section.  
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2.1. Introduction 
Pilus Assembly 
 
2.1 Bacterial Secretion Systems 
Secretion systems are used by a variety of bacteria to transport proteins across their 
outer membranes. The secretion of virulence factors, such as toxins, and the 
assembly of adhesive organelles on the bacterial cell surface are crucial steps in the 
transmission of infection and hence are possible targets for anti-microbial reagents. 
Current successful antimicrobial agents target different microbial modes of action 
such as DNA replication or protein synthesis (Cegelski et al. 2008). Targeting these 
factors stimulates bacterial evolution due to the effect antimicrobial agents have on 
microbial survival. An alternative method of pathogenesis prevention is to target 
only the virulence properties of bacteria, for example the attachment of bacteria to 
host cells via hair-like appendages termed pili. In this way, microbes can still survive 
but no longer infect the host, and hence problems with antibiotic resistance will be 
kept to a minimum.   
 
The general secretory pathway (GSP) involves the translocation of proteins across 
the cytoplasmic membrane via the sec machinery, and the assembly of these proteins 
into pili on the bacterial surface using a specific secretion apparatus (Stathopoulos et 
al. 2000). This thesis focuses on one type of GSP, the chaperone-usher pathway, that 
assembles over 30 adhesins each associated with a specific disease (Hung et al. 
1998; Sauer et al. 2000).  
 
2.1.1 Chaperone-usher pathway 
The two widest researched chaperone-usher systems are the Type 1 pilus and the P 
pilus from uropathogenic Escherichia coli, encoded for by the fim and pap gene 
clusters, respectively (Hull et al. 1981; Sauer et al. 2004).
 
P pili and Type 1 pili are 
involved in pyelonephritis and cystitis respectively, and their transmission is highly 
dependent on the conserved subunits’ order and number in the final pilus structure 
(Wiles et al. 2008).   
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P pili are assembled by the PapD chaperone and the PapC usher, and consist of six 
subunits of 2 nm in diameter (PapG, PapF, PapE, PapK, PapA, PapH) arranged in a 
specific order (Figure 2.1.1) (Dhakal et al. 2009). PapG has an adhesion domain 
(PapGadhesin) and a pilin domain (PapGpilin) is the first subunit translocated across the 
outer membrane. This adhesin binds to host tissues, via a di-galactose binding 
domain, and initiates bacterial infection. In between the adapter subunits, PapF and 
PapK, is the major component of the tip fibrillum, PapE, which is present in five to 
ten copies (Kuehn et al. 1992). After the assembly of the flexible tip, thousands of 
PapA subunits translocate across the outer membrane and assemble into a rigid right-
handed helix (Mu et al. 2006). Finally, pilus assembly terminates by incorporating a 
single copy of PapH.  
 
 
 
Figure 2.1.1 – Schematic structure of P pili (left) and Type 1 pilus (right) assembled on the outer 
membrane.  In P pilus (Pap) subunits are labelled A (yellow), K (green), E (blue), F (orange), G (red) 
and H (light blue), the chaperone D (brown) and the usher C (grey).  In Type 1 pilus (Fim) the 
subunits are labelled A (yellow), F (green), G (orange) and H (red), the chaperone C (brown) and the 
usher D (grey) (Figure adapted from (Leney et al. 2011). Both PapG and FimH contain both an 
adhesion and pilin domain. 
 
41 
 
Type 1 pili have only four subunits (FimA, FimF, FimG, FimH) and are assembled 
by a chaperone, FimC and the usher, FimD. FimA subunits fold into a similar helical 
rod to those of PapA in P pili; however the tip fibrillum is shorter (Jones et al. 1995), 
consisting of an adhesion domain, FimH, and adaptor subunits FimF and FimG 
(Figure 2.1.1). 
 
2.1.2 Role of the Periplasmic Chaperone 
Periplasmic chaperones play an important role in the chaperone-usher pathway. The 
chaperone was first thought to have a role in the chaperone-usher pathway when its 
high sequence identity among Gram-negative pathogens was observed (Hung et al. 
1996). In 1989, the first X-ray structure of the PapD chaperone was solved, showing 
PapD consisted of two immunoglobulin domains positioned at right angles to each 
other (Figure 2.1.2) (Holmgren et al. 1989). The chaperones all have a conserved, 
characteristic hydrophobic core and a series of hydrophobic residues on the surface-
exposed G1 strand.  
 
 
 
Figure 2.1.2 - Crystal structure of PapD chaperone (PDB file 3DPA) (Holmgren et al. 1989). The 
hydrophobic residues (L103, I105, L107) on the G1 strand (red) and the basic residues (R8 and K112) 
(magenta) are conserved between all pilus related chaperones. Structure drawn using Pymol (DeLano 
2002).  
 
 
F1 strand 
G1 strand 
  R8 
 K112 
   L103 
 I105 
 L107 
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2.1.3 Chaperone-subunit complexes 
All pilus subunits alone fold into a structure with an Ig-like fold, but the C-terminal 
β-strand of the typical Ig domain is lacking. These pilus subunits, therefore, are 
unstable and prone to aggregation. During the chaperone-usher pathway pilus 
subunits are stabilised by binding to a periplasmic chaperone, preventing them from 
degradation by proteases such as DegP (Bakker et al. 1991). This mechanism, 
known as donor strand complementation (DSC), results in a stable chaperone-
subunit interaction whereby the chaperone’s hydrophobic G1 strand is inserted into 
the subunit’s hydrophobic pocket (Figure 2.1.3a). The first evidence of DSC was 
found in the crystal structure of FimCFimH (Knight et al. 1997) and was further 
supported by the following PapDPapK, PapDPapH, PapDPapE, PapDPapF and 
PapDPapA chaperone-subunit crystal structures from P pilus (Sauer et al. 1999; 
Sauer et al. 2002; Verger et al. 2006; Verger et al. 2007; Verger et al. 2008). In each 
case specific chaperone residues, named P1-P4, insert into the subunits’ P1-P4 
hydrophobic pockets (Figure 2.1.3b). 
 
                 
 
Figure 2.1.3 - a) Topology diagram of chaperone G1 strand (red) bound to a subunit (blue) showing 
residues P1-P4 fitting into pockets P1-P4 (the empty P5 pocket is also shown). The subunit also has 
an N-terminal extension (not shown) that extends from the A1 strand. b) Crystal structure of the 
chaperone PapD (red) bound to the PapE subunit (blue) with P1-P4 residues of the chaperone 
indicated as ball-and-stick structures (PDB file 1N01) (Sauer et al. 2002). Structure drawn using 
Pymol (DeLano 2002). 
 
 
(b) (a) 
P5 pocket 
N-terminus 
C-terminus 
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2.1.4 Subunit-subunit complexes 
All pilus subunits have an N-terminal extension (Nte) made up of alternating 
hydrophobic residues. This is absent in the X-ray crystal structure due to its 
disordered nature, but plays a vital role in subunit-subunit interactions. Figure 2.1.4 
shows the crystal structure of PapE bound to KNte (a peptide representing the Nte of 
PapK subunit). As expected, due to the similarity in alternating hydrophobic 
residues, the Nte binds into the same hydrophobic groove (this time, using the P1-P5 
pockets) on the subunit as the chaperone’s G1 strand does during DSC. In this case 
the Nte aligns antiparallel to the F strand (unlike the chaperone G1 strand) in an 
interaction known as donor strand exchange (DSE).  
 
               
Figure 2.1.4 - (a) Topology diagram of PapKNte (red) bound to a PapENtd subunit (blue) showing 
residues P1-P5 fitting into pockets P1-P5; (b) Crystal structure of a DSE complex with PapENtd (blue) 
bound to KNte (red).  (PDB file 1N12) (Sauer et al. 2002). PapENtd is a version of PapE in which the 
Nte is deleted to prevent self-polymerisation of PapE subunits in solution. The structure was drawn 
using Pymol (DeLano 2002). 
 
 
2.1.5 The donor strand exchange (DSE) mechanism 
At the usher, chaperone-subunit complexes undergo a mechanism termed donor 
strand exchange (DSE) resulting in the formation of the final subunit-subunit 
complex and its translocation across the outer membrane. During DSE, the 
chaperone’s G1 strand in the chaperone-subunit complex is gradually replaced, 
(a) (b) 
N-terminus 
N-terminus 
C-terminus 
C-terminus 
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residue by residue with the N-terminal extension of an incoming subunit in a zip-in-
zip-out mechanism.  
 
Mass spectrometry, in combination with other biochemical techniques has been used 
to follow this DSE mechanism in detail (Remaut et al. 2006; Rose et al. 2008; Rose 
et al. 2008; Verger et al. 2008). Mass spectrometry experiments by Rose et al. set 
out to test how thousands of structurally similar subunits could assemble in the 
precise order and number essential for pilus function (Rose et al. 2008). Since the 
subunit specificity was thought to be determined by the pilus subunits themselves 
(Lee et al. 2007), all 25 possible DSE reactions between chaperone-subunit 
complexes (PapD bound to PapG, PapF, PapE, PapK, PapA) and subunit Ntes were 
carried out, and their observed reaction rates determined (Rose et al. 2008). On 
comparison of the DSE rates of reaction, it was seen that cognate reactions (i.e. those 
observed in vivo) occur at higher rates than their non-cognate counterparts. It was 
concluded, therefore, that each subunit groove interacts differently with different 
Ntes, hence the Nte must impart some specificity to the DSE reaction. 
 
By comparing the different subunit Nte sequences, shown in Figure 2.1.5, it is not 
obvious how this subunit specificity is conferred. Further detailed MS experiments 
using chimeric peptides showed that the residues on the Nte at, and around, the P5 
pocket (i.e. residues P5-1, P5, P5+1 and P5+2) are the most important in determining 
the DSE reaction rate (Rose et al. 2008). Further kinetic analysis of peptides with 
mutations in these residues were needed to gain an insight into the precise role of 
individual residues on the subunit Nte in conferring specificity in the DSE 
mechanism; the results of these experiments will be discussed further in this Chapter. 
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Figure 2.1.5 - Subunit Nte sequences of PapX subunits with P2-P5 residues highlighted in red. The 
black rectangles indicate the section of the Nte used in DSE experiments by Rose et al. 2008.  
 
 
 
2.1.6 Additional factors that may contribute to subunit specificity 
Although the N-terminal extension on the incoming subunit alone contributes to the 
subunit ordering in pilus biogenesis, this is not the only factor thought to be involved 
as DSE occurs in minutes in vivo at the usher without an external energy source 
(Jacob-Dubuisson et al. 1994) as opposed to the hour timescale observed with in 
vitro experiments (Rose et al. 2008). Indeed simulations using simple mathematical 
models showed that using the pseudo first order rates of DSE obtained using 
peptides equivalent to the Nte, a correct assembled pilus would be unlikely to occur 
(E. Paci, R. J. Rose, S. E. Radford, A. E. Ashcroft, unpublished data). 
 
One major component absent in the in vitro studies described above is the outer 
membrane usher. More recent studies have, therefore, concentrated on the usher and 
the role it may have in pilus subunit specificity and DSE catalysis. Studies of the 
usher are described in the second part of this chapter. 
 
 
2.1.7 Role of the Outer Membrane Usher in DSE 
The usher protein is crucial for the translocation of pilus subunits across the bacterial 
outer membrane, since on deletion of the membrane usher, chaperone-subunits 
accumulate in the periplasm, and no pili form (Klemm et al. 1990). Cryo-electron 
 GPFPPPGMSLPEYWGEEHVWWDGRAAFHGEVVRPAC  HNte 
APTIPQGQGKVTFNGTVVDAPC  ANte 
SDVAFRGNLLDRPC  KNte 
VDNLTFRGKLIIPAC  ENte 
DVOINIRGNVYIPPC  FNte 
 P4  P5  P2  P3 
 P5-1  P5+1 
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microscopy and other biophysical studies have shown that the usher outer membrane 
protein is a dimer, consisting of two monomers connected by detergent molecules 
(Li et al. 2004; Ng et al. 2004; So et al. 2006; Remaut et al. 2008); however, it has 
been suggested that only one usher is needed for function (Huang et al. 2009).  
 
How pilus assembly at the usher occurs without an external energy source, e.g., 
ATP, is fascinating (Jones et al. 1993). The energy needed to drive the self-assembly 
process is thought to come from the difference in stabilities between the chaperone-
subunit and the subunit-subunit interactions (Zavialov et al. 2003). The subunit-
subunit complex adopts a more compact conformation compared with that of the 
chaperone-subunit complex. It is thought that the chaperone traps the subunit in a 
higher energy, partially folded state, which then collapses on binding an Nte to form 
a lower energy, more compact structural arrangement (Zavialov et al. 2003). The 
increased stability obtained from this conformational change releases the free energy 
needed to drive pilus assembly (Zavialvo et al. 2005). 
 
The usher, both from P pilus and Type 1 pili, consists of four domains: an N-
terminal domain (~125 residues) termed UsherN, a middle plug domain (residues 
~220 to ~325), termed UsherP, surrounded by a central β-barrel domain (residues 
~135 to ~640), and a C-terminal domain (residues ~638 to ~809) termed UsherC 
(Figure 2.1.6) (Brandenburg et al. 2005; Capitani et al. 2006; Bleiholder et al. 2011). 
Together the usher domains act to catalyse DSE and to thread the pilus subunits one 
by one through the usher β-barrel until the final pilus is formed. 
 
 
 
 
Figure 2.1.6 - Usher domains: N-terminal domain (blue, UsherN); plug domain (pink, UsherP); β-
barrel domain (black); C-terminal domain (green, Usher C1 and Usher C2).  
 
 
The periplasmic N-terminal domain of the usher is thought to be the initial binding 
site for chaperone-subunit complexes prior to DSE and pilus biogenesis (Ng et al. 
2004). The differential affinity of chaperone-subunit complexes for the usher’s N-
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terminal domain matches the order in which the subunits are translocated (Dodson et 
al. 1993). It has been suggested that this difference in affinity partly explains how 
the tip subunit, PapG, binds preferentially to the usher over PapA, which is present at 
a significantly higher concentration than all other pilus subunits combined in the 
periplasm (Ahn et al. 2004). Additional evidence from X-ray crystallography shows 
UsherN to bind predominantly to the N-terminal domain of the chaperone and partly 
to the chaperone-bound subunit in the FimDNFimCFimHpilin (UsherN-chaperone-
subunit) complex (Nishiyama et al. 2005) (Figure 2.1.7). This binding of the 
chaperone-subunit complexes to UsherN is thought to catalyse DSE by positioning 
the incoming chaperone-subunit complex in close proximity to the preceding 
chaperone-subunit complex (Remaut et al. 2008). 
 
 
 
 
Figure 2.1.7 – Crystal structure of the chaperone-subunit complex, FimCFimHpilin (brown-red) bound 
to the N-terminal domain of the Usher, FimD (blue) (PDB file 1ZE3) (Nishiyama et al. 2005). 
FimHpilin corresponds to FimH where the adhesion domain has been removed. The structures were 
drawn using Pymol (DeLano 2002).  
 
 
Prior to pilus biogenesis, the usher’s plug domain resides inside the usher’s β-barrel 
preventing the passage of solutes or periplasmic proteins across the channel (Remaut 
et al. 2008; Phan et al. 2011) (Figure 2.1.8A). Upon binding of the first chaperone-
subunit complexes to the N-terminal domain, the usher β-barrel undergoes a 
conformational change resulting in the plug being released from the β-barrel 
(Saulino et al. 1998; Bayburt et al. 2010; Aminlashgari et al. 2012; Bechara et al. 
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2012) (Figure 2.1.8b). Once the usher is activated, the plug remains in the periplasm 
and here it is thought to play an additional role in donor strand exchange catalysis 
(Huang et al. 2009).   
 
 
 
 
 
Figure 2.1.8 (a) Crystal structure of the inactivated outer membrane usher, FimD (PDB file 3OHN) 
(Phan et al. 2011) showing the plug domain (pink) located inside the barrel (black). The N-terminal 
and C-terminal domains were deleted in this construct. (b) Crystal Structure of the chaperone-subunit 
complex FimCFimH (brown-red) translocating the FimD usher (PDB file 3RFZ) (Phan et al. 2011). 
The N-terminal domain, plug, β-barrel and C-terminal domain of the usher are highlighted in blue, 
pink, black and green respectively. The structures were drawn using Pymol (DeLano 2002).   
 
 
 
After the chaperone-subunit complex has bound to UsherN and the plug is released 
from the β-barrel, the chaperone-subunit complex is passed (directly or indirectly) to 
the C-terminal domain, either during or after DSE (Aminlashgari et al. 2012) (Figure 
2.1.7b). The exact function of the usher’s C-terminal domain in pilus biogenesis is 
unknown; however, it is crucial in pilus formation since on deletion of the C-
terminal domain no pilus biogenesis occurs (Huang et al. 2009). Recent studies have, 
however, suggested a role in subunit discrimination for UsherC (Ahn et al. 2004) in 
addition to a potential role in usher activation (Saulino et al. 1998). 
 
(b) (a) 
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Altogether, there are still key questions remaining about how the usher catalyses 
pilus biogenesis and how it discriminates between different pilus subunits to result in 
the correct ordering of subunits in the final macromolecular pilus structure. This 
thesis aims to characterise further the binding of chaperone-subunits to different 
usher domains from P pilus. Mass spectrometry has been used to detect the different 
chaperone-subunit-usher interactions and measure any potential differences in their 
gas phase stabilities. In addition, ion mobility spectrometry-mass spectrometry, in 
combination with molecular modelling, has been used to try and predict the binding 
interface of chaperone-subunit-usher interactions that have not been characterised 
previously by other biophysical methods. 
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2.2. Results and Discussion 
Pilus Assembly 
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2.2.1 Monitoring Donor-Strand Exchange by ESI-MS 
Pilus donor strand exchange has been studied by a variety of biochemical techniques 
including cation exchange chromatography (Vetsch et al. 2006), SDS-PAGE (Sauer 
et al. 2002; Barnhart et al. 2003; Remaut et al. 2008) and fluorescence based assays 
(Nishiyama et al. 2010). Analysis of the precise mechanistic details of pilus 
biogenesis by these methods is challenging due to difficulties analyzing these 
complex multi-component systems. Mass spectrometry is an ideal technique to study 
protein complexes within a multi-complex system since each component can be 
separated by its unique m/z. Throughout this chapter, an ESI-MS method based on 
previous ESI-MS experiments (Remaut et al. 2006; Rose et al. 2008; Rose et al. 
2008; Verger et al. 2008) was used to measure second order rate constants of DSE 
and to determine factors affecting the rates of DSE during pilus biogenesis.  
 
The PapDhisPapENtd and PapDhisPapHNtd1 complexes used in the first part of this 
chapter were expressed and purified by a combination of Denis Verger, Gilles Phan, 
William Allen (Birkeck College, London) and myself (Materials and Methods 
Section 2.4.8). A typical example of the protein purification for the chaperone-
subunit complexes is shown for PapDhisPapENtd in Figure 2.2.1. All chaperone-
subunit complexes were expressed periplasmically (Materials and Methods Section 
2.4.8). A single peak eluted off the nickel affinity column in all cases corresponding 
to a mixture of dissociated PapDhis and the non-covalent PapDhisPapENtd complex 
(Figure 2.2.1A). Any dissociated PapDhis was further removed by cation exchange 
chromatography (Figure 2.2.1B). The final purity of the chaperone-subunit complex 
was confirmed by SDS-PAGE (Figure 2.2.1C) and the molecular weight determined 
using ESI-MS (Materials and Methods Section 2.4.3).   
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Figure 2.2.1 – Protein purification of the chaperone-subunit complex, PapDhisPapENtd. A) Metal 
affinity chromatography showing PapDhisPapENtd and PapDhis eluting off the column on increasing the 
concentration of imidazole; B) Cation exchange chromatography showing on decreasing ammonium 
sulphate concentration the free chaperone, PapDhis, is separated from the PapDhisPapENtd complex; C) 
SDS-PAGE showing the periplasmic fraction before purification and the final pure PapDhisPapENtd 
complex.  
 
 
ESI-MS conditions were initially optimised using a LCT Premier (nano-ESI Tof 
MS) for detection of all chaperone-subunit complexes. The LCT Premier offers 
increased sensitivity over the Q-Tof (previously used in (Remaut et al. 2006), (Rose 
et al. 2008) and (Verger et al. 2008)) and hence is a more sensitive instrument for 
analysis of DSE reactions. Optimum pH, buffer concentration, chaperone-subunit 
concentration and MS ionisation conditions were chosen to minimise salt adduct 
formation and increase the signal to noise ratio. Additional electron microscopy 
(EM) experiments were carried out to determine if pilus donor strand exchange is 
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possible in the volatile buffer used. Pili self-assembled from the intact chaperone-
subunit complex PapDPapEV56E were observed on incubation alone overnight at 
room temperature and a concentration of 20 µM in ammonium acetate buffer at pH 
6.0 (the mutation on PapE was designed for other experiments to prevent interaction 
with the usher and is not thought to affect the DSE properties of PapDPapE) (Figure 
2.2.2).  
 
 
 
Figure 2.2.2 – Negative stain electron microscopy image of PapDPapEV56E fimbriae formed in 100 
mM ammonium acetate pH 6.0, 22 ºC. The scale bar represents 200 nm. 
 
  
The non-covalent ESI (m/z) mass spectrum of the chaperone-subunit complex, 
PapDhisPapENtd, is shown in Figure 2.2.3. Since the PapDPapE chaperone-subunit 
complex can undergo DSE with itself, a truncated PapE construct was used in which 
the entire Nte was removed, creating the construct PapENtd (Sauer et al. 2002) 
(Section 2.4.8.1). This construct has been shown previously to be a good model for a 
donor-strand acceptor (Sauer et al. 2002; Verger et al. 2007). ESI-MS analysis of the 
PapDhisPapENtd complex showed a narrow charge state distribution suggesting the 
non-covalent chaperone-subunit complex has been preserved on transition into the 
gas phase. A small amount of dissociated chaperone, PapDhis is also observed which 
is present in solution (Rebecca Rose – PhD Thesis, University of Leeds, 2008). Very 
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little PapENtd is observed in the m/z spectrum suggesting the chaperone, PapDhis may 
ionise preferentially to the subunit PapENtd during electrospray ionization.  
 
 
 
 
Figure 2.2.3 – ESI-MS spectrum of chaperone-subunit complex, PapDhisPapENtd in 5 mM ammonium 
acetate pH 6.0. Peaks corresponding to PapDhisPapENtd (DE), PapDhis (D) and PapENtd (E) are shown 
in blue, red and purple respectively. 
 
 
To test the new parameters and the different instrument conditions for 
reproducibility with previous work published on the specificity and pseudo first 
order rates of donor strand exchange (Rose et al. 2008), a donor strand exchange 
(DSE) reaction between the chaperone-subunit complex, PapDhisPapENtd and the N-
terminal extension of PapE, termed ENte, was monitored using nanoESI-MS. This 
chaperone-subunit complex, PapDhisPapENtd, was chosen for the study since it is the 
fastest chaperone-subunit complex to undergo DSE in vitro (Rose et al. 2008). The 
Nte peptide, ENte, was used to mimic the Nte of the full length subunit, PapE. This 
assumption is thought to be valid since the subunit’s Nte is thought to act 
independently from the subunit to which it is bound (Lee et al. 2004; Lee et al. 
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2007). The sequence used for the ENte is shown below in Table 2.2.1. Note that two 
lysine residues were added C-terminally to increase solubility. 
 
 
Peptide Peptide Sequence 
ENte VDNLTFRGKLIIKKamide 
Table 2.2.1 – Peptide sequence used to model DSE reaction between chaperone-subunit complex 
PapDhisPapENtd and pilin subunit PapENtd1. KKamide was also added C-terminally to the peptide to 
increase its solubility. 
 
 
The ESI-MS spectra aquired 1, 5 and 24 h after initiating DSE at room temperature, 
in 5 mM ammonium acetate pH 6.0, by addition of peptide ENte (25 µM) to the 
chaperone-subunit complex, PapDhisPapENtd (250 µM) are shown in Figure 2.2.4. As 
the reaction goes to completion, the peaks corresponding to PapDhisPapENtd decrease 
in intensity as the products PapENtdENte and PapDhis are formed. Small amounts of 
the reaction intermediate, PapDhisPapENtdENte, is also observed. A control experiment 
whereby PapDhisPapENtd alone was incubated under identical conditions remained 
the same after 24 h of incubation at room temperature, indicating the changes in the 
mass spectra in Figure 2.2.4 are due to the DSE reaction between PapDhisPapENtd and 
ENte (data not shown). 
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Figure 2.2.4 – Mass spectra of DSE reaction between PapDhisPapENtd (DE) and ENte after 1 hour (top), 
5 hours (middle) and 24 hours (bottom). PapDhisPapENtd (DE - blue) decreases with time and PapDhis 
(D - red), PapENtdENte (EE - green), PapENtd (E - purple) increase. Small amounts of PapDhisPapENtdE-
Nte intermediate (DEE - pink) also can be observed. The charge states observed for each species are 
shown in the top spectrum.  
 
 
Free PapENtd is seen to increase in intensity in the mass spectra throughout the 
reaction time course with ENte suggesting it is a product of DSE. One possible reason 
for this is the dissociation of the PapENtdENte reaction product in the gas phase. 
Indeed if MS source ionisation conditions are lowered (less energy available for 
sample ionisation), the PapDhis and PapENtd dissociation products decrease in 
intensity and the intensity of the PapENtdENte product increases (Figure 2.2.5). Even 
at the lowest ionisation conditions used, cone voltage 30 V, source temperature 30 
ºC, ion energy 80 V and capillary voltage 1.6 kV, PapENtd is still observed in the 
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spectrum, hence it is possible that dissociation is occurring in solution. Further 
experimental evidence is needed for a firm conclusion but experiments were 
continued based on the supposition that product dissociation occurs in the MS 
ionisation source, and hence that the dissociated products formed do not affect the 
rate of DSE. Indeed, in support of this assumption, collision induced dissociation 
(CID) experiments have shown subunit-subunit complexes to be less stable in the 
gas phase than all chaperone-subunit complexes (Rebecca Rose – PhD Thesis, 
University of Leeds, 2008).   
 
 
 
 
Figure 2.2.5 – Mass spectra of the DSE reaction between PapDhisPapENtd after 112 hours. Low energy 
ionisation conditions (cone voltage 30 V, source temperature 30 ºC, ion energy 80 V, capillary 
voltage 1.6 kV) were used in the top spectrum, higher energy ionisation conditions (cone voltage 70 
V, source temperature 60 ºC, ion energy 100 V, capillary voltage 1.75 kV) in the bottom spectrum. 
The intensity of peaks corresponding to PapENtdENte (EE, green) increases on lowering the energy of 
the ESI source conditions, while the intensity of peaks corresponding to PapDhis (D, red) and PapENtd 
(E, purple) decrease (compared with the higher energy ESI source conditions). Small amounts of 
PapDhisPapENtd (DE, blue) are also shown. Since dissociation of PapENtdENte occurs in both spectra, 
the higher energy ionisation conditions were chosen for use in all subsequent MS experiments. 
 
 
The mass spectral data shown in this thesis are comparable to the ESI-MS results 
published by Rose et al. 2008 indicating the newly optimized MS conditions can be 
used for comparison with previous pilus DSE MS data (Rose et al. 2008). 
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2.2.2 Determining Second Order Rate Constants by ESI-MS 
Previous mass spectrometry methods used to monitor pilus assembly have provided 
observed rates of the donor strand exchange reaction, only comparable within an 
experiment (Remaut et al. 2006; Rose et al. 2008). A method was developed to 
determine quantitatively second order rate constants for DSE. This method allows 
rate constants independent of initial reactant concentration to be determined, 
allowing a more accurate and quantitative comparison of the reactivity of chaperone-
subunit complexes with different N-terminal extension peptides. 
 
 
2.2.3 Quantification of ESI-MS data 
The initial concentration of chaperone-subunit and peptide can be measured 
experimentally (see Sections 2.4.12 and 2.4.3 respectively). Exact quantification by 
ESI-MS during the DSE reaction is challenging due to the difference in ionisation 
properties of proteins of comparable molecular weights. Mass spectrometry is an 
ideal technique for the detection of multiple components in solution allowing the 
relative change in populations within a complex mixture to be determined. Providing 
the ion intensity measured directly correlates with concentration, quantitative kinetic 
analysis by ESI-MS is possible.  
 
To ensure that the relative ion intensity of the chaperone-subunit complexes 
correlates with chaperone-subunit concentration in solution, and that the 
concentration used is in the linear range of the detector, an internal standard was 
added to the reaction mixture. Internal standards are commonly used in mass 
spectrometry to increase the reproducibility and precision of data between 
consecutive data acquisitions, and to highlight any instrumental problems occurring. 
The chaperone-subunit complex, PapDhisPapHNtd1, was chosen as an internal 
standard due to its inability to undergo DSE (Verger et al. 2006) (Section 2.2.6). A 
stable PapH construct, referred to as PapHNtd1, was used whereby the proline-rich N-
terminal region of the Nte, known not to be involved in DSE and potentially 
responsible for insolubility and non-specific aggregation of the subunit, was 
removed (Verger et al. 2006) (Section 2.4.8.1). PapDhisPapHNtd1 is an ideal internal 
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standard since it is structurally similar to all other chaperone-subunit complexes, and 
hence it can be assumed that its ability to undergo ionisation is similar to that of 
other chaperone-subunit complexes.   
 
 
   
 
 
Figure 2.2.6 – Mass spectrum of 4 μM PapDhisPapENtd (DE, blue) and 2.5 μM PapDhisPapHNtd1 (DH, 
orange) in 5 mM ammonium acetate pH 6.0, room temperature. Dissociated products PapDhis (D from 
PapDhisPapENtd and D* from PapDhisPapHNtd1, red), PapENtd (E, purple) and PapHNtd1 (H, yellow) are 
shown. The difference in molecular weight between D and D* is the addition of a GS linker between 
the C-terminus of PapD and the his-tag present in the PapDhisPapHNtd1 construct.    
 
 
Mass spectra were acquired for the chaperone-subunit complex, PapDhisPapENtd, at 
concentrations (0.4 μM-3.6 μM), containing a fixed PapDhisPapHNtd1 concentration 
(4 μM). Figure 2.2.6 shows an example of one of the resulting spectra with charge 
state distributions corresponding to PapDhisPapENtd and PapDhisPapHNtd1 labelled in 
blue and orange, respectively. Additional peaks correspond to PapDhis, PapENtd and 
PapHNtd1 and are a result of PapDhisPapENtd and PapDhisPapHNtd1 dissociation.   
 
The relative ion intensities for the charge states corresponding to the chaperone-
subunit complexes PapDhisPapENtd and PapDhisPapHNtd1, respectively, were summed 
and plotted as a ratio (relative protein response) against PapDhisPapENtd 
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concentration (Figure 2.2.7). The data are linear over the concentration range used. 
Data for PapDhisPapENtd concentrations below 0.75 μM deviate slightly from the line 
due to inaccuracies in measuring peak areas when the signal reaches the noise level 
in the instrument. Data obtained for chaperone-subunit concentrations below 0.75 
μM, therefore, were discarded in future DSE experiments.    
 
 
 
Figure 2.2.7 – Linearity of relative protein response as a function of concentration. The intensity of 
chaperone-subunit (PapDhisPapENtd) peaks in the mass spectrum relative to the intensity of the internal 
standard (PapDhisPapHNtd1) as a function of the chaperone-subunit (PapDhisPapENtd) concentration is 
plotted.  The conditions of the experiment are as shown in Figure 2.2.5. 
 
 
One common problem in ESI-MS is ion suppression. Ion suppression is caused when 
less volatile species change the efficiency of droplet formation or evaporation, which 
in turn prevents less charged ions entering the gas phase and reaching the detector 
(Annesley 2003). Concern was raised as to whether the large excess of peptide added 
in DSE experiments would affect the relative ion intensity of PapDhisPapHNtd1 and 
PapDhisPapENtd, and whether their ionisation levels would be significantly reduced to 
levels close to the noise in the instrument.    
 
61 
 
To test this possibility, the intensity ratio of PapDhisPapENtd to the PapDhisPapHNtd1 
was monitored on addition of various concentrations of raffinose.  Raffinose, a 
trisaccharide composed of glucose, galactose and fructose (Figure 2.2.8), is 
commonly used as an internal standard in MS. Raffinose was used since it ionises 
easily by ESI, it does not interact with any chaperone-subunit complex, and most 
importantly it is small enough in molecular weight to avoid analysis problems such 
as overlapping peaks in the mass spectra. 
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Figure 2.2.8 – Raffinose structure (average molecular weight = 504.42 Da) used to monitor ion 
suppression during ESI-MS.  
 
 
Mass spectra of PapDhisPapENtd and PapDhisPapHNtd1 on addition of raffinose at 
concentrations 15 µM and 30 µM are shown in Figure 2.2.9. Peaks corresponding to 
PapDhisPapENtd (DE, blue) and PapDhisPapHNtd1 (DH, orange) remain at a constant 
ion intensity ratio of 1:1 independent of raffinose concentration. The total ion count 
(TIC) for each spectral acquisition also remained approximately constant (Figure 
2.2.9), proving the addition of raffinose does not suppress the ionisation of 
PapDhisPapENtd or PapDhishisPapHNtd1. 
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Figure 2.2.9 – Mass spectra for 2.5 μM PapDhisPapENtd (DE – blue) and 2.5 μM PapDhisPapHNtd1 (DH 
– orange) on addition of raffinose at concentrations 15 μM (top) and 30 μM (bottom). Raffinose peak 
labelled corresponds to its sodium adduct (m/z 527). All peaks are colour coded as in Figure 2.2.6.  
TIC = total ion count (aquired over one minute in each case).  
 
 
Addition of raffinose concentrations up to 50 μM did not affect the PapDhisPapENtd 
to PapDhisPapHNtd1 ratio (Table 2.2.2). Altogether, these ESI-MS experiments show 
that chaperone-subunit concentration can be measured quantitatively by ESI-MS by 
comparison of the chaperone-subunit intensity of interest with the internal standard 
(PapDhisPapHNtd1), if the correct experimental conditions are used.   
 
Raffinose 
Concentration (μM) 
PapDhisPapENtd intensity / 
PapDhisPapHNtd1 intensity 
3.18 0.96 
3.75 0.92 
6.25 0.92 
7.50 0.89 
12.5 0.91 
15.0 1.02 
25.0 0.96 
30.0 0.98 
50.0 1.03 
Table 2.2.2 - The effect of increasing raffinose concentration on the PapDhisPapENtd to 
PapDhisPapHNtd1 ratio.  The intensity ratio is constant within 5% error, suggesting addition of a large 
excess of peptide with not effect the method for determination of chaperone-subunit concentrations. 
Note, a constant concentration of 2.5 μM was maintained for both chaperone-subunit complexes in 
this experiment (5 mM ammonium acetate pH 6.0, room temperature).  
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2.2.4 Derivation of second order rate constants 
Since the chaperone-subunit concentration can now be determined quantitatively 
throughout the DSE reaction through addition of an internal standard, 
PapDhisPapHNtd1, the second order rate constant rather than observed rate 
(determined from the relative loss of chaperone-subunit ions compared to all other 
ions in the mass spectrum) can be determined. 
 
The derived equation for the DSE rate constant was based on the assumption that one 
chaperone-subunit complex, PapDPapX, reacts with one Nte of an incoming subunit, 
XNte, to form a subunit-Nte complex, PapX-XNte, via a ternary intermediate, 
PapDPapX-XNte (Equation 2.1).  
  
                                                     Equation 2.1  
                          
For simplicity, the backward reaction rate constant, k-2, was assumed to be 
negligible.  This assumption is valid since chaperone-subunit complexes undergo a 
conformational change to a more compact, thermodynamically stable structure on 
transition to the subunit-peptide complex, causing the release of energy needed to 
drive pilus assembly (Jones et al. 1993; Zavialov et al. 2003; Zavialvo et al. 2005; 
Vetsch et al. 2006). In previous studies a transient chaperone-subunit-Nte 
intermediate was detected in the Saf pilus system (Remaut et al. 2006), a system 
closely related to Pap. In P pilus, this intermediate does not accumulate during the 
DSE reaction of P pili and hence is rarely observed in the mass spectra of DSE 
reactions (Rose et al. 2008). Once this PapDPapX-XNte intermediate complex forms, 
DSE must therefore occur rapidly in the Pap system suggesting that the binding of 
the Nte to the chaperone-subunit complex (k1) is the rate limiting step in the DSE 
reaction of P pili. Based on these assumptions, Equation 2.1 can be fitted to a second 
order rate equation from which the rate constants, k1 and k-1, can be determined 
(Equation 2.2). For this study, since no or very little DSE intermediate was observed 
(Rose et al. 2008) it can be assumed from Equation 2.1 that k2 >> k-1, and hence k-
1[PapDPapX-XNte] can be approximated to zero (Equation 2.3).  
 
k2 k1 
k-2 k-1 
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   PapDPap  
  
     PapDPap                                                  
 
   PapDPap  
  
     PapDPap                                                                               
                                                                                          
The above equation (Equation 2.3) can be integrated and rearranged in terms of 
chaperone-subunit concentration, [PapDPapX] (Equation 2.5) based on Equation 2.4 
that states that the decrease in the concentration of the chaperone-subunit complex is 
equal to the loss of Nte peptide over time, since one chaperone-subunit reacts with 
one peptide during DSE (See Appendix 1 for full derivation).  
 
            Nte 0     PapDPap  0              )                                uation   4    
                                                             
where   Nte 0 is the initial concentration and        is the concentration at time t. 
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where y is the dilution factor with the internal standard, PapDhisPapHNtd1, prior to 
mass spectral acquisition. 
 
All subsequent DSE experiments where the loss of chaperone-subunit complex with 
time is quantified can be fitted, therefore, to Equation 2.5 to determine an accurate 
second order rate constant, k1, for the DSE reaction studied. 
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2.2.5 Experimental determination of second order rate constants using MS 
To determine the rate constant of the DSE reaction between PapDhisPapENtd and ENte, 
ESI mass spectra were acquired over a time course of 7 h on addition of ENte to 
PapDhisPapENtd. A constant concentration of PapDhisPapHNtd1 was added 30 s prior to 
each spectral acquisition, to ensure all non-specific interactions between 
PapDhisPapHNtd1 and species in DSE reaction solution were kept to a minimum.   
 
 
Figure 2.2.10 – ESI mass spectra of the DSE reaction between PapDhisPapENtd and ENte after 1 h (top), 
3 h (middle) and 7 h (bottom). The charge state series of ions corresponding to PapDhisPapENtd, the 
internal standard PapDhisPapHNtd1, and the DSE products (PapENtd-ENte, PapDhis and PapENtd) are 
shown in blue, lilac and black respectively. The rate constant was measured from the decrease in 
intensity of the 11+, 12+, and 13+ ions originating from PapDhisPapENtd compared with the 12+, 13+ 
and 14+ ions of the internal standard.   
 
 
Initially, the predominant species are the chaperone-subunit complex, 
PapDhisPapENtd, and the internal standard, PapDhisPapHNtd1 (Figure 2.2.10). Small 
amounts of dissociated chaperone-subunit complex are also observed, equivalent to 
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less than 5% of the total protein concentration (determined by native PAGE, 
Rebecca Rose - PhD Thesis, University of Leeds, 2008). On addition of peptide Nte, 
the chaperone-subunit peaks decrease in intensity and the peaks relating to the 
chaperone and subunit-Nte DSE products increase relative to the internal standard, 
PapDhisPapHNtd1. The theoretical and experimental masses for all species observed 
are accurate to ± 0.05 % and are listed in the Materials and Methods Section 
2.4.14.3, Table 2.4.3. Since the internal standard intensity is assumed to remain 
constant throughout the DSE reaction, the DSE reaction rate was determined in real 
time as the DSE reaction proceeds, by fitting the decrease in 
PapDhisPapENtd:PapDhisPapHNtd1 ratio over time to the DSE rate equation (Equation 
2.5) (Figure 2.2.11).   
 
 
Figure 2.2.11 – The decrease of the normalized PapDhisPapENtd concentration (determined from the 
relative ion intensity of PapDhisPapENtd:PapDhisPapHNtd1) over time during a DSE reaction with ENte 
peptide. Only one repeat of the data is shown for simplicity, although to demonstrate reproducibility 
three repeats were performed and the errors between replicates reported in Table 2.2.3. 
 
 
The second order rate constant for the DSE reaction between PapDhisPapENtd and the 
peptide ENte was determined to be 0.32 M
-1
s
-1
 (Table 2.2.3). This is in reasonable 
agreement with the rate of 0.03 M
-1
s
-1 
reported by others for Fim pilus DSE using 
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cation exchange chromatography methods (Vetsch et al. 2006), taking into account 
for the difference in pilus system and that a ten-fold rate difference can be observed 
between different chaperone-subunit complexes and their corresponding cognate 
Ntes (Rose et al. 2008). The quantitative nanoESI-MS method described thus allows 
determination of second order rate constants for complex reactions with ease and an 
accuracy which can enable detailed analysis of the role of individual residues in 
controlling the rate and specificity of pilus assembly. On comparison to the previous 
method of DSE analysis by ESI-MS (Rose et al. 2008) a shorter time scale is also 
used. This reduces problems with chaperone-subunit dissociation, solvent 
evaporation and peak broadening which inevitably increase with time.   
 
 
2.2.6 The P5 residue in DSE is important in determining subunit specificity 
Previously, by using ENte and HNte-derived peptides in which the C-terminal five 
residues were swapped, it was shown that the C-terminal half of the Nte plays a 
crucial role in determining DSE rates (Rose et al. 2008). Based on studies of Saf 
DSE, it is thought that the P5 residue on the Nte fits tightly into the P5 pocket to 
initiate the unzipping of the chaperone’s G1 strand of the chaperone from the 
chaperone-subunit complex (Verger et al. 2008). On analysis of the crystal structure 
of the PapDPapH chaperone-subunit complex, the P5 pocket was found to be closed, 
explaining why PapDPapH does not undergo DSE and hence its role in terminating 
pilus biogenesis by anchoring the final pilus to the outer membrane (Verger et al. 
2008). It was predicted, therefore, that on substituting the P5 residue of ENte with a 
smaller residue (i.e. one that does not fit as well into the P5 pocket) the DSE rate 
would decrease. To investigate this possibility, the synthetic peptide equivalent to 
the N-terminal 12 residues of PapE (ENte) was resynthesised where the P5 residue 
was altered from leucine to valine or alanine (sequences shown in Figure 2.2.12), 
and the rate constant of DSE determined using the ESI-MS approach described 
above.         
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Figure 2.2.12 a) The decrease of the normalized PapDhisPapENtd concentration (determined from the 
relative ion intensity of PapDhisPapENtd:PapDhisPapHNtd1) over time during a DSE reaction with 
peptides ENte (blue), ENteL10V (red solid line) and ENteL10A (red dashed line). b) DSE rate constants 
for the same DSE reactions showing the standard error between triplicate measurements. The insert 
shows the peptide sequences used with the alternate hydrophobic residues in bold font and the residue 
substituted highlighted in red. 
 
 
The results show that substituting the Nte P5 residue to smaller residues decreases 
the rate of DSE significantly from 0.32 M
-1
s
-1
 for the wild-type ENte sequence to 0.10 
M
-1
s
-1
 and 0.09 M
-1
s
-1
 for the valine and alanine substituted peptides, respectively 
(Figure 2.2.12, Table 2.2.3). As predicted, the P5 residue fitted less tightly into the 
subunit’s P5 pocket, therefore, making DSE less likely to occur and thus the DSE 
rate constant was reduced for the DSE reactions between PapDhisPapENtd and the P5 
substiuted peptides. The DSE rate constants for PapDhisPapENtd reaction with 
ENteL10V and ENteL10A are comparable suggesting that once the P5 residue is small 
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enough not to fit tightly into the P5 pocket, making it even smaller does not affect 
the DSE rate further.  This was surprising since a clearer effect on DSE rate was 
observed for the SafA-SafB complex on the altering the size of the P5 residue 
(Remaut et al. 2006). Altogether, the results support the view that the P5 residue of 
the Nte in the incoming subunit is a critical determinant of the rate of DSE. 
 
Peptide 
Residue 
Substituted 
Rate Constant, 
logk (µM
-1
s
-1
) 
Rate Constant, k 
(M
-1
s
-1
) 
ENte None -6.49 ± 0.06 0.32 (+ 0.05, - 0.04) 
ENteL10V P5 -7.00 ± 0.24 0.10 (+ 0.05, - 0.03) 
ENteL10A P5 -7.05 ± 0.17 0.09 (+ 0.07, - 0.04) 
Table 2.2.3 - Second order rate constants (pH 6.0, 22 ºC) between PapDhisPapENtd and the substituted 
peptides ENteL10V and ENteL10A. Rate constants are displayed in terms of logk and the derived rate 
constant, k. The standard error between triplicate DSE reactions are shown. 
 
 
2.2.7 The P5+1 and P5-1 residues modulate the rate of DSE  
The complementarity between subunit grooves and Ntes that imparts specificity to 
DSE, is thought to contribute to the correct incorporation of subunits into the 
growing pilus fibre (Rose et al. 2008). The C-terminal half of the Nte (P5-1, P5, 
P5+1, P5+2 residues) has been shown to be the more important in determining the 
rate of DSE, with docking of the P5 residue into the P5 pocket initiating DSE (Rose 
et al. 2008; Verger et al. 2008). The role of the P5-1 and P5+1 residues in DSE, 
however, has not been determined. Although the side-chains of the P5+1 and P5-1 
residues are directed away from the subunit’s hydrophobic groove in the crystal 
structure of the DSE product (Figure 2.2.13) (Sauer et al. 2002), these residues, 
nonetheless, could play a role in the progress of the DSE reaction and thus be 
important determinants of subunit specificity. 
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Figure 2.2.13 - Structure of the subunit-Nte DSE product, PapENtdENte (blue-pale blue). The structure 
was modelled based on the PapENtdKNte crystal structure (PDB 1N12) (Sauer et al. 2002) with 
residues from KNte substituted with the corresponding residues in ENte. The P5-1, P5 and P5+1 
residues are highlighted in orange, red and green, respectively.  
 
 
To investigate the potential role of the P5-1 and P5+1 residues in determining the 
rate of DSE, ENte peptides were designed in which these residues were substituted 
individually with alanine in the variants ENteK9A and ENteI11A, respectively (Figure 
2.2.13) and the rate of DSE with PapDhisPapENtd was determined using these 
peptides by the ESI-MS approach described above. Substituting at the P5+1 position 
to alanine had a surprising effect on the rate constant of DSE with PapDhisPapENtd 
with a 3-fold decrease in second order rate constant observed from 0.32 M
-1
s
-1
 for 
the wild type ENte to 0.12 M
-1
s
-1
 on substitution from isoleucine to alanine at the 
P5+1 position (Figure 2.2.14, Table 2.2.4). Remarkably, this difference in rate 
constant is similar in magnitude to that of the valine or alanine substitution at the P5 
residue, suggesting that the P5+1 and the P5 residues are equally important in 
determining the rate of DSE for this subunit:Nte pair (Table 2.2.4). In comparison, 
substitution at the P5-1 position decreased the rate of DSE only slightly (from 0.32 
M
-1
s
-1
 for wild-type to 0.22 M
-1
s
-1
 for ENteK9A) (Figure 2.2.14, Table 2.2.4) 
implying that the P5-1 residue has a relatively minor effect in determining the rate of 
DSE. 
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Figure 2.2.14 a) DSE rate constants for the DSE reaction between PapDhisPapENtd and the peptides 
ENte (blue), ENteK9A (orange), ENteL10A (red) and ENteI11A. b) DSE rate constants for the DSE 
reaction between PapDhisPapENtd and the peptides ENte (blue), ENteK9E (orange), ENteL10V (red), 
ENteI11V and HNte (purple). The standard error between triplicate measurements is shown in all cases. 
The inserts show the peptide sequences used with the alternate hydrophobic residues in bold font and 
the residues substituted highlighted in orange, red and green for the P5-1, P5 and P5+1 residues, 
respectively. 
 
 
Peptide 
Residue 
Substituted 
Rate Constant, 
logk (µM
-1
s
-1
) 
Rate Constant, k 
(M
-1
s
-1
) 
ENte None -6.49 ± 0.06 0.32 (+ 0.05, - 0.04) 
ENteK9A P5-1 -6.66 ± 0.13 0.22 (+ 0.07, - 0.06) 
ENteL10A P5 -7.05 ± 0.17 0.09 (+ 0.07, - 0.04) 
ENteI11A P5+1 -6.92 ± 0.13 0.12 (+ 0.04, - 0.03) 
Table 2.2.4 - Second order rate constants (pH 6.0, 22 ºC) between PapDhisPapENtd and the substituted 
peptides ENteK9A, ENteL10A and ENteI11A. Rate constants are displayed in terms of logk and the 
derived rate constant, k. The standard error between triplicate DSE reactions are shown. 
 
 
 
As the residues immediately C-terminal to the P5 residue (P5+1) in ENte were found 
to influence the DSE rate, we next investigated the effect of these residues on DSE in 
PapDhisPapENtd by substituting residues from the non-cognate HNte sequence into the 
sequence of ENte at the P5-1, P5 and P5+1 positions (Figure 2.2.14b). This was 
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performed in order to aid our understanding of the role of the residues within the Nte 
in determining DSE specificity. Indeed if residues at the P5-1, P5 and P5+1 sites are 
important in modulating the rate of DSE, the DSE rate constant with these 
substituted peptides would be expected to decrease substantially, possibly to that of 
slowest PapDhisPapENtd/Nte DSE reaction i.e., that with its non-cognate peptide 
(HNte) (Rose et al. 2008). Second order rate constants for the DSE reaction between 
PapDhisPapENtd and the cognate (ENte) and non-cognate (HNte) peptides showed a 
decrease in rate constant from 0.32 M
-1
s
-1
 for the cognate reaction to 0.10 M
-1
s
-1
 for 
the non-cognate reaction (Table 2.2.5). This is comparable to previous data that 
showed non-cognate DSE reactions, i.e. DSE reaction between chaperone-
subunit:Nte pairs that are not adjacent to each other in the final pilus structure, are 
much slower than the equivalent DSE reaction that occurs in vivo (the cognate 
reaction) (Rose et al. 2008). Substitution of the P5 residue from leucine (in ENte) to 
valine (in HNte) in the variant ENteL10V demonstrates that replacement of a critical 
residue at the DSE initiation site reduces the rate constant of DSE substantially, to a 
rate equivalent to that observed for the reaction with HNte (Figure 2.2.14 and Table 
2.2.5). Strikingly, substitution from lysine (the P5-1 residue in ENte) to glutamic acid 
(the equivalent residue in HNte) in the variant ENteK9E also decreased the second 
order rate constant substantially, to a rate comparable with that with HNte (Figure 
2.2.13 and Table 2.2.5). In comparison, substitution of isoleucine to valine at the 
P5+1 position ENteI11V had very little effect on the DSE rate constant, with only a 
minor decrease from 0.32 M
-1
s
-1
 for ENte to 0.29 M
-1
s
-1
 with ENteI11V (Figure 2.2.14 
and Table 2.2.5).  
 
Peptide 
Residue 
Substituted 
Rate Constant, 
logk (µM
-1
s
-1
) 
Rate Constant, k 
(M
-1
s
-1
) 
ENte None -6.49 ± 0.06 0.32 (+ 0.05, - 0.04) 
ENteK9E P5-1 -6.80 ± 0.13 0.16 (+ 0.06, - 0.04) 
ENteL10V P5 -7.05 ± 0.17 0.09 (+ 0.07, - 0.04) 
ENteI11V P5+1 -6.54 ± 0.13 0.29 (+ 0.10, - 0.08) 
HNte None -6.98 ± 0.22 0.10 (+ 0.07, - 0.04) 
Table 2.2.5 - Second order rate constants (pH 6.0, 22 ºC) between PapDhisPapENtd and the substituted 
peptides ENteK9E, ENteL10V, ENteI11V and HNte. Rate constants are displayed in terms of logk and the 
derived rate constant, k. The standard error between triplicate DSE reactions are shown. 
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The HNte substituted peptides show differences in the relative importance of the P5-1 
and P5+1 sites compared with those of the alanine scan (Figure 2.2.14A, B), where 
the P5+1 substitution had a greater effect on DSE than the P5-1 substitution. The 
different substitutions at the P5-1 and P5+1 position in ENte show the roles of the 
P5+1 and P5-1 residues are dependent on the precise nature of the side-chain 
introduced. Electrostatic interactions at the P5-1 position are thought to play a role in 
DSE initiation since a larger effect on the DSE rate constant of the ENteK9E 
substitution was observed compared with the ENteK9A substitution at the P5-1 
position (Table 2.2.4 and 2.2.5). A trend comparable to that observed at the P5 
position was observed on decreasing the size of the amino acid side chain at the 
P5+1 site from isoleucine (in ENte) to valine (the equivalent residue in HNte), or 
further to alanine, showing smaller amino acids substituted at this P5+1 position 
decrease the DSE rate constant with PapDhisPapENtd (Tables 2.2.4, 2.2.5), (Figure 
2.2.12, Table 2.2.3). This decrease in side-chain volume may prevent hydrophobic 
surface interactions taking place which are needed to dock the Nte onto the 
chaperone-subunit complex before the chaperone’s G1 strand can unzip from the 
subunit’s hydrophobic groove in the chaperone-subunit complex. 
 
 
2.2.8 P5+1 and P5-1 residues alone cannot restore the fast kinetics of ENte  
Previous experiments using chimeric peptides in which the N-terminal seven 
residues of one peptide Nte is fused to the C-terminal five residues of another 
peptide’s Nte demonstrated that the C-terminal region of the Nte alone determines 
the rate of DSE (Rose et al. 2008). To investigate further the extent of the P5+1 and 
P5-1 residues’ roles in determining the rate of DSE with PapDhisPapENtd, E-HNte 
chimeric peptides were used which undergo very slow rates of DSE (Figure 2.2.15) 
(Rose et al. 2008). ENte residues were substituted individually into the E-HNte peptide 
at the P5-1, P5 or P5+1 positions with the aim of increasing the rate of DSE to 
mirror that obtained between the PapDhisPapENtd and ENte reaction. The control DSE 
reaction with PapDhisPapENtd and the peptide E-HNte showed a decrease in rate 
constant from 0.32 M
-1
s
-1
 for the cognate DSE reaction (PapDhisPapENtd + ENte) to a 
value comparable to the non-cognate reaction (PapDhisPapENtd + HNte) of 0.05 M
-1
s
-1
 
(Figure 2.2.15, Table 2.2.6). This supports previous ESI-MS data confirming that the 
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residues C-terminal to the glycine residue at the P4 site are the most important in 
determining the rate of DSE (Rose et al. 2008).  
 
Figure 2.2.15 - DSE rate constants for the DSE reaction between PapDhisPapENtd and the peptides ENte 
(blue), E-HNteE9K (orange), E-HNteV10L (red), E-HNteV11I (green), E-HNte, (blue-purple) and HNte 
(purple). The standard error between duplicate measurements is shown in all cases. The inserts show 
the peptide sequences used with the alternate hydrophobic residues in bold font, the ENte and HNte 
sequences in blue and purple respectively, and the residues substituted highlighted in orange, red and 
green for the P5-1, P5 and P5+1 residues respectively. 
 
 
Substitution of ENte residues back into E-HNte individually at the P5-1 and P5+1 
positions in E-HNte (i.e., E-HNteE9K and E-HNteV11I, respectively) had very little 
effect on the second order rate constants of DSE (Table 2.2.6, Figure 2.2.15). These 
results suggest that in the absence of the P5 residue, the P5+1 and P5-1 residues 
cannot restore the DSE rate to that of the cognate reaction. The E-HNteV10L 
substitution, which introduces the cognate P5 leucine residue of ENte into E-HNte, 
increases the DSE rate constant to 0.45 M
-1
s
-1
, a value similar to that of the cognate 
reaction rate constant with ENte (Table 2.2.6, Figure 2.2.15). The cognate P5 residue 
alone can act to modulate DSE rates (Figure 2.2.15), by aiding the docking of the 
Nte into the empty P5 pocket of the accepting subunit for DSE.   
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Peptide 
Residue 
Substituted 
Rate Constant, 
logk (µM
-1
s
-1
) 
Rate Constant, k 
(M
-1
s
-1
) 
ENte None -6.49 ± 0.06 0.32 (+ 0.05, - 0.04) 
E-HNteE9K P5-1 -7.44 ± 0.36 0.04 (+ 0.05, - 0.02) 
E-HNteV10L P5 -6.35 ± 0.04 0.45 (+ 0.05, - 0.04) 
E-HNteV11I P5+1 -7.00 ± 0.15 0.10 (+ 0.04, - 0.03) 
E-HNte None -7.31 ± 0.19 0.05 (+ 0.03, - 0.02) 
Table 2.2.6 - Second order rate constants (pH 6.0, 22 ºC) between PapDhisPapENtd and the substituted 
peptides E-HNteE9K, E-HNteV10L, E-HNteV11I and E-HNte. Rate constants are displayed in terms of 
logk and the derived rate constant, k. The standard error between duplicate DSE reactions are shown. 
 
 
The DSE rate constants in this thesis show the crucial role of the P5 residue on the 
incoming subunits’ N-terminal extension in DSE initiation. Indeed, substitution of 
this single amino acid can decrease the rate constant of DSE by up to 3-fold (Figures 
2.2.12 and 2.2.14). This supports and extends previous data that has showed the role 
of the P5 pocket in the chaperone-subunit complex in subunit specificity during DSE 
(Verger et al. 2006; Verger et al. 2008). Furthermore, the closed P5 pocket of the 
chaperone-subunit complex, PapDhisPapH, prevents DSE and hence in vivo this 
chaperone-subunit complex is used to terminate pilus biogenesis (Verger et al. 
2006). The residues either side of the P5 residue on the N-terminal extension of 
PapE were shown here to play a role also in determining subunit specificity during 
pilus biogenesis (Figures 2.2.14 and 2.2.15), possibly by aiding the initial docking of 
the subunit N-terminal extension onto the accepting chaperone-subunit complex 
prior to DSE.   
 
The DSE rates between chaperone-subunit complexes and their cognate N-terminal 
extensions shown here are too slow to explain how pili assemble on the minute 
timescale in vivo. Additional factors are needed for pilus biogenesis such as the 
interaction with the large β-barrel transmembrane usher protein, PapC, through 
which subunits translocate after DSE. In vitro experiments involving the fim usher 
from Type 1 pili have shown that the usher can catalyse pilus assembly compared to 
when the usher is absent (Vetsch et al. 2006). The precise mechanism of the catalysis 
and subunit ordering of the usher in DSE is still largely unknown. The role of the 
PapC usher in pilus biogenesis, in particular in determining subunit specificity was, 
therefore, investigated further using ESI-MS.   
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2.2.9 Role of the Usher in Pilus Biogenesis 
 
 
During pilus biogenesis, the chaperone-subunits are thought to be targeted initially to 
the ushers’ N-terminal domain (UsherN) (Ng et al. 2004). The binding of the 
chaperone-subunits to UsherN is thought to aid DSE catalysis through correctly 
positioning the donor N-terminal extension of the incoming chaperone-subunit close 
to the P5 pocket on the accepting subunit (Remaut et al. 2008). The binding of the 
chaperone-subunit complexes to UsherN was, therefore, further investigated using 
ESI-MS.      
 
For all subsequent experiments, the chaperone-subunit complexes PapDhisPapENtd 
and PapDhisPapHNtd1 constructs were used as previously described (Section 2.2.1 and 
2.2.3 respectively). Since PapA is known to self-associate, a truncated construct was 
used in which the region N-terminal to the conserved Nte binding sequence of PapA 
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was removed, and the conserved glycine at the P4 site was substituted with Asn, 
creating PapANtd1G15N (Verger et al. 2007). Wild-type PapK, PapF and PapG subunits 
were used.  
 
The following work in Sections 2.2.10, 2.2.11 and 2.2.12 was carried out as a team 
with Dr. Bethny Morrissey (University of Leeds) and Gabriel Waksmans’ group 
(Birkbeck College, London). Gilles Phan, William Allen (Birkbeck College, 
London) and myself equally contributed to the expression and purification of the 
chaperone-subunit complexes PapDhisPapANtd1G15N, PapDhisPapK, PapDPapF, 
PapDhisPapENtd and PapDhisPapHNtd1). I expressed and purified all the PapDhisPapG 
and PapDhisPapGpilin chaperone-subunit complexes used in addition to the 
PapGadhesion protein used in ternary complex formation. All usher domains were 
expressed and purified by Ana Toste-Rego, Gilles Phan and William Allen 
(Birkbeck College, London). The mass spectra in all cases for the usher project were 
acquired by Dr. Bethny Morrissey (University of Leeds). All modeling of the 
chaperone-subunit-usher ternary complexes was performed by myself.    
 
The protein purification for the PapDhisPapGpilin chaperone-subunit complex is 
shown (for example in Figure 2.2.16) and was expressed periplasmically (Materials 
and Methods Section 2.4.8). A single peak eluted off the nickel affinity column 
corresponding to a mixture of dissociated PapDhis and the non-covalent 
PapDhisPapGpilin complex (Figure 2.2.16A). Any dissociated PapDhis was further 
removed by cation exchange chromatography (Figure 2.2.16B). The final purity of 
the chaperone-subunit complexes in all cases were confirmed by SDS-PAGE (Figure 
2.2.16C) and the molecular weight determined using ESI-MS (Materials and 
Methods Section 2.4.3).   
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Figure 2.2.16 – Protein purification of the chaperone-subunit complex, PapDhisPapGpilin. A) Metal 
affinity chromatography showing PapDhisPapENtd and PapDhis eluting off the column on increasing the 
concentration of imidazole; B) Cation exchange chromatography showing on decreasing ammonium 
sulphate concentration the free chaperone, PapDhis, is separated from the PapDhisPapGpilin complex; C) 
SDS-PAGE showing the periplasmic fraction before purification and the final pure PapDhisPapGpilin 
complex.  
 
 
2.2.10 Chaperone-Subunit-Usher Ternary Complexes identified by ESI-MS 
The interaction of chaperone-subunit complexes with UsherN had not been studied 
previously by ESI-MS. Chaperone-subunit complexes PapDhisPapG, PapDPapF, 
PapDhisPapENtd, PapDhisPapK, PapDhisPapANtd1G15N and PapDhisPapHNtd1 were 
incubated separately with the N-terminal domain of the PapC usher (UsherN) in 5 
mM ammonium acetate pH 6.8 (Morrissey et al. 2012). After 5 minutes, the ESI-MS 
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mass spectra (acquired by Dr. Bethny Morrissey, University of Leeds) showed the 
presence of ternary complexes between all chaperone-subunits and the UsherN. All 
complexes were confirmed by their charge state distribution and corresponding 
molecular weight (Morrissey et al. 2012). One usher domain was bound to one 
chaperone-subunit complex in each case, suggesting the binding is specific. The 
mass spectrum of the ternary complex, PapDhisPapGUsherN, is shown for example 
in Figure 2.2.17.     
 
 
Figure 2.2.17 - ESI-MS of the chaperone-subunit complex, PapDhisPapG, bound to UsherN. The 
charge series corresponding to PapDhisPapG and PapDPapGhisUsherN are highlighted in blue and red 
respectively. Unbound UsherN is not shown on this m/z scale. PapDhisPapG was expressed and 
purified by myself. The mass spectrum was acquired by Dr. Bethny Morrissey (formerly University 
of Leeds). 
 
 
2.2.11 Stability of Chaperone-Subunit-Usher Ternary Complexes 
The differential binding of subunits to the N-terminal domain of the usher is thought 
to contribute to the subunit specificity in pilus biogenesis (Dodson et al. 1993; Ng et 
al. 2004). Unfortunately the KD of the chaperone-subunit-UsherN interactions could 
not be determined accurately from the ESI mass spectra due to differences in the 
ionisation properties of the chaperone-subunits, chaperone-subunit-usher complexes, 
and their individual components, in addition to problems associated with potential 
complex dissociation in the gas phase. Since all chaperone-subunit complexes are 
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capable of forming stable interactions with UsherN in the gas phase, the difference in 
the gas phase stabilities of these ternary complexes was investigated by Dr. Bethny 
Morrissey (University of Leeds) to probe further the origins of subunit specificity 
during pilus biogenesis (Morrissey et al. 2012).  
 
Collision induced dissociation (CID) MS/MS has been widely used to compare the 
gas phase stability of protein complexes (Benesch et al. 2003; Canon et al. 2009; 
Dodds et al. 2011), including the stability effect of ligand binding (Van Duijn et al. 
2006; Hopper et al. 2009) and mutations (Hyung et al. 2009) on protein complexes. 
The chaperone-subunit-UsherN ternary complexes were subjected to CID-MS/MS 
(by Dr. Bethny Morrissey, formerly University of Leeds) in the trap region of the 
Synapt HDMS. The collision energy applied to the ternary complex precursor ions 
was increased until no complex remained and the chaperone-subunit-usher complex 
had completely dissociated. The fraction of the chaperone-subunit-UsherN ion 
intensity remaining compared with the total ion intensity of all ions in the mass 
spectrum was plotted as a function of normalized collision energy (Figure 2.2.18), 
and the energy required to fragment 50 % each of the ternary complexes compared 
(Figure 2.2.18). PapDPapGUsherN was found to be the most stable ternary complex 
in vacuo (Figure 2.2.18). This is consistent with the known high affinity of 
PapDPapG for UsherN determined using SPR experiments (Dodson et al. 1993). The 
other five chaperone-subunit-usher complexes showed substantially weaker, but 
nonetheless significant, gas phase stabilities relative to PapDPapGUsherN (Figure 
2.2.18) (Morrissey et al. 2012). 
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Figure 2.2.18 - Stability of different PapDhisPapXUsherN ternary complexes determined using CID-
MS/MS. The CID-MS/MS fragmentation profiles of the ternary complexes are shown (left) along 
with the normalised collision energy required to fragment 50 % of the ternary complex into its 
individual components (right). PapDhisPapG, PapDhisPapENtd, PapDhisPapK, PapDhisPapHNtd1 were 
expressed and purified by myself. The MS data were acquired by Dr. Bethny Morrissey (formerly 
University of Leeds). 
 
 
It is interesting to note that PapG is the only subunit amongst the pilin subunits that 
contains two domains, a pilin domain, PapGpilin, and an adhesion domain, 
PapGadhesion (Figure 2.2.19). This additional adhesion domain could be enhancing the 
gas phase stability of the PapDhisPapGUsherN compared with all other 
PapDhisPapXUsherN complexes. Indeed, the presence of the adhesion domain in 
FimH, an equivalent subunit to PapG in the Type 1 pilus system, binds strongly to 
the Fim usher and plays a crucial role in removing the plug domain form the β-barrel 
of the usher, ready for subunit translocation through the usher during pilus 
biogenesis (Phan et al. 2011). 
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Figure 2.2.19 – Crystal structures of A) PapD (brown) bound to PapGpilin (green) in the PapDPapGpilin 
complex (PDB file: 2WMP) and B) PapGadhesion (blue) (PDB file:1J8S).   
 
 
To determine whether the PapG adhesion domain enhances the gas phase stability 
observed for the PapDhisPapGUsherN complex, constructs were designed whereby 
the adhesion domain of PapG in the chaperone-subunit complex, PapDPapG, was 
deleted (creating PapDPapGpilin) and the PapGadhesin domain (residues 1-196 of 
PapG) was expressed alone. Both PapDPapGpilin and PapGadhesion bound to the 
UsherN, forming complexes in a 1:1 stoichiometry as detected by ESI-MS.  On 
comparison of the CID/MS/MS of the ternary complexes formed (by Dr. Bethny 
Morrissey, formerly University of Leeds), the PapDPapGpilinUsherN complex 
stability is dramatically reduced compared with that of the full PapDPapGUsherN 
complex (Figure 2.2.20). This suggests a role of the PapGadhesin in PapDPapXUsherN 
complex stability, enhancing the gas phase binding affinity of PapG for UsherN over 
all other pilin subunits (Figure 2.2.20). Additional CID-MS/MS binding experiments 
(by Dr. Bethny Morrissey, formerly University of Leeds) between PapGadhesion and 
the UsherN revealed gas phase stabilities comparable to that of PapDPapGpilin with 
UsherN bound (Figure 2.2.20). Together, these data suggest that a potential binding 
interface exists between the UsherN domain of PapC and the adhesion domain of 
PapG. This additional interaction would explain the increased stability of the 
PapDPapGUsherN ternary complex over all other PapDPapXUsherN complexes and 
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may act in facilitating the activation of the usher, required to initiate pilus 
biogenesis. 
 
 
 
 
Figure 2.2.20 - Stability of different PapDPapXUsherN ternary complexes determined using CID-
MS/MS. The CID-MS/MS fragmentation profiles of the ternary complexes are shown (left) along 
with the normalised collision energy required to fragment 50 % of the ternary complex into its 
individual components (right). PapDhisPapG, PapDhisPapGpilin (PapDPapGp) and PapGadhesion (PapGad) 
were expressed and purified by myself. The MS data were acquired by Dr. Bethny Morrissey 
(formerly University of Leeds). 
 
 
2.2.12 Predicting the Binding Interface of Chaperone-Subunit-Usher Ternary 
Complexes 
Since a previously unexpected binding interface between the chaperone-subunit 
complex, PapDPapG, and the N-terminal domain of PapC has been suggested 
(Figure 2.2.20), ion mobility spectrometry mass spectrometry (IMS-MS) was used 
by Dr. Bethny Morrissey (formerly University of Leeds) to analyse the complexes 
between each domain of PapG with UsherN. In parallel, other PapDPapX complexes 
were analysed by ESI-IMS-MS for comparison. The IMS-MS mass spectrum of the 
PapDPapFUsherN ternary complex is shown in Figure 2.2.21. A single charge state 
distribution is observed corresponding to the ternary PapDPapFUsherN complex 
with a calculated molecular weight of 55,805 ± 2 Da which is within 0.01 % of the 
molecular weight predicted from the amino acid sequence (55,801 Da). A small 
amount of free PapDPapF is also observed in the ESI-IMS-MS driftscope which is 
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thought to be in equilibrium with the PapDPapFUsherN ternary complex in solution. 
The cross-sectional areas of the PapDPapF and PapDPapFUsherN complexes were 
determined by Dr. Bethny Morrissey (formerly University of Leeds) from the arrival 
time distributions of the lowest charge state ions corresponding to each complex. 
The collision cross-section of PapDPapF was 2520 Å
2
 for the 12+ charge state ion 
which corresponds well with the theoretical cross section, 2441 Å
2
, calculated (by 
myself) using the Leeds Algorithm (Smith et al. 2009; Knapman et al. 2010). This 
suggests that PapDPapF adopts a ‘native-like’ structure on transition into the gas 
phase. The collision cross-sectional area of the lowest charge state of the 
PapDPapFUsherN complex was calculated to be 2878 Å
2
. This is 10 % smaller than 
the expected cross section (3218 Å
2
) based on the theoretically determined cross 
section calculated (by myself) using the PapDPapFUsherN crystal structure. It is 
possible that structural collapse is occurring on transition into the gas phase resulting 
in a smaller measured cross-section. The difference observed here is more likely due 
to the experimental error in particular in measuring collision cross-sectional areas 
when using a denatured calibration (Bush et al. 2010). Indeed, additional work using 
a different calibration with native proteins will be needed to take this work further.     
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Figure 2.2.21 – ESI-IMS-MS driftscope plot of PapDPapFUsherN. The peaks corresponding to the 
12+ and 13+ charge states of the free PapDPapF complex are highlighted in blue. The 14+, 15+, and 
16+ charge states corresponding to the ternary PapDPapFUsherN complex are highlighted in white. 
The MS data were acquired by Dr. Bethny Morrissey (formerly University of Leeds). 
 
 
Since the crystal structure of PapDPapFUsherN has been determined, molecular 
modeling was used (by myself) to determine if the binding interface between UsherN 
and the chaperone-subunit complex PapDPapF could have been predicted based on 
the information obtained from the IMS-MS data alone. Rigid body docking was used 
whereby UsherN was manually docked using Pymol (DeLano 2002) onto all 
possible areas of the chaperone-subunit complex PapDPapF and the theoretical 
collision cross section calculated using the Leeds algorithm (Smith et al. 2009; 
Knapman et al. 2010). The most structurally compact and expanded structures along 
with the PapDPapFUsherN crystal structures are highlighted in Figure 2.2.22 along 
with their theoretically calculated collision cross-sectional areas. The difference 
between collision cross-sections between all structures shown in Figure 2.2.22 is 
comparable to the experimental error associated with measuring collision cross-
sections from the IMS data alone. These results thus show that the binding interface 
between PapDPapF and UsherN cannot be predicted based on the IMS data alone.  
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Figure 2.2.22 - Crystal Structure of PapDPapF (black-orange) PDB file:2W07 (Verger et al. 2008), 
UsherN (red) PDB file:1ZE3 (Nishiyama et al. 2005) and PapDPapFUsherN PDB files:2W07 (Verger 
et al. 2008) and 1ZE3 (Nishiyama et al. 2005) (black-orange-red) along with modeled 
PapDPapFUsherN structures. The theoretical collision cross sectional areas, calculated using the 
Leeds algorithm (Smith et al. 2009; Knapman et al. 2010) are shown for all structures. Note the 
collision cross-sectional areas observed experimentally are for the lowest charge state. 
 
 
The ESI-IMS-MS data show that ternary PapDPapXUsherN complexes can be 
separated from free PapDPapF and UsherN based on their collision cross-sectional 
areas. Unfortunately increased IMS resolution is needed to further interpret cross 
section measurements in regards to determining binding interfaces of the 
PapDPapFUsherN complexes. Steps are being made to increase the resolution of the 
IMS-MS approach with the more modern instruments (Synapt G2 and Synapt G2S) 
compared with the Synapt HDMS used in these experiments (Giles et al. 2011). 
Although determining the exact binding interface of chaperone-subunit-usher ternary 
complex remains challenging, in the future, IMS could be utilised as a rapid, 
efficient tool for analyzing protein-protein complexes by ruling out unlikely binding 
sites based on cross-sectional area measurements alone.  
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2.3. Conclusions 
Pilus Assembly 
 
Despite making several inroads into the subject, the complex mechanism by which 
multiple pilin subunits assemble in such a precise order and stoichiometry to create a 
functional pilus on the outer membrane of E.coli still presents intriguing questions. 
In this thesis, an in vitro method has been developed to determine second order rate 
constants of DSE using ESI-MS. The use of a chaperone-subunit complex, 
PapDhisPapHNtd1, as an internal standard enabled quantitative analysis of the 
concentration of the chaperone-subunit complex, PapDhisPapENtd, on DSE carried out 
with multiple substituted N-terminal extension peptides. The method developed 
allowed second order DSE rate constants to be determined in real time over reduced 
reaction times compared with previous studies, minimising problems associated with 
solvent evaporation and complex dissociation which inevitably increase with 
reaction time. This method produces rapid, reliable results, consistent with other ion-
exchange methods for determining second-order DSE rate constants in vitro (Vetsch 
et al. 2006).    
 
The second order rate constants of DSE measured in this thesis reveal new 
information about the role of individual residues in the Nte in controlling binding of 
the incoming subunit’s Nte to the chaperone-subunit complex, and hence the rate of 
DSE initiation. The size and availability of the P5 pocket in the chaperone-subunit 
complex has been shown to modulate rates of DSE (Remaut et al. 2006; Rose et al. 
2008; Verger et al. 2008). Therefore, the role of the P5 residue on the N-terminal 
extension of the incoming subunit that fits tightly into the P5 pocket on the accepting 
chaperone-subunit complex in DSE was initially investigated. Decreasing the size of 
the P5 residue on the N-terminal extension resulted in the decrease of the rate of 
DSE (Figure 2.2.12) showing the amino acid residue at the P5 position is crucial for 
efficient DSE. The role of the residues either side of the P5 residue (the P5+1 and 
P5-1 residues) on the N-terminal extension were also investigated. The data show 
that although the side-chains of the P5+1 and P5-1 residues are orientated away from 
the binding groove towards the solvent in the final subunit-Nte complex (Figure 
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2.2.13) (Sauer et al. 2002), they play a role in determining the rate of DSE possibly 
by stabilising the Nte-chaperone-subunit complex. Indeed, crystallography data on 
Fim subunits from Type 1 pili show that residues surrounding the subunits’ 
hydrophobic groove can flip in and out of the hydrophobic groove on transition from 
the loose, chaperone-bound state to the more compact subunit-subunit interaction in 
the pilus tip, thus stabilising the native pilus structure (Le Trong et al. 2010). The 
results presented here reveal that every residue in the C-terminal half of the Nte is 
involved in DSE, irrespective of its location in the final DSE product. 
 
The effect of the P5, P5+1 and P5-1 residues on the rate of DSE demonstrated here, 
whilst significant, is not sufficient to rationalise the ordering of subunits in the fully 
assembled pilus, especially once the concentration of different subunits in the 
periplasm is taken into account (as PapA is found in vast excess to the other 
subunits). The usher’s differential affinities for subunits, along with its catalytic 
ability, therefore, must also play a key role in controlling the order of subunit 
polymerisation (Ng et al. 2004; Nishiyama et al. 2008).  
 
Work in conjunction with Dr. Bethny Morrissey (formerly University of Leeds) 
showed that ESI-MS could be used to examine the binding of the chaperone-subunit 
complexes to the N-terminal domain of the usher, UsherN. CID-MS/MS experiments 
by Dr. Bethny Morrissey showed that the chaperone-subunit complex PapDPapG 
had an increased gas phase stability compared with all other chaperone-subunit 
complexes, consistent with the surface plasmon resonance data that showed 
PapDPapG to have a higher affinity for the usher compared to all other chaperone-
subunit complexes (Dodson et al. 1993; Saulino et al. 1998; Sauer et al. 2004). 
Further resolution of PapDPapG into its components PapDPapGpilin and PapGadhesion 
revealed a previously unexpected role of the adhesion domain of the PapG subunit in 
targeting the chaperone-subunit complex, PapDPapG to the usher, ensuring it binds 
preferentially to all other chaperone-subunit complexes for pilus biogenesis 
initiation.  
 
A model was proposed for pilus biogenesis involving the usher (Figure 2.3.1) 
(Morrissey et al. 2012). Pilus assembly initiates through the binding of PapDPapG to 
the N-terminal domain of the usher. This results in the removal of the plug domain 
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from the β-barrel into the periplasm. The PapDPapG complex is then passed to the 
C-terminal domain of the usher either directly or indirectly via the plug domain 
freeing up the N-terminal domain for binding to the second chaperone-subunit 
complex, PapDPapF. Once bound and the P5 residue on the PapF N-terminal 
extension is correctly positioned next to the P5 pocket on PapG, DSE can occur 
resulting in the release of the chaperone, PapD, from the PapDPapG complex. 
Finally PapG is translocated across the lumen of the usher simultaneously with 
PapDPapF moving across to the C-terminal domain, ready for the next incoming 
chaperone-subunit, PapDhisPapE, to bind UsherN. More recently, binding studies 
using biolayer interferometry have shown the interaction of the plug domain with the 
N-terminal of the usher and its contribution to the final subunit stoichiometry in the 
pilus (Volkan et al. 2012) consistent with the results presented here and in Morrissey 
et al. (Morrissey et al. 2012). A refined model in which the plug domain binds to 
UsherN upon exiting the lumen was proposed (Volkan et al. 2012) (Figure 2.3.1).  
 
 
Figure 2.3.1 - Mechanism of pilus biogenesis. Pilus biogenesis commences with PapDPapG (brown-
red) binding to UsherN (blue) (A). Once bound to the usher, the plug domain (dark blue) then moves 
out of the lumen of the barrel (B, C, D). PapDPapG is then transported either directly (i) or indirectly 
(ii, iii) via the plug domain to the ushers C-terminal domain (Usher C comprised of UsherC1 (light 
green) and UsherC2 (green)). UsherN is then released ready for binding to the second chaperone-
subunit PapDPapF (brown-orange). Once bound to the UsherN, PapDPapF is positioned close to 
PapDPapG ready for DS  and PapG subunit translocation through the ushers β-barrel. Figure taken 
from Morrissey et. al. 2012 (Morrissey et al. 2012).   
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In summary, the data on DSE rate constants on the role of the P5, P5-1 and P5+1 
residues in the N-terminal extension of the incoming chaperone-subunit complex 
combined with the differential affinity of different subunits to  the usher together 
help explain how multiple subunits can arrange in such a specific order on the outer 
membrane during pilus biogenesis. Additional DSE experiments (building on 
previous data shown in Sections 2.2.5 - 2.2.8) involving the intact PapC usher will 
be needed to develop further our understanding of the DSE mechanism, allowing the 
role of the individual usher domains in defining the rate controlling the order of 
subunit assembly to be discerned.  
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2.4. Materials and Methods 
Pilus Assembly 
 
2.4.1 Reagents 
 
Mass Spectrometry 
CH3OH, CH3CH2OH, HCl and NH4OH were purchased from Fisher Scientific 
(Loughborough, UK).  CH3COONH4 and CsI were purchased from Sigma-Aldrich 
Corporation (Poole, Dorset, UK) and raffinose was from ULTRA Scientific (Kent, 
UK). 
 
Protein Expression and Purification 
Agar, yeast extract, tryptone, ampicillin, isopropyl β-D-1-thiogalactopyranoside 
(IPTG) and Tris base were purchased from Melford Laboratories Ltd. (Suffolk, UK). 
Glycerol, SDS, imidazole and NaCl were purchased from Fisher Scientific 
(Loughborough, UK). 30 % Acrylamide, instant blue stain, DTT, Tris-tricine SDS 
buffer (10x) and the protein standard marker for SDS-PAGE were purchased from 
Severn Biotech (Kidderminster, UK), Expedeon (Cambridgeshire, UK), Formedium 
(Norfolk, UK), Invitrogen (Paisley, UK) and Fermentas (Germany), respectively. All 
other chemicals used in protein expression and purification were purchased from 
Sigma-Aldrich Corporation (Poole, Dorset, UK). 
 
2.4.2 Buffer Preparation 
Ammonium acetate buffers were made at 5 mM in deionised (18 MΩ) water. The pH 
was adjusted by addition of HCl or NH4OH. The ammonium acetate buffer was 
stored at 4 ºC for one week maximum and filtered through a 200 nm-pore filter 
(minisart high-flow single-use sterile filter, Sartorius, Surrey, UK) before use. 
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2.4.3 Peptide Preparation 
The Nte peptides from PapE along with the substituted Nte peptides were purchased 
from CSS Albachem, Gladsmuir, UK. Each peptide was C-terminally amidated, and 
two lysine residues were added to the C-terminus of each sequence to aid solubility. 
Peptides were dissolved in 5 mM CH3COONH4, pH 6.0 and stored at -20 C. The 
concentration of peptide was determined accurately by quantitative amino acid 
analysis (performed by Peter Sharratt, University of Cambridge, UK). 
 
2.4.4 Growth Media 
Luria-Bertani (LB) medium was purchased from Merck (Germany) and sterilised by 
autoclaving at 120 C at 15 p.s.i. for 20 min. Terrific Broth (TB) was made by 
dissolving 12 g tryptone, 24 g yeast extract and 4 mL glycerol in 1 L deionised (18 
MΩ) water. The TB was autoclaving at 120 C at 15 p.s.i. for 20 min and once cool, 
filter sterilised KH2PO4 (2.31 g) and K2HPO4 (12.54 g) added to a final 
concentration of 17 mM and 72 mM, respectively. Filter-sterilised antibiotics were 
added to the LB/TB media when appropriate. 
 
2.4.5 LB agar plates 
1.5 g of bacto-agar was added per 100 mL of LB medium and sterilised by 
autoclaving at 120 C at 15 p.s.i. for 20 min. Antibiotics were added to the agar 
solution once the temperature had reached 55 C. 20 mL of the molten agar mixture 
was poured into a 100 mm diameter petri dish and allowed to set at room 
temperature before storage at 4 C. 
 
2.4.6 Competent Cell Preparation 
Single C600 cell colonies from freshly streaked agar plates were grown in 10 mL LB 
medium at 37 ºC, shaking at 200 rpm for 16 h. Cells were then sub-cultured (1:20) 
into 100 mL fresh LB medium and grown at 37 ºC, shaking at 200 rpm until an 
O.D.600 of 0.45 was reached. Cell were then centrifuged at 4000 rpm (JS 5.3, 
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Beckman Coulters, UK) at 4 ºC for 10 min and the pellet resuspended in 10 mL of 
sterile, pre-chilled 100 mM CaCl2 and stored on ice for 2 h. Cells were then 
centrifuged again, as before, and resuspended in 2 mL of 100 mM CaCl2, 30 % (v/v) 
glycerol at 4 ºC. The competent cells were divided into 100 L aliquots in sterile 
reaction tubes, snap frozen and stored at -80 ºC (Sambrook 1989). 
 
2.4.7 Transformation of plasmid DNA 
The plasmids encoding the chaperone-subunit complexes, PapDhisPapENtd, 
PapDhisPapANtd1G15N, PapDhisPapG(II), PapDhisPapGpilin, PapDPapK, PapDhisPapF, 
PapDhisPapHNtd1 and PapGadhesion were supplied by Professor Gabriel Waksman’s 
group (Birkbeck College, London). Escherichia coli (E.coli) C600 cells were 
purchased from Stratagene (Cambridge, UK) and made competent using the protocol 
described in Section 2.4.6. 
 
1 µL of purified plasmid DNA was incubated on ice with 50 µL of competent C600 
E.coli cells. After 30 min, the cell/plasmid mixture was heat-shocked at 42 ºC for 45 
s before returning the cells to ice for a further 2 min. 500 µL of sterile LB media was 
then added and the cells incubated, shaking at 200 rpm, for 1 h at 37 ºC. 20-100 µL 
of transformed cells were plated onto agar plates containing the appropriate 
antibiotic selection and incubated overnight at 37 ºC.         
 
2.4.8 Protein Expression  
2.4.8.1 Chaperone-subunit complexes 
All Pap chaperone-subunit complexes were expressed and purified by a combination 
of Dr Denis Verger, William Allen and Gilles Phan at Birkbeck College, University 
of London and myself here at the University of Leeds. The same protocol was used 
in each case. All chaperone-subunit complexes expressed and purified are described 
below. 
 
PapDhis-PapHNtd1 complex - The PapHNtd1 used is a truncated PapH construct with 
the proline-rich region of the Nte (residues Pro2-Gln22) removed (Verger et al. 
2006). The truncated version of PapH was used to aid solubility (Verger et al. 2006).  
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PapDhis-PapENtd complex - The PapENtd construct has the residues Asp2-Ile12 on 
its Nte deleted to prevent PapE self-polymerisating (Sauer et al. 2002; Verger et al. 
2006). 
 
 PapDPapFG8N complex - The P4 residue on the PapF subunit was mutated from 
Gly to Asn making the construct PapFG8N to prevent PapF self-polymerisation 
(Verger et al. 2008). 
 
PapDhis-PapAG15NNtd1 complex - The PapAG15NNtd1 construct has the P4 residue 
substituted with Asn, in addition to the N-terminal extension being truncated to 
prevent self-polymerisation (Verger et al. 2007). 
 
PapDhis-PapGpilin complex - Residues 214-336 from PapG(II) were used to create 
the PapGpilin construct (Morrissey et al. 2012). 
 
PapGadhesion complex - The N-terminal 196 amino acids of PapG were used to create 
the PapGadhesion complex (Dodson et al. 2001).   
 
Slightly different histidine-tags and linkers were used for the different Pap chaperone 
constructs (Table 2.4.1), all will be referred to throughout simply as PapDhis. The 
presence of his-tags has previously been shown not to affect the function of the PapD 
chaperone (Sauer et al. 1999; Sauer et al. 2002; Verger et al. 2006; Verger et al. 
2007). 
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Table 2.4.1 – PapD constructs used in the chaperone-subunit complexes along with the antibiotic 
resistance of the plasmid to which the gene is inserted. 
 
 
2.4.8.2 Pre-culture 
Initially bacterial glycerol stocks were prepared by inoculating 10 mL of sterile LB 
media (containing the appropriate antibiotic) with one colony from an agar plate and 
incubating at 37 ºC overnight, shaking at 200 rpm. 700 µL of the overnight starter 
culture was then mixed with 300 µL sterile glycerol solution in a 1.5 mL Eppendorf 
tube to make the final bacterial glycerol stock. Glycerol stocks were stored at -80 ºC. 
 
 Pre-cultures were mediated by addition of 20 µL bacterial glycerol stock to 500 mL 
sterile LB media. The media were incubated overnight at 37 ºC overnight, shaking at 
200 rpm and used immediately for large-scale protein over-expression. 
 
2.4.8.3 Periplasmic protein expression 
Eleven 2 L flask each containing 1 L of TB media were pre-warmed overnight at 37 
ºC. 30 mL of pre-culture was added to each flask along with 1 mL of 100 mg/mL 
ampicillin and/or 30 mg/mL kanomycin (stored at -20 ºC). The culture was 
incubated at 37 ºC, shaking at 200 rpm in an orbital shaking incubator, and the 
optical density (O.D) at 600 nm measured at regular intervals. At an OD of 0.6, the 
Pilin Complex Vector 
Antibiotic 
Resistance 
Inducer Tag on PapD 
PapDhisPapENtd1 
pMMB91 (PapDhis), 
pTrc99A (PapENtd1) 
Kan (PapDhis), 
Amp (PapENtd1) 
IPTG 
6his on  PapD (no 
linker) 
PapDhisPapANtdG15N pTrc99A Amp IPTG 6his (GS link) 
PapDhisPapG(II) pTrc99A Amp IPTG 6his (GS link) 
PapDPapK 
pMMB91 (PapD), 
pTrc99A (PapK) 
Kan (PapD), 
Amp (PapK) 
IPTG no tag 
PapDhisPapF pTrc99A Amp IPTG 
6his on PapD (GA 
link) 
PapDhisPapHNtd1 pTrc99A Amp IPTG 6his (GS link) 
PapDhisPapG(II)pillin pTrc99A Amp IPTG 6his (GS link) 
PapGadhesin pTrc99A Amp IPTG - 
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C600 cells were induced by addition of 1 mL of 1 M filter sterilised IPTG.  After 3.5 
hours, the cultures were harvested at 5000 rpm (JLA 8.1, Beckman Coulters, UK), 4 
ºC.   
 
2.4.8.4 Periplasmic Extraction 
The wet cell pellets were resuspended gently in 20 % (w/v) sucrose, 20 mM Tris-
HCl, pH 8.0 (4 mL sucrose solution for every 1 g cells). 40 μL of 0.5 M  DTA and 
40 μL of lysozyme (10 mg/mL) were added and the cells mixed on ice for 20 min to 
extract the periplasm. Finally 80 μL of 1M MgCl2 was added to stop the reaction and 
the resulting mixture centrifuged for 20 mins at 12, 000 rpm (JA 25.50, Beckman 
Coulters, UK), 4 ºC. The pellet was discarded and the supernatant containing the 
periplasmic proteins dialysed overnight into 20 mM Tris-HCl, 150 mM NaCl, pH 
8.0, 5 % (v/v) glycerol, 4 ºC for the his-tagged PapDPapX complexes or 20 mM 
MES pH 6.0, 10 mM NaCl, 1 mM EDTA, 5 % (v/v) glycerol, 4 ºC for the non his-
tagged PapDPapX complexes. Following dialysis, the periplasmic extract was 
centrifuged for a further 10 min at 12, 000 rpm (JA 25.50, Beckman Coulters, UK), 
4 ºC to remove any residual cell debris before protein purification. 
 
2.4.9 Protein purification 
2.4.9.1 PapDhisPapX complexes 
Metal affinity chromatography 
The periplasmic extract was initially purified by nickel affinity chromatography 
using a HisTrap HP 5 mL column (GE Healthcare, Buckinghamshire, UK). All 
solutions were filtered using a 0.22 μm Steritop filter (Millipore, Massachusetts, 
USA) and degassed using a Buchi Vac V-500 vacuum pump (Buchhi Labortechnik 
AG, Switzerland) prior to passing through the column. The column was equilibrated 
with 10 column volumes of 20 mM Tris-HCl, 150 mM NaCl, pH 8.0 at 4 ºC and the 
periplasmic extract was then added at a flow rate of 2 mL/min using a peristaltic 
pump. The column containing the his-tagged proteins was transferred to an ÄKTA 
prime purification system (GE Healthcare, Buckinghamshire, UK) and washed with 
5 column volumes of 20 mM Tris-HCl, 150 mM NaCl, pH 8.0 at 4 ºC at a flow rate 
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of 2 mL/min. The column was further washed with 20 mM, 40 mM and 50 mM 
imidazole in 20 mM Tris-HCl, 150 mM NaCl, pH 8.0 to remove any non-
specifically bound proteins.  Finally the his-tagged proteins were eluted by addition 
of 20 mM Tris-HCl, 150 mM NaCl, 500 mM imidazole, pH 8.0. The fractions 
containing his-tagged protein as detected by spectrophotometry at A280 and SDS-
PAGE were combined and stored on ice before further purification by hydrophobic 
interaction chromatography. 
 
Hydrophobic interaction chromatography 
The his-tagged proteins were further purified by hydrophobic interaction 
chromatography using a HiTrap Phenyl HP 5 mL column (GE Healthcare, 
Buckinghamshire, UK) for the chaperone-subunit complexes PapDhisPapENtd, 
PapDhisPapANtd1G15N, PapDhisPapGpilin, PapDPapK, PapDhisPapF, and 
PapDhisPapHNtd1. A HiTrap Butyl FF 5 mL column (GE Healthcare, 
Buckinghamshire, UK) was alternatively used for purification of the PapDhisPapG(II) 
complex. For all chaperone-subunit complexes, the column was initially washed 
with 0.5 M NaCl to remove any proteases present from previous purification 
procedures and then equilibrated with ten column volumes of 20 mM Tris-HCl, 1 M 
ammonium sulphate, pH 8.0, 4 ºC. All solutions were filtered using a 0.22 μm 
Steritop filter and degassed using a Buchi Vac V-500 vacuum pump prior to passing 
through the column. 20 mM Tris-HCl, 3 M ammonium sulphate, pH 8.0 was added 
drop by drop to the his-tagged protein mixture until a final concentration of 1 M 
ammonium sulphate was reached. The protein solution was then loaded onto the 
column using a peristaltic pump at a flow rate of 2 mL/min.  The column was 
transferred to an ÄKTA prime purification system and was washed with 5 column 
volumes of 20 mM Tris-HCl, 1 M ammonium sulphate, pH 8.0. Bound proteins were 
then eluted over a linear gradient of 1-0 M ammonium sulphate in 20 mM Tris-HCl, 
pH 8.0 over 100 mL using a flow rate of 2 mL/min.  PapDhis typically eluted at 30 
mL followed by the PapDhisPapX complex. The pooled PapDhisPapX fractions, 
conformed by SDS-PAG , were concentrated to 500 μL in 20 mM TrisHCl, 150 
mM NaCl, pH 8.0 using a Vivaspin 20 concentrator with a 30,000 MWCO (Sartorius 
Stedim Biotech., Germany) and stored in 30 % (v/v) glycerol at - 20 ºC until further 
use.   
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2.4.9.2 PapDPapX complexes 
Cation exchange chromatography 
For protein complexes containing PapD lacking a his-tag, protein complexes were 
expressed as described above. The periplasmic extract was initially purified by 
cation exchange chromatography using a SP HiTrap FF 5 mL column (GE 
Healthcare, Buckinghamshire, UK). All solutions were filtered using a 0.22 μm 
Steritop filter and degassed using a Buchi Vac V-500 vacuum pump prior to passing 
through the column. The column was equilibrated with 10 column volumes of 20 
mM MES, 150 mM NaCl, pH 6.0 at 4 ºC and the periplasmic extract added at a flow 
rate of 2 mL/min using a peristaltic pump. The column containing the PapDPapX 
proteins was transferred to an ÄKTA prime purification system (GE Healthcare, 
Buckinghamshire, UK) and washed with 5 column volumes of 20 mM MES, 150 
mM NaCl, pH 6.0 at 4 ºC at a flow rate of 2 mL/min. The proteins were eluted by 
applying a linear gradient of 0-150 mM NaCl in 20 mM MES pH 6.0, over 100 mL. 
The fractions containing PapDPapX protein as detected by spectrophotometry at A280 
and SDS-PAGE were combined and stored on ice before further purification by 
hydrophobic interaction chromatography. 
 
Hydrophobic interaction chromatography   
The non his-tagged PapDPapX proteins were purified by hydrophobic interaction 
chromatography in a similar way to that of his-tagged proteins (Section 2.4.9.1) 
however 20 mM MES, pH 6.0 was used instead of 20 mM TrisHCl, pH 8.0. The 
fractions corresponding to the PapDPapX complexes were confirmed by SDS-PAGE 
and concentrated using a Vivaspin 20 concentrator with a 30,000 MWCO (Sartorius 
Stedim Biotech., Germany) to 500 µL in 20 mM TrisHCl, pH 8.0 and 30 % (v/v) 
glycerol added for storage at -20 ºC.   
 
2.4.9.3 PapGadhesion 
The PapGadhesion purification procedure was based on that reported previously by the 
Waksman group (Dodson et al. 2001). PapGadhesion was expressed periplasmically 
and the periplasm, containing the PapGadhesion, extracted according to the procedure 
mentioned previously (Section 2.4.8.4). PapGadhesion was selectively precipitated in 
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30 % (w/v) ammonium sulphate and the solution centrifuged at 4000 rpm (JS 5.3, 
Beckman Coulters, UK) for 10 min. The pellet containing the PapGadhesion was 
resuspended in 20 mM MES pH 5.8 and further dialysed into 20 mM MES pH 5.8 at 
4 ºC, overnight.  
 
Cation exchange chromatography 
Using a peristaltic pump, the solution containing PapGadhesion was loaded onto a 5 mL 
S Sepharose column (GE Healthcare, Buckinghamshire, UK) that had been 
previously equilibrated with 10 column volumes of 20 mM MES pH 5.8 at 4 ºC. The 
column was then transferred to an ÄKTA prime purification system (GE Healthcare, 
Buckinghamshire, UK) and washed with 5 column volumes of 20 mM MES pH 5.8 
at 4 ºC at a flow rate of 2 mL/min.  The proteins were eluted by applying a linear 
gradient of 0-500 mM NaCl in 20 mM MES pH 6.0, over 100 mL.  The fractions 
containing PapGadhesion protein as detected by spectrophotometry at A280 and SDS-
PAGE were combined and stored on ice before further purification by hydrophobic 
interaction chromatography.   
 
Hydrophobic interaction chromatography 
PapGadhesion was further purified by hydrophobic interaction chromatography using a 
HiTrap Butyl FF 5 mL column (GE Healthcare, Buckinghamshire, UK). The column 
was initially equilibrated with ten column volumes of 20 mM MES, 1 M NaCl pH 
5.8, 4 ºC.  The protein solution was loaded onto the column in 20 mM MES, 1 M 
NaCl pH 5.8 using a peristaltic pump at a flow rate of 2 mL/min.  The column was 
transferred to an ÄKTA prime purification system and PapGadhesin eluted over a 
linear gradient of 1-0 M NaCl in 20 mM MES, pH 5.8 over 100 mL using a flow rate 
of 2 mL/min. The pooled PapGadhesin fractions, confirmed by SDS-PAGE, were 
concentrated to 500 μL in 20 mM M S, 150 mM NaCl, pH 5.8 using a Vivaspin 20 
concentrator with a 30,000 MWCO (Sartorius Stedim Biotech., Germany) and stored 
in 30 % (v/v) glycerol at - 20 ºC until further use.   
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2.4.10 Usher Domains 
PapC usher domain UsherN (residues 4-131) was expressed periplasmically and 
purified as reported (Morrissey et al. 2012). UsherN was additionally Strep-tagged to 
aid purification. All usher domains were kindly provided by Ana Toste-Rego, Gilles 
Phan and William Allen (Birkbeck College, London) and stored at –20 ºC in 20 mM 
TrisHCl pH 8.0, 150 mM NaCl, 30 % (v/v) glycerol.  
 
2.4.11 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE) 
SDS-PAGE gels were used to monitor the purification of all chaperone-subunit 
complexes. Tris-tricine buffered gels were used in all cases (Table 2.4.2).  
 
Solution Component 
Resolving Gel 
volume (mL) 
Stacking Gel 
volume (mL) 
30 % (w/v) Acrylamide: 0.8 % (w/v) bis-
acrylamide 
7.5 0.83 
3 M Tris-HCl, 0.3 % (w/v) SDS pH 8.45 5.0 1.55 
H2O 0.44 3.72 
Glycerol 2.0 - 
10 % (w/v) Ammonium persulphate 0.1 0.20 
TEMED 0.01 0.01 
Table 2.4.2 – Tri-tricine buffered SDS-PAGE gel. The volumes to add are sufficient for two 8 cm by 
10 cm gels using a 1.5 mm spacer.  
 
 
Protein samples were diluted two-fold in 2 x loading buffer (50 mM Tris-HCl pH 
6.8, 100 mM DTT, 2 % (w/v) SDS, 0.1 % (w/v) bromophenol blue, 10 % (v/v) 
glycerol) and boiled for a minimum of five min before loading onto the gel. 
Invitrogen Mark 12 standard protein markers were loaded into one lane to aid 
identification of protein bands. A cathode buffer containing 200 mM TrisHCl, 200 
mM Tricine, 0.2 % (w/v) SDS pH 8.25 was used along with the anode buffer 
containing 400 mM TrisHCl pH 8.8. Gels were electrophoresed at a constant current 
of ~ 30 mA until the samples entered the resolving gel, at which point the current 
was adjusted to 55-60 mA. Gels were stained using Instant Blue stain and imaged 
directly. SDS-PAGE gels were photographed using the Syngene InGenius gel 
documentation system. 
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2.4.12 Dialysis Procedure 
The chaperone-subunit complexes and usher domains were dialysed into mass 
spectrometry-compatible buffers (typically 5 mM ammonium acetate pH 6.0) before 
analysis. 25 μL of protein was inserted into the well of a dialysis button (Hampton 
Research, Laguna Niguel, USA) and covered with a cellulose dialysis membrane 
(molecular weight cut-off at 3500 Da, Spectrum Laboratories, Inc.) and held in place 
by a rubber O-ring. The button was left in 100 mL of ammonium acetate buffer at 4 
°C for 2-3 days.  The buffer was changed every 4-8 hours to ensure complete 
removal of salt. Once dialysis was complete, the sample was removed from the 
microdialysis button using a 5 mL Hamilton syringe.   
 
The final concentration of each chaperone-subunit complex was calculated using the 
Beer-Lambert law by measuring the absorbance at 280 nm and using the theoretical 
extinction coefficients determined from the amino acid sequence (using Protparam 
online software) (Edelhoch 1967; Gill et al. 1989; Pace et al. 1995). 
 
2.4.13 Electron Microscopy 
Carbon/formvar-coated 300 mesh electron microscopy grids were purchased from 
the Electron Microscopy suite in the Faculty of Biological Sciences, University of 
Leeds. 2 % (w/v) solution of uranyl acetate was obtained from the Electron 
Microscopy suite in the Faculty of Biological Sciences, University of Leeds.  
 
10 μM PapDPap V56E (kindly provided by Gilles Phan, Birkbeck College, London) 
was incubated at room temperature overnight in 5 mM ammonium acetate pH 6.0. 10 
μl of the pili formed were then placed on freshly ionised formvar- and carbon-coated 
EM grids for 30 sec. The grids were then blotted with filter paper to remove excess 
solvent and the samples stained with 2 % (w/v) uranyl acetate for 30 sec. The grids 
were then blotted again and air-dried before analysis. All images were taken using a 
Philips CM10 electron microscope operating at 80 keV. 
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2.4.14 Acquisition of Mass Spectrometry Data 
2.4.14.1 Calibration 
Before all experiments were carried out, the mass spectrometers were calibrated 
using a 0.1 mg/mL aqueous solution of CsI. Ion clusters of range m/z 1691.8 Da to 
4809.5 Da were used to calibrate the required m/z range and ensure a mass accuracy 
of 0.02 %. 
 
2.4.14.2 MS Configuration and Settings 
A LCT Premier mass spectrometer (Waters UK Ltd., Manchester, UK) equipped 
with a chip-based nano-electrospray ionisation source (Triversa NanoMate, Advion 
Biosciences Corpn., Ithaca, NY, USA) was used to monitor the DSE reactions. A 
cone voltage of 70 V, capillary voltage of 1.75 kV, nebulising gas pressure of 0.5 
psi, and a source temperature of 50 ºC was used in all MS experiments.  Spectra 
were acquired using a 1 second scan, over a m/z range of 1000-5000 for all 
complexes except those containing the PapDPapG chaperone-subunit, in which case 
ions were acquired over the m/z range of 1000-7000. Spectra from a steady total ion 
chromatogram (TIC) over 1 minute were combined to produce the final summed 
mass spectra. 
 
2.4.14.3 Processing of Mass Spectrometry Data 
MassLynx software (Waters UK Ltd., Manchester, UK) was used to process all mass 
spectrometry data. A CsI calibration was applied initially to the combined mass 
spectra to correct the mass to within 0.01 % mass accuracy. All data were smoothed 
(twice over ten channels) using a Savitsky-Golay algorithm (Savitzky et al. 1964). 
The baseline was subtracted where necessary, and peaks centred according to area 
(95 % peak height with a minimum peak width of 5 channels at half peak height). 
Different species were identified by their molecular weight (Mw in Equations 2.4.1 
and 2.4.2). 
 
    
     
 
 
                        Equation 2.4.1 
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                      Equation 2.4.2 
 
where n = charge state, (m/z) = mass to charge ratio with n charges  
 
 
The experimental and expected molecular weights are shown in Table 2.4.3. All 
molecular weights match those predicted within 0.02 %. 
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Protein/Peptide  
involved in DSE Reaction 
Measured mass 
(Da) 
Calculated mass 
MW (Da) 
N-terminal Extension Peptides 
 
  
ENte 1644 1644 
ENte L10V 1630 1630 
ENte L10A 1602 1602 
ENte K9A 1587 1587 
ENte I11A 1602 1602 
ENte K9E 1645 1645 
ENte I11V 1630 1630 
E-HNte 1660 1660 
E-HNte E9K 1660 1659 
E-HNteV10L 1674 1674 
E-HNteV11I 1674 1674 
HNte
+
 1496 1496 
 
DSE Products 
 
  
PapDhis
# 
PapDhis* 
25,382 
25,527 
25,385 
25,529 
PapENtd - ENte 16,322 16,327 
PapENtd - ENte L10V 16,309 16,313 
PapENtd - ENte L10A 16,280 16,284 
PapENtd - ENte K9A 16,263 16,269 
PapENtd - ENte I11A 16,281 16,284 
PapENtd - ENte K9E 16,327 16,328 
PapENtd - ENte I11V 16,305 16,313 
PapENtd - E-HNte 16,348 16,342 
PapENtd - E-HNte E9K 16,337 16,342 
PapENtd - E-HNteV10L 16,353 16,357 
PapENtd - E-HNteV11I 16,354 16,357 
PapENtd - HNte
+
 16,171 16,178 
 
Chaperone-Subunit Complexes 
 
PapDhisPapENtd 
 
 
 
40,063 
 
 
 
40,064 
PapDhisPapHNtd1 
PapDhisPapK 
PapDhisPapANtd1G15N 
PapDhisPapFG8N 
PapDhisPapG 
42,262 
42,222 
41,285 
40,311 
60,994 
42,263 
42,222 
41,288 
40,314 
61,013 
   
Table 2.4.3 - A comparison between the calculated molecular masses based on amino acid sequences 
and the measured molecular masses from the nanoESI-MS analyses. 
+
 represents an N-terminally 
acetylated peptide. # and * correspond to PapDhis from PapDhisPapENtd and PapDhisPapHNtd1, 
PapDhisPapG, PapDhisPapANtd1G15N respectively. 
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2.4.15 Analysis of Mass Spectrometry Data 
2.4.15.1 Determination of Second-Order Rate Constants 
25 μM of chaperone-subunit complex, PapDhisPapENtd, was incubated at 25 ºC 
individually with each peptide at a concentration of 250 μM in 5 mM ammonium 
acetate pH 6.0.  Time points were taken every 30 min until a maximum of 8 h.  At 
each time-point, the chaperone-subunit and peptide mixture was diluted 1 in 10 with 
the internal standard PapDhisPapHNtd1 (2.5 μM final concentration in 5 mM 
ammonium acetate pH 6.0) before spraying immediately into the mass spectrometer.    
 
The concentration of PapDhisPapENtd versus time was determined by comparison of 
the PapDhisPapENtd ion intensity with that of the internal standard PapDhisPapHNtd1.  
Using these data, the protein concentration versus time was derived from the 
assumption that one chaperone-subunit complex reacts with only one Nte peptide, 
and hence the loss of chaperone-subunit is equal to the loss of peptide with time.  
The PapDhisPapENtd to PapDhisPapHNtd1 intensity ratio for the DSE reactions was 
then plotted versus time and fitted to equation 2.5 in each case using OriginPro7.5 
software (OriginLab Corpn., Northampton, MA, US) to determine the second order 
rate constant, k1.   
 
2.4.15.2 IMS-MS of Chaperone-Subunit-Usher Complexes 
All the ESI-IMS-MS data on the chaperone-subunit-usher ternary complexes were 
acquired by Bethny Morrissey (formerly University of Leeds). For these IMS-MS 
experiments, a ramped wave height of 3-11 V at a speed of 200 m/s was used. Drift 
times were corrected for both mass dependent and mass independent times, 
(Knapman et al. 2010) and  drift time cross-section functions were calibrated as 
previously described (Smith et al. 2009). The cross section corresponding to the 
lowest charge state was reported in each case. 
 
2.4.15.3 Computational Modelling of Chaperone-Subunit-Usher Complexes 
Computational cross-sections were calculated from Protein Data Bank (PDB) 
structures using the Leeds Method Algorithm (Smith et al. 2009; Knapman et al. 
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2010). PDB codes for the chaperone-subunit complex PapDPapFG8N (pdb 2W07) 
was used. Since no crystal structure is available for UsherN, the equivalent residues 
from the crystal structure in the Fim system were used from Type 1 pili (FimDNtd - 
res. 3-124) (pdb 1ZE3) (Phan et al. 2011) to estimate the collision cross section area. 
Tags used to aid purification of usher domains were not included in the modelled 
collision cross sectional area calculations.   
 
No solved crystal structures for Pap ternary chaperone-subunit-usher were available. 
As such, the chaperone-subunit:usher binding interface was predicted based on an 
equivalent chaperone-subunit:usher binding interface found in Type 1 pili, for which 
crystal structures are available (Eidam et al. 2008). For the ternary complexes 
involving UsherN, the chaperone-subunit complex, PapDPapX, was sequenced 
aligned with the equivalent FimCFimF chaperone-subunit complex in Type 1 pili 
from the FimCFimFUsherN crystal structure (Eidam et al. 2008) to create the 
modelled PapDPapXUsherN(Fim) complex. Rigid body docking was used in which 
structures were manually docked onto each other using Pymol (DeLano 2002) to 
predict the most expanded and compact ternary complexes.  
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Amyloid 
3.1. Introduction 
 
3.1.1 Amyloidosis 
The correct folding of proteins into their native, functional state is highly dependent 
on protein sequence, the environment, and the presence of chaperones (Anfinsen 
1973; Hartl 1996). If any of the above conditions is altered, protein misfolding can 
occur resulting in disease. Amyloidosis is the term given to protein 
misfolding/aggregation that results in long straight, unbranched polymers with a 
cross-β structure termed amyloid fibrils. These amyloid fibril structures are 
associated with over thirty different diseases, the most common of which in humans 
are Alzheimer’s, Parkinson’s and Type II diabetes mellitus (Chiti et al. 2006). 
 
Amyloid fibrils are typically characterised by their ordered array of β-strands 
running perpendicular to the fibril long axis, termed a cross-β structure (Figure 
3.1.1A). This cross-β structure is shown clearly in X-ray fibre diffraction data 
whereby the signals present correspond to the distance between β-strands within the 
β-sheets (4.7 Å) and the spacing between β-sheets (10 Å) (Figure 3.1.1A, B) (Luhrs 
et al. 2005). Imaging of these fibrils by electron microscopy is also used to confirm 
amyloid fibril formation with long, straight, twisted fibrils being the typical 
characteristics observed (Figure 3.1.1C) (Gras et al. 2011). The presence of amyloid 
fibrils is also demonstrated by their ability to bind dyes such as Congo red and 
Thioflavin T (ThT). Congo red is used to stain amyloid fibrils in tissues and exhibits 
apple-green birefringence upon visualisation with polarised light (Ladewig 1945; 
Westermark et al. 1999; Hatters et al. 2011). Thioflavin T binds amyloid fibrils and 
causes an increase in fluorescence at 480 nm on excitation at 440 nm (Naiki et al. 
1989; Biancalana et al. 2010).   
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Figure 3.1.1 - Characterisation of Amyloid Fibrils A) Molecular model (PDB file: 2BEG) of the 
cross-β structure suggested for the Aβ1-42 amyloid fibrils associated with Alzheimer’s disease (Luhrs 
et al. 2005); B) X-ray fibre diffraction pattern of amyloid fibrils showing scattering at 4.7 Å and 10 Å 
corresponding to the distance between the β-strands within the β-sheets and the distance between β-
sheets, respectively; C) Electron microscopy image of long, straight beta-2 microglobulin amyloid 
fibrils (taken myself). Scale bar represents 200 nm. A and B were adapted from Luhrs et al. (Luhrs et 
al. 2005) and Stromer et al. (Stromer et al. 2005), respectively. 
 
 
3.1.2 Mechanism of Amyloid Formation 
Amyloid formation is thought to follow a typical nucleated growth mechanism 
comprising a lag phase (or nucleation phase) and an elongation phase (Figure 3.1.2). 
The lag phase is the rate-limiting step whereby monomers unfold and rearrange to 
form the critical nucleus that is rapidly extended to form mature fibrils during the 
elongation phase (Harper et al. 1997; Chiti et al. 2003; Xue et al. 2008; Kashchiev et 
al. 2010). Interestingly, this lag phase can be eliminated by the addition of short pre-
formed amyloid fibrils, called seeds, at the start of the reaction (Figure 3.1.2).   
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Figure 3.1.2 - Kinetics of amyloid fibril formation by a de novo nucleation-dependent mechanism 
(red) or after addition of amyloid seeds (blue). De novo fibril formation comprises a nucleation (lag) 
phase whereby monomers rearrange to oligomers before reaching the critical nucleus, and an 
elongation phase whereby the nucleus rapidly extends resulting in amyloid fibril formation. If 
amyloid seeds are added to monomeric protein (blue), the lag phase is reduced and the elongation 
phase is evident immediately.  
 
 
During the lag phase of fibril formation, monomers are thought to assemble into 
oligomeric species. The presence of these heterogeneous oligomeric intermediates 
has been shown to correlate with amyloid disease progression (Lue et al. 1999; 
Wang et al. 1999; Tomic et al. 2009). It has been suggested that the oligomers 
formed during fibrillogenesis are the toxic species rather than the fibril end products 
themselves (Bucciantini et al. 2002; Reixach et al. 2004; Winner et al. 2011). 
Attention has turned to the structure of these amyloidogenic intermediates and their 
role in toxicity. The structure of the amyloidogenic intermediates of an amyloid 
forming protein beta-2 microglobulin (β2m) will be the main focus of this thesis 
chapter.  
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3.1.3 Beta-2 microglobulin 
β2m is a 99-residue protein that is the light chain of the non-covalently bound major 
histocompatibility complex 1 (MHC 1). In its native state, β2m consists of seven β-
strands (A-G) arranged as two β-sheets (ABED and CFG) in a β sandwich fold 
connected by a disulphide bond between residues Cys 25 and Cys 80 (Figure 3.1.3 
and 3.1.4). In healthy individuals, β2m dissociates from the MHC I complex and 
circulates in the blood before being degraded by the kidneys (Figure 3.1.3) (Floege 
et al. 1996); however, in patients with kidney failure who undergo long-term 
dialysis, the concentration of β2m increases up to 60-fold due to its lack of removal 
by the kidneys (Floege et al. 1996). Eventually, in these cases, β2m is found 
deposited as amyloid fibrils in osteoarticular tissues, resulting in a condition termed 
dialysis-related amyloidosis (DRA) (Floege et al. 1996).  
 
 
 
Figure 3.1.3 - Dialysis related amyloidosis (DRA) schematic showing β2m (PDB file: 2YXF) (Iwata 
et al. 2007) dissociating from the major histocompatibility complex 1 (MHC 1). β2m circulating in the 
blood is then either degraded by the kidneys and removed from the body or in the case of renal 
failure, accumulates in the body and forms fibrils that lead to bone and joint destruction causing the 
condition dialysis related amyloidosis (DRA).  
 
 
Despite the wealth of information in the literature on DRA, the precise mechanism of 
β2m amyloid assembly remains unknown. In vitro studies have shown β2m remains 
soluble at pH 7.5 with no evidence of amyloid formation even after 100 days of 
incubation at 37 ºC (Eichner et al. 2009). Additional biological factors such as the 
patients’ age (Van Ypersele de Strihou et al. 1991), the duration of kidney failure 
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(Davison 1995) and post-translational modifications of β2m (Capeillereblandin et al. 
1991; Miyata et al. 1996; Niwa et al. 1997; Esposito et al. 2000; Bellotti et al. 2001; 
Heegaard et al. 2002) are needed to facilitate amyloid formation in vivo. 
 
 
3.1.4 β2m Fibril Formation in vitro 
Amyloid fibrils can be formed in vitro from wild-type human β2m at pH 2.5 in a 
short time-scale using low ionic strength (< 100 mM) buffer (Kad et al. 2001). The 
highly dynamic acid-unfolded β2m forms long straight, unbranched, twisted fibrils 
(as observed by electron microscopy) via a nucleation-dependent mechanism (Xue et 
al. 2008) (Figure 3.1.2). Fibrils formed at acidic pH display all the hallmarks of 
amyloid including a cross-β fibre diffraction pattern, Congo red birefringence, 
nucleation-dependent polymerisation kinetics, in addition to binding thioflavin T, 
apolipoprotein E, glycosaminoglycans, the serum amyloid P component and the anti-
amyloid antibody WO1 (Smith et al. 2003; Gosal et al. 2005; Myers et al. 2006) 
(Figure 3.1.1). 
 
Approximately 60 % of the β2m sequence, as determined using small synthetic 
peptides and theoretical prediction algorithms (Kozhukh et al. 2002; Hasegawa et al. 
2003; Ivanova et al. 2003; Jones et al. 2003; Ivanova et al. 2004; Pawar et al. 2005; 
Ivanova et al. 2006), has the potential to assemble into amyloid fibrils in vitro. In full 
length β2m only a small region (residues 60-70) has been shown to affect fibril 
nucleation and elongation kinetics at pH 2.5 and low ionic strength (Platt et al. 2008; 
Routledge et al. 2009). This region contains six aromatic residues and is predicted to 
be highly aggregation prone (Pawar et al. 2005); however, contrasting proline 
scanning studies have revealed additional residues (Leu23, His51 and Val82) crucial 
in elongating fibril seeds (Chiba et al. 2003). Both the thermodynamics involved in 
fibril assembly and the stability of the fibrils affect the assembly of β2m amyloid 
fibrils (Plattt et al. 2005; Routledge et al. 2009). The presence of the disulphide bond 
between the β-strands B and F which introduces residual structure into the acid-
unfolded state is crucial for long-straight amyloid fibril formation (Smith et al. 2001; 
Hasegawa et al. 2003).  
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Figure 3.1.4 - MHC 1 complex (PDB file: 2X70) (Celie et al. 2009) showing the heavy α-chain (black 
ribbon) and the light chain (β2m coloured). The non-covalently bound β2m molecules that are released 
aggregate into fibrils associated with the human disease DRA. The β-strands of the β2m molecule are 
labelled A-G.  
 
It is only once β2m is released from MHC 1 that amyloid formation occurs; hence, it 
is important to note the structural contacts β2m makes with MHC 1 since these 
regions are exposed on release from the MHC 1 complex. The D β-strand and the 
connecting DE loop of β2m are involved in strong binding to the α-chain of MHC 1. 
Mutations in this loop (e.g. W60G) have been shown to prevent MHC 1 assembly 
(Esposito et al. 2008). On release from the MHC 1 complex this D β-strand becomes 
highly dynamic (Hodkinson et al. 2009) and aggregation-prone (Esposito et al. 2008; 
Ricagno et al. 2008; Santambrogio et al. 2010). 
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3.1.5 Fibril Formation as monitored by ESI-MS 
Mass spectrometry has enabled significant structural advances in the understanding 
of the mechanism of amyloid formation, in particular concerning the oligomeric 
intermediates on- or off-pathway to fibril formation (Ashcroft 2010). From ESI-MS 
alone, structural details about monomeric proteins are immediately evident based on 
their charge state distribution in the m/z spectrum (Introduction Section 1.6, Figure 
1.8). Studies on the intrinsically disordered protein, α-synuclein monomer whose 
aggregation is associated with Parkinson’s disease, has shown multiple distinct 
populations present in the mass spectrum (Frimpong et al. 2010; Natalello et al. 
2011). Monomeric β2m has been studied extensively by ESI-MS, revealing 
predominantly one native-like conformation at neutral pH. β2m is thought to 
populate three distinct conformations at low pH (a compact, partially compact and 
expanded structure) (Figure 3.1.5) (Borysik et al. 2004; Smith et al. 2007).  
 
 
 
Figure 3.1.5 - ESI mass spectra of β2m at A) pH 6.23 and B) pH 2.6. The charge state distributions 
corresponding to the different β2m conformations are highlighted as red Gaussian curve. This Figure 
was adapted from Smith et al. (2007). 
 
Recent advances in IMS-MS have enabled detailed structural characterisation of co-
populated amyloidogenic intermediates that is not possible by ESI-MS alone. The 
peptide Aβ, whose assembly into amyloid fibrils is associated with Alzheimer’s 
disease, is just one of many examples that have been studied extensively by ESI-
IMS-MS (Bernstein et al. 2005; Berstein et al. 2009; Kloniecki et al. 2011; Gessel et 
al. 2012a; Gessel et al. 2012b). Recent work in this area by Bowers and co-workers 
has suggested two alternative pathways of fibril formation for the peptides Aβ40 and 
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Aβ42. Aβ40 forms compact tetramers that slowly convert into amyloid fibrils, whereas 
Aβ42 forms hexamers and dodecamers on the same time-scale, consistent with its 
more aggregation-prone tendency (Bernstein et al. 2009). 
    
ESI-IMS-MS has also been used to separate structurally distinct β2m monomeric 
conformations based on their shape and charge (Smith et al. 2007). The compact 
conformer present at low pH is comparable by collision cross-section calculations to 
the native β2m monomer structure (Smith et al. 2009) as characterised by NMR 
(Verdone et al. 2002; Eichner et al. 2011) and X-ray diffraction (Trinh et al. 2002) 
showing that significant structure is still present to some extent under denaturing 
conditions.  
 
ESI-IMS-MS can also be used to separate individual non-covalently bound 
oligomeric species from the highly heterogeneous samples present during amyloid 
formation. This technique has advantages over other biochemical techniques such as 
fluorescence or light-scattering which only report an average of all the oligomeric 
species present in solution. ESI-IMS-MS has been used previously to observe small 
β2m oligomers on-pathway to long, straight fibril formation at pH 2.5 in vitro; 
however, no large oligomers (> hexamer) were observed under these conditions 
(Smith et al. 2010). This lack of higher ordered species observed combined with 
numerical modelling studies suggests six non-covalently bound β2m monomers come 
together to form a nucleus which rapidly extends by monomer addition into mature 
amyloid fibrils (Xue et al. 2008; Smith et al. 2010). Collision cross-section 
measurements of the β2m oligomers at low pH and ionic strength have allowed 
further structural insight into β2m amyloid fibril formation. The collision cross-
sections of the β2m oligomers observed are consistent with a stacked conformation 
of end-to-end β2m monomers rather than an alternative more compact, globular 
arrangement (Smith et al. 2010) (Figure 3.1.6).   
 
122 
 
 
Figure 3.1.6 - Collision cross-sections of β2m monomer and oligomers at pH 2.5 (black circles) along 
with a range of protein standards (open triangles). The cross-section of the disulphide bond-reduced 
β2m monomer (β2m-red), elongated/acid unfolded (β2m-A), partially compact (β2m-P), 
compact/native (β2m-N) are shown with the average cross-sections of all the dimer (D), trimer (T) and 
tetramer (Q) charge state ions. The linear I27 concatanated pentamer, (I27)5 and more compact 
protein standards human leukocyte antigen complex 1 (HLA-1) and transthyretin (TTR) as analysed 
at pH 6.5 are highlighted for comparison with the β2m oligomer cross-sections. The solid line 
represents the cross-sections expected for a range of molecular weights assuming a sphere of density 
0.44 Da/A
3
. The dotted line shows the assembly of β2m. This Figure was adapted from Smith et al. 
(2010). 
  
 
Here, mass spectrometry in parallel with other biochemical techniques was used to 
unravel structural details at the molecular level of the β2m oligomeric intermediates 
involved in amyloid fibril formation at pH 2.5. By creating single point mutations 
throughout the β2m sequence and subsequent analysis of the fibril formation kinetics, 
new residues important in β2m fibrilogenesis were revealed building on previous 
experiments by Routledge et al. and Platt et al. (Platt et al. 2008; Routledge et al. 
2009). One variant in particular, H51A, on further analysis by ESI-IMS-MS revealed 
striking differences not only in the oligomer number compared to wild-type β2m, but 
also differences in the structural dynamics of the oligomers formed consistent with a 
role in impeding amyloid fibril formation.   
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3.2. Amyloid 
Results and Discussion 
3.2.1 β2m mutagenesis 
Although several hypotheses have been put forward, the nature of the interfaces 
between β2m monomers within different oligomeric species during fibril formation is 
yet to be determined. To unravel details of these structural intermediates, 
mutagenesis was performed on a variety of residues throughout the β2m sequence 
(Figure 3.2.1). We hypothesised that a mutated residue present in an oligomeric 
interface could affect the stability of that oligomer, and may result in differences in 
its fibril formation kinetics compared with the wild-type protein. Alternatively, if the 
mutated residue was not involved in oligomer formation, the oligomer stability 
should remain comparable with that of the wild-type protein. In all cases, 
mutagenesis to alanine was performed due to its small side chain and its inability to 
undergo hydrogen bonding and partake in electrostatic interactions. 
 
Figure 3.2.1 – Native β2m structure (blue ribbon) (PDB file:2YXF) (Iwata et al. 2007) showing the 
position of the variants (red sticks) used to probe the structural interface of the β2m oligomeric 
intermediates.  
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All β2m variants were expressed and purified by ion exchange chromatography 
followed by size exclusion chromatography (SEC) (Materials and Methods Section 
3.4.3). Wild-type β2m, L64A, H84A and 
15
N H51A were expressed and purified by 
myself. The F30A, Y63A, L54A and R97A proteins were kindly provided by 
Thomas Jahn (formerly University of Leeds). The H51A and V82A proteins were 
kindly provided by Katy Routledge (formerly University of Leeds). All variants were 
confirmed to be pure by SDS-PAGE, monomeric by SEC (data not shown) and each 
was identified by their correct molecular weight using ESI-MS by myself (Materials 
and Methods Section 3.4.5, Table 3.3.3). One example of a typical purification is 
shown in Figure 3.2.2 below.  
 
Figure 3.2.2 - Expression and purification of the β2m variant, L64A. A) Anion exchange 
chromatography where the first peak corresponds to L64A; B) SEC showing a single monomeric peak 
eluting off the Superdex 75 column; C) SDS PAGE showing pure β2m L64A and the molecular 
weight markers (Da); D) ESI-MS of purified L64A β2m of correct molecular weight (expected mass = 
11818 Da).  
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An example of the data obtained from protein purification is shown for the β2m 
variant L64A (Figure 3.2.2). Two peaks typically eluted off the column during anion 
exchange chromatography (Figure 3.2.2A), the first larger peak corresponded to the 
protein of interest and the second peak to other protein impurities present in the 
sample (data not shown). SEC data confirmed the L64A β2m variant was 
monomeric, with only a single peak eluting off the Superdex 75 column (Figure 
3.2.3B). Other peaks were occasionally observed during SEC with the other β2m 
variant corresponding to dimer and other higher order β2m oligomers (data not 
shown). In these cases, only the peak corresponding to the monomeric protein was 
collected for further experiments. The final purity of the β2m L64A variant was 
confirmed by SDS-PAGE (Figure 3.2.2C) and ESI-MS confirmed the molecular 
weight of the β2m variant protein to within a mass accuracy of 0.01 % compared 
with that predicted based on the protein’s amino acid sequence (Figure 3.2.2D) 
(Materials and Methods Section 3.4.5, Table 3.4.3).    
 
3.2.2 Fibril formation of β2m variants at pH 2.5 
All β2m variants were selected since they have been shown previously to form fibrils 
at pH 2.5 in 25 mM sodium phosphate, 25 mM sodium acetate (Routledge et al. 
2009). Since mass spectrometry will be the primary tool in this thesis to study the 
oligomers formed during fibril formation, a volatile buffer compatible with ESI-MS 
was needed in which amyloid fibrils form. Fibril formation, therefore, was 
performed with the wild-type protein and all the other β2m variants in 100 mM 
ammonium formate pH 2.5, incubating at 37 ºC with agitation at 600 rpm (Smith et 
al. 2010). On analysis by negative stain EM, all β2m variants formed fibrils with a 
long straight morphology comparable to that of wild-type β2m in 100 mM 
ammonium formate pH 2.5 (Figure 3.2.3). The volatile mass spectrometry buffer 
used here does not affect the fibril morphology and, therefore, was the buffer used 
throughout this thesis chapter.      
 
Using low resolution techniques such as EM, very few differences are observed in 
the final fibril morphology between the β2m variants, showing that these single 
amino acid substitutions do not grossly alter the course of amyloid fibril formation. 
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If any amino acid side chains altered are present in the oligomer interfaces or are 
involved in oligomer formation, differences in the fibril formation kinetics might be 
expected. Experiments by Routledge et al. have shown the lag times of fibril 
formation to increase by up to 3-fold in the case of the H51A variant compared with 
that of the wild-type β2m protein (Routledge et al. 2009). 
 
 
Figure 3.2.3 – Negative stain electron microscopy of fibrils formed in 100 mM ammonium formate 
pH 2.5, 37 ºC, 600 rpm, by wild-type β2m and the β2m variants, F30A, H51A, L54A, Y63A, L64A, 
H84A, V82A and R97A. The scale bar in each case represents 200 nm.   
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3.2.3 Fibril formation kinetics of β2m variants  
Thioflavin T (ThT), an amyloid fibril binding dye (see Section 3.1.2), was added to 
fibril growth assays of each variant to monitor the rate of fibril formation (Materials 
and Methods Section 3.4.8). Due to difficulties in reproducing lag times of fibril 
formation accurately between experiments, wild-type β2m was analysed 
simultaneously with each of the β2m variants in parallel on each day of analysis and 
the fold change in lag time (Materials and Methods Section 3.4.9) for each variant 
was compared with that of the wild-type β2m (Figure 3.2.4). Of the β2m variants 
studied, F30A, Y63A, L64A, H84A and R97A all have a lag time comparable to that 
of the wild-type β2m (Figure 3.2.4) suggesting these mutations do not affect the rate 
of amyloid fibril formation at pH 2.5. 
 
 
    
Figure 3.2.4 - Comparison of the kinetics of fibril formation of the variants F30A, H51A, Y63A, 
L64A, V82A, H84A and R97A with respect to wild-type (red). The fold change in lag time compared 
to wild-type β2m is shown for comparison. The horizontal blue lines represent ± 1 standard deviation 
from 5 repeats of the wild-type β2m proteins lag time. The variants, H51A and V82A, which show 
repeatedly different lag times compared with the wild-type β2m, are highlighted in blue and purple, 
respectively, and marked with an asterisk. The error bars (where shown) represent ± 1 standard 
deviation. All experiments were performed in 100 mM ammonium formate pH 2.5, shaking at 600 
rpm (Materials and Methods 3.4.8).     
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The removal of a charged residue towards the C-terminus of β2m in the variant, 
R97A, has previously been shown to enhance the ability of β2m to form fibrils at pH 
7.0 (Jones et al. 2003). At pH 2.5 the lag time of fibril formation is comparable to 
that of the wild-type protein (Figure 3.2.4). This is most likely due to the lack of 
native structure in the C-terminus of the monomeric β2m at the low pH used in this 
study. Val82 was the only residue that decreased the lag time of fibril formation on 
substitution to alanine. Val82 is located close to the disulphide bond (Cys80) and has 
been shown to slow fibril formation on mutation to proline (Chiba et al. 2003). The 
nature of the backbone and side-chains around the disulphide bond in β2m appears to 
be important in determining the rate of amyloid fibril formation, even at low pH.      
 
Figure 3.2.5 - Structures of β2m highlighting the different conformations of the D stand (green) 
between free β2m (PDB file: 1LDS) (Trinh et al. 2002) and the MHC 1 bound form (PDB file: 
3AM8). The location of the His51 is highlighted in blue on each structure.   
 
The following Sections (3.2.3 to 3.2.6) focus in more detail on the β2m variant, 
H51A, since this is the only variant shown here to increase the lag time of fibril 
formation significantly (Figure 3.2.4). His51 is located on the D strand of native β2m 
and is involved in the non-covalent binding of β2m to MHC 1 (Figure 3.2.5). All 
crystal structures to date show a bulged D-strand in complex with MHC 1 with the 
residue Asp53 (the β-bulge residue at the centre of the D strand) hydrogen bonded to 
Arg35 on the MHC 1 (Shields et al. 1998). On release from the MHC 1 complex, 
this D-strand becomes solvent exposed and thus may be involved in initiating β2m 
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aggregation. Crystal structures of free β2m have shown that the D-strand can adopt a 
straight conformation (Figure 3.2.5A), with this regular edge strand thought to be 
involved in promoting aggregation (Trinh et al. 2002). More recent observations 
have suggested the D-strand adopts a bent conformation in the β2m oligomeric state 
(Calabrese et al. 2008). These studies were performed at neutral pH upon addition of 
Cu
2+
, and not under the acidic conditions used in this thesis. NMR studies 
additionally have indicated that the D-strand is very flexible in solution (Okon et al. 
1992; Verdone et al. 2002) with molecular dynamics simulations showing the 
straight D-strand to be populated increasingly on decreasing pH (Park et al. 2006). 
On transition of the D-strand from the bent to the straight conformation (Figure 
3.2.5), His51 rotates 180º. Substitution of this residue to alanine is thought to cause 
slight structural perturbations in the D-strand conformation, which results in 
increased lag time of amyloid formation observed in this thesis (Figure 3.2.6).  
 
Figure 3.2.6 - Plot of the normalised ThT kinetics of fibril formation for β2m wild-type (red) and 
H51A (blue). One replicate is shown for simplicity and a sigmoidal curve fitted to guide the eye 
through the data points. Data was acquired using the PTI spectrofluorimeter (Materials and Methods 
Section 3.4.8.2). 
 
At neutral pH, native-like features are present in the β2m amyoidogenic intermediate 
(Jahn 2006). Under acidic conditions, β2m is unfolded with very little secondary 
structure persists (Plattt et al. 2005; Smith et al. 2010). The extent as to which the 
conformation of the D strand in β2m plays a role  at pH 2.5 in amyloid fibril 
formation is unknown and remains to be determined.   
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ThT fluorescence is a powerful technique for analysing fibrillation kinetics, but it 
does not report on the oligomeric species formed during the lag phase of 
fibrillogenesis (Figure 3.2.6). Mass spectrometry is an ideal technique for the 
analysis of these intermediates since it can detect individual oligomeric species from 
within a heterogeneous mixture, but also give an idea of the shape of these oligomers 
through the use of IMS-MS. ESI-MS/ESI-IMS-MS was used, therefore, to unravel 
any structural differences in the oligomeric intermediates between H51A and wild-
type β2m formed at pH 2.5 which may explain the differences in ThT kinetics 
observed (Figures 3.3.4 and 3.2.6). 
 
3.2.4 Comparison of ESI Mass Spectra from wild-type β2m and H51A  
Previous ESI-MS studies have analysed the conformers formed within monomeric 
β2m at different pH values together with their role in initiating fibril formation 
(Borysik et al. 2004; Borysik et al. 2004; Smith et al. 2007). Both β2m (Figure 3.1.6) 
and the β2m variant H51A (data not shown) populate three distinct monomeric 
populations at pH 2.5, an unfolded, partially folded and compact state. Here, we 
chose to investigate β2m oligomers on-pathway to amyloid fibril formation and their 
role in fibrillogenesis. On initial dilution of lyophilised wild-type β2m into 100 mM 
ammonium formate pH 2.5 oligomers up to trimer were instantly observed in the ESI 
mass spectrum (Figure 3.2.7). In contrast, with the H51A variant, many more higher 
ordered oligomers were present in the H51A m/z spectrum compared with those 
detected for wild-type β2m (Figure 3.2.7). For H51A, charge state distributions 
corresponding to oligomers up to a pentamer in size are observed clearly suggesting 
the H51A variant is more highly aggregation prone compared with wild-type β2m at 
low pH. 
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Figure 3.2.7 - ESI-MS mass spectra of wild-type β2m (A) and H51A (B) over 2500-5000 m/z range in 
100 mM ammonium formate pH 2.5. The charge states corresponding to the dimer (D), trimer (T), 
tetramer (Q) and pentamer (P) are highlighted. The spectra were obtained 1 min after dissolution of 
each protein into the MS buffer at pH 2.5.  
 
The ESI-MS mass spectra of wild-type β2m and H51A show several oligomeric 
species contributing to the same m/z ratio. For example, at m/z 2949.5 in the H51A 
mass spectrum, co-populated species are present corresponding to the 8+ dimer, 12+ 
trimer and 16+ tetramer ions, and at m/z 3932.2 the 6+ dimer, 9+ trimer, 12+ 
tetramer and 15+ pentamer ions (Figure 3.2.7B). The added dimension of ion 
mobility spectrometry was used to separate these co-populated species. The IMS-MS 
driftscope plots of wild-type β2m and the β2m variant H51A in 100 mM ammonium 
formate pH 2.5 are shown in Figure 3.2.8. The data show the power of IMS in 
separating multiple populations within a single sample, and as a result, each 
oligomer was assigned uniquely based on its m/z value and isotopic distribution. On 
comparison of the arrival time distributions for the oligomeric complexes, the higher 
order species were found to have a shorter drift time compared with lower order 
species of the same m/z. Charge also has an effect on the arrival time distribution, 
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with lower charged ions taking longer to reach the detector than more highly charged 
species. 
For wild-type β2m and H51A, oligomeric species up to hexamer are observed one 
minute after dilution into pH 2.5 buffer (Figure 3.2.8), albeit these larger species 
being in very low abundance (< 5% of the total ion count) (Figure 3.2.7). The 
additional IMS separation can not only distinguish between oligomers of same m/z, 
but can also enable identification of higher order oligomers by separating them from 
ions coming from the buffer.   
 
 
Figure 3.2.8 - ESI-IMS-MS of A) wild-type β2m and B) the H51A β2m variant in 100 mM ammonium 
formate pH 2.5. The mass spectrum in each case is shown on the right and the oligomers highlighted 
(monomer-red, dimer-orange, trimer-yellow, tetramer-green, pentamer-blue, hexamer-purple). The 
spectra were obtained 1 min after dissolution of each protein into the MS buffer at pH 2.5.  
 
The collision cross-sectional areas for all charge states arising from all of the wild-
type and H51A oligomers were estimated from the experimental data (Materials and 
Methods Section 3.4.10.2), and the lowest charge states shown in Figure 3.2.9 for 
comparison. The cross-section of the wild-type and H51A oligomers were identical 
within the experimental error (5 %). Consistent with previous characterisation of 
β2m oligomers by ESI-IMS-MS (Smith et al. 2010), the oligomers adopt a more 
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extended structure compared with that of globular proteins. The cross sections of an 
end-to-end linked concatamer of five titin I27 Ig domains (I27)5 (52 kDa; 4,297 Å
2
) 
and the globular transthyretin tetramer (TTR) (47 kDa; 2,900 Å
2
) were determined 
by Dr. David Smith experimentally (formerly University of Leeds) (Smith et al. 
2010) and are shown as a comparison. The wild-type β2m tetramer has a collision 
cross-section of 4172 Å
2
 and the collision cross-section of the H51A tetramer is 
4067 Å
2
, which is consistent with a more expanded than globular structure, 
comparable with previously published data (Smith et al. 2010). 
 
 
Figure 3.2.9 - Collision cross-sectional areas for the lowest charge state ions measured by ESI-IMS-
MS for β2m wild-type and H51A monomer. and their oligomers. The cross-sections for the 
transthyretin tetramer (TTR) and (I27)5 (a linear pentamer of I27 domains) as determined by Dr. 
David Smith (formerly University of Leeds) are shown for comparison (Smith et al. 2010) along with 
their structures (TTR PDB file:1ICT, (I27)5 PDB file:1TIT). The solid line represents the expected 
cross-sections calculated for a range of molecular weights assuming a perfect sphere of density 0.44 
Da/Å
3
. The dotted line is simply to guide the eye through the data points.   
 
Although more oligomers of higher order are populated initially at low pH for the 
H51A β2m variant compared with wild-type β2m, it is interesting to compare how the 
oligomer distribution changes throughout the lag time of fibril formation. An 
experiment was set up whereby wild-type β2m or the H51A variant were incubated 
separately at 37 ºC, shaking at 600 rpm, in 100 mM ammonium formate pH 2.5. At 
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various time points, samples were removed for analysis by ThT fluorescence 
analysis (to determine how far the sample was through the lag-phase of fibril 
formation) and were simultaneously analysed by ESI-IMS-MS (Materials and 
Methods Sections 3.4.8.2 and 3.4.10.2). The ESI-IMS-MS mass spectra for H51A 
and wild-type β2m at 50 % through the lag phase of fibril formation are shown in 
Figure 3.2.10. 
 
 
Figure 3.2.10 - ESI-IMS-MS of A) wild-type β2m and B) the H51A β2m variant in 100 mM 
ammonium formate pH 2.5 at 50 % of the lag phase of amyloid fibril formation (1 h and 1.5 h, 
respectively). The monomer and oligomers are highlighted in both Driftscope plots (monomer-red, 
dimer-orange, trimer-yellow, tetramer-green, pentamer-blue).   
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On analysis of the ESI-IMS-MS driftscope plot for wild-type β2m, oligomers up to 
tetramer are readily observed (Figure 3.2.10A). One charge state is also visible 
corresponding to the 13+ pentamer; however, this is very low in abundance. In 
comparison with the same ESI-IMS-MS driftscope plot taken at 0 % through the lag 
phase of fibril formation, the oligomer population has decreased (for example, 
charge state distributions corresponding to the pentamer and hexamer are no longer 
observed 50 % into the lag phase) suggesting these oligomers have rapidly extended 
into pre-fibrillar species or into amyloid fibrils (Figures 3.2.8A and 3.2.10A). At the 
end of the lag phase, all oligomer peaks disappear and the sample becomes 
challenging to spray into the gas phase, presumably due to the high population of 
insoluble amyloid fibrils present. This suggests the oligomers observed are on-
pathway or transient off-pathway species formed during amyloid fibril formation 
since very little remain detectable at the end of the lag phase post-fibril formation. 
 
The higher order oligomers are still populated for the H51A variant at 50 % of the 
lag phase (Figure 3.2.10B). It is possible that these oligomers are slower to convert 
into amyloid fibrils and hence remain visible by ESI-IMS-MS for longer time 
periods compared with wild-type β2m. These subtle differences in the oligomer 
structure may not be evident from low resolution cross-section measurements alone. 
Therefore, the oligomers formed from wild-type β2m and H51A were investigated 
further by CID-MS and subunit exchange dynamics to determine whether any 
differences in the stability of the oligomers could explain the differences in the lag 
time of fibre assembly of the two proteins.  
 
 
3.2.5 Gas Phase Oligomer Stability using ESI-CID-MS  
Since no structural differences were apparent in the oligomer collision cross-sections 
between wild-type β2m and the H51A variant by ESI-IMS-MS, the gas phase 
stability of the oligomers formed was further investigated by the use of CID-MS. If 
His51 is involved in the dimer interface, then the gas phase dimer stability may be 
affected. Ions corresponding to the 9+ dimer of wild-type β2m and H51A were 
separately selected in the quadrupole of the Synapt HDMS mass spectrometer and 
subjected to CID fragmentation in the trap region. On increasing the collision energy 
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applied to the dimer 9+ ions, product ions were detected corresponding to the wild-
type β2m or H51A monomers (Figures 3.2.11, 3.2.12). The fragmentation profiles for 
wild-type and the H51A dimer are identical suggesting both dimers have the same 
gas phase stability under the ESI-MS conditions used here. 
 
 
Figure 3.2.11 - ESI-CID-MS fragmentation profile for the wild-type dimer 9+ (m/z 2637) (red) and 
the H51A dimer 9+ (m/z 2622) (blue). One example is shown for simplicity. In each case the dimer 
9+ was selected in the transfer region of the Synapt HDMS for fragmentation by CID.  
 
The products of CID-MS have been used to unravel structural details including 
subunit stoichiometries, in addition to detecting ligand binding to multi-complex 
protein assemblies (McCammon et al. 2005). Typically during CID, the internal 
energy provided to dissociate the protein complex causes one subunit to unfold, 
taking the majority of the charge with it, before it is finally released and the product 
ions detected (Sciuto et al. 2011). This is termed asymmetric division since the 
charge is not equally distributed between the product ions in the m/z spectrum 
(Figure 3.2.12B). Alternatively, although relatively uncommon, symmetrical division 
can occur. In this case, the energy needed to dissociate the complex is much less than 
the energy needed to unfold one of the subunits, resulting in product ions of equal 
charge in the m/z spectrum (Figure 3.2.12A) (Dodds et al. 2011). On comparison of 
surface induced dissociation (SID) and CID experiments on protein complexes, 
Wysocki and co-workers suggested that analysis of the charge distribution in the 
product ion spectrum can reveal information about the nature of the protein-protein 
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interaction present (Dodds et al. 2011). For example, if electrostatic interactions are 
present at the protein-protein interface which are particularly stable in the gas phase, 
subunit unfolding is likely to occur resulting in asymmetric division. Alternatively, if 
only hydrophobic interactions are present, then symmetric division will be more 
favourable (Dodds et al. 2011).     
 
 
Figure 3.2.12 - Schematic of dimer CID dissociation behaviours; A) symmetrical division where the 
energy for subunit unfolding is greater than that of subunit dissociation; B) asymmetrical division 
where the energy for subunit dissociation is greater than subunit unfolding resulting in one subunit 
unfolding prior to subunit dissociation, taking majority of the charge with it. The two different 
monomers are shown as blue and red balls. 
 
The product ions resulting from CID-MS of the wild-type β2m and H51A 9+ and 
11+ dimers are shown in Figure 3.2.13. In all cases, the most abundant product ions 
are the 4+ and 5+ monomer, and the 5+ and 6+ monomer for the dimers 9+ and 11+ 
respectively. This symmetric division suggests that the wild-type and H51A dimers 
are held weakly together in the gas phase by predominantly hydrophobic, rather than 
electrostatic interactions. Further experimental evidence is needed to confirm the 
nature of this interaction. Since the dimers here are formed at pH 2.5 where little 
residual structure is present in the β2m monomer, it is possible the lack of subunit 
unfolding upon CID activation is simply due to the β2m monomer already being 
slightly unfolded in the dimer and thus further unfolding cannot be observed. The 
β2m trimer was also observed to undergo symmetrical division (data not shown), 
suggesting the nature of the monomer-monomer interface and dimer-monomer 
interface could be conserved. 
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Figure 3.2.13 – ESI-CID/MS Product ion spectrum of wild-type β2m (red) and H51A (blue) of dimer 
9+ (A, B, C, D) and dimer 11+ (E, F, G, H) at a collision energy of 0 eV (A, C, E, G) and 80 eV (B, 
D, F, H). The ions relating to the dimer and monomer ions are labelled D and M respectively. 
 
Unfortunately, no differences were observed by CID-MS between wild-type β2m and 
the H51A β2m variant (Figures 3.2.11 and 3.2.13). The gas phase stability cannot be 
used to explain differences in fibrillation kinetics; therefore, the subunit dynamics of 
the oligomers formed during amyloid fibril formation were next investigated.  
 
 
3.2.6 Measuring Subunit Dynamics by ESI-MS  
The dynamics of the β2m oligomers formed during fibrillogenesis can be determined 
using subunit exchange experiments whereby 
14
N and 
15N β2m oligomers are mixed 
and the rate of exchange between the two species monitored by ESI-IMS-MS (Smith 
et al. 2010). If the oligomers are dynamic entities and undergo rapid exchange with 
one another, then mixed oligomers containing both 
14
N and 
15
N protein will be 
present in the mass spectrum (Figure 3.2.14). For example, three peaks would be 
observed for a rapidly exchanging dimer in a 1:2:1 ratio (
14
N/
14
N, 
14
N/
15
N and 
15
N/
15
N), four peaks for a rapidly exchanging trimer in a 1:3:3:1 ratio (
14
N/
14
N/
14
N, 
14
N/
14
N/
15
N, 
14
N/
15
N/
15
N and 
15
N/
15
N/
15
N) and five peaks for a rapidly exchanging 
tetramer in a 1:4:6:4:1 ratio (
14
N/
14
N/
14
N/
14
N, 
14
N/
14
N/
14
N/
15
N, 
14
N/
14
N/
15
N/
15
N, 
14
N/
15
N/
15
N/
15
N and 
15
N/
15
N/
15
N/
15
N). Alternatively, if the oligomers are static 
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entities, no exchange will occur and only ions corresponding to all 
14
N and all 
15
N 
proteins will be observed at a 1:1 ratio in the mass spectrum (Figure 3.2.14).    
 
 
Figure 3.2.14 - Subunit exchange schematic showing the expected 
14
N/
15
N ratios for fully exchanged 
dimers and trimers and dimers and trimers that do not undergo exchange. 
14
N and 
15
N dimers and 
trimers are shown in red, mixed 
14
N/
15
N dimers and trimers are shown in blue. Figure adapted from 
Smith et al. (Smith et al. 2010). 
 
14
N and 
15
N wild-type protein were incubated separately in 100 mM ammonium 
formate pH 2.5 at room temperature for a few minutes to allow an equilibrium to 
establish, then mixed gently and a mass spectrum acquired after 1 minute (Figure 
3.2.15). The peaks corresponding to the dimer 6+, trimer 9+ and tetramer 12+ ions 
overlap in the m/z spectrum, hence, the data for the exchange of these species was 
discarded. After one minute of incubating 
14
N and 
15N β2m, the dimer 5+ and 7+ 
both undergo rapid exchange with one another forming mixed 
14
N/
15
N dimers as 
evident from the ESI mass spectrum. This shows the dimers are dynamic entites, 
rapidly dissociating and associating with other monomers in solution. It is possible 
that the mixed oligomers observed here do not form in solution and instead form 
during the ESI process. Previous experiments whereby 
14
N and 
15
N wild-type β2m 
monomers were sprayed separately but simultaneously into the ESI source suggest 
this is not the case, since no mixed oligomers were observed using this sample 
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introduction and ionisation process (Smith et al. 2010). The rapidly exchanging 
dimer is consistent with the CID-MS data (Section 3.2.5) which suggests the 
monomers are held together by weak hydrophobic interactions in the gas phase. A 
rapidly exchanging dimer would dissociate very readily as analysed by CID-MS. 
The 
14
N trimer 8+ undergoes a small amount of exchange in solution in comparison 
to the trimer 11+ which is fully exchanged (as shown by a 1:3:3:1 ratio of 
14
N
14
N
14
N:
 14
N
14
N
15
N:
 14
N
15
N
15
N:
 15
N
15
N
15
N in the mass spectrum) after only a few 
minutes of incubation with 
15N β2m (Figure 3.2.15). This is consistent with previous 
experimental data that have shown two β2m trimers present in solution; one lower 
charged, stable trimer and another highly charged, dynamic trimeric species (Smith 
et al. 2010). In comparison, the wild-type β2m tetramer undergoes very little 
exchange in solution suggesting it is more stable and less dynamic than the expanded 
trimer and all the dimeric species observed. On comparison of all charge states of the 
dimer, trimer and tetramers, the higher charged species undergo exchange more 
rapidly than the lower charged species. This suggests that the more compact, lower 
charged species are more stable and less dynamic than their more expanded, higher 
charged counterparts.  
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Figure 3.2.15 - 
14
N and 
15
N subunit exchange of the dimer, trimer and tetramer ions of wild-type β2m. 
Samples of 
14
N and 
15
N wild-type β2m were mixed in a 1:1 ratio for 1 min in 100 mM ammonium 
formate pH 2.5 before mass spectral acquisition. Peaks corresponding to all 
14
N and all 
15
N oligomers 
are shown in red, and peaks corresponded to mixed 
14
N/
15
N oligomers in blue.   
 
Although the subunit exchange data reveal differences in the stabilities of the 
different oligomeric intermediates formed instantaneously at pH 2.5, it is interesting 
to determine whether the dynamics of these oligomers changes over time during 
fibril formation and whether any differences can be observed in the wild-type 
oligomers compared with those of other β2m variants. Thus, the subunit dynamics of 
β2m fibril formation were investigated at various time points throughout the lag 
phase of fibril formation. In these experiments, 
14
N wild-type β2m was incubated at 
37 ºC, shaking at 600 rpm, in 100 mM ammonium formate pH 2.5 and at various 
time points during the lag phase 
15
N wild-type β2m (kept on ice throughout) was 
added and the subunit exchange monitored by ESI-MS over a 50 minute time-course 
at room temperature (Materials and Methods Section 3.4.10.4). In all cases, the lag 
phase was additionally monitored using Thioflavin T kinetics and fibril formation 
was at the end of the reaction confirmed by negative stain EM (data not shown). 
Note, due to the lack of agitation and incubation of the 
15
N labelled sample, fibrils do 
not form. The mass spectrum of 
15
N wild-type β2m protein therefore remained 
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constant throughout the subunit exchange experiments (data not shown). Peaks 
corresponding to the 
15
N wild-type β2m protein can be used effectively as an internal 
standard to compare mass spectra between different time points assuming no subunit 
exchange occurs between the β2m oligomers. 
The subunit exchange kinetics for the dimer (6+, 7+ and 8+), trimer (10+, 11+) and 
tetramer (13+) of wild-type β2m are shown in Figure 3.2.15. After 1 min of 
incubation with 
15
N wild-type β2m, subunit exchange had occurred between all the 
14
N and 
15
N wild-type β2m oligomers present (Figures 3.2.15 and 3.2.15A top 
spectrum). After 50 min of mixing with 
15
N wild-type β2m, more mixed oligomers 
were observed suggesting that the dimer, trimer and tetramer all undergo rapid 
exchange with one another until they reach an equilibrium in which equal amounts 
of 
14
N and 
15
N monomers are present in the oligomeric state (Figure 3.2.16A bottom 
spectrum). The amount of subunit exchange for 
14
N wild-type after 50 min of mixing 
with 
15
N wild-type is comparable whether the 
14
N wild-type was taken at 0 % or 50 
% of the lag time of fibril formation (Figure 3.2.16A and B top spectra). This 
suggests the oligomers observed in the mass spectrum under these experimental 
conditions are the same throughout the lag time of fibrillogenesis.  
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Figure 3.2.16 - 
14
N and 
15
N subunit exchange of the dimer 6+, 7+, 8+, trimer 10+, 11+ and tetramer 
13+ ions. Samples of 
14
N wild-type (A and B) or H51A (C and D) were mixed with 15N wild-type and 
15
N H51A, respectively in a 1:1 ratio for 1 min (top spectra in each case) and 50 min (bottom spectra 
in each case) at 0 % (A and C) and 50 % (B and D) of the lag phase. Peaks corresponding to all 
14
N 
and all 
15
N oligomers are shown in red, and peaks corresponded to mixed 
14
N/
15
N oligomers in blue.   
 
In contrast to wild-type β2m, on mixing 
14
N H51A with 
15
N H51A very little subunit 
exchange occurred after 1 min (Figure 3.2.16C top spectrum). After 50 min of 
incubation, no exchange had occurred with no peaks observed corresponding to the 
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mixed 
14
N H51A:
15
N H51A dimers, trimers and tetramers (Figure 3.2.16C bottom 
spectrum). The ratio of the unexchanged 
14
N H51A to 
15
N H51A oligomer peaks are 
not of equal abundance in the m/z spectrum at the start of the reaction even though 
14
N H51A and 
15
N H51A were mixed in a 1:1 ratio (Figure 3.2.16C). This is most 
likely due to the experimental error associated with measuring the 
14
N H51A and 
15
N 
H51A protein concentrations initially in combination with the manual mixing of the 
14
N H51A and 
15
N H51A samples in a 1:1 (v/v) ratio. For this reason, the expected 
1:2:1, 1:3:3:1 and 1:4:6:4:1 ratios for the dimer, trimer and tetramer, respectively 
will not be observed. Peaks would still be expected to be visible corresponding to 
mixed oligomers if subunit exchange was occurring in solution.   
A difference between the H51A and wild-type oligomers was also evident on 
comparison of the subunit dynamics at 50 % of lag time (Figure 3.2.16B and D). For 
the H51A oligomers formed during the lag phase, very little subunit exchange 
occurs, suggesting these oligomers are more stable entities compared with the more 
rapidly exchanging wild-type oligomers. Very little exchange occurs even after 50 
min of incubation with 
15
N H51A (Figure 3.2.16D bottom spectrum). This difference 
in subunit exchange for H51A compared with wild-type β2m may explain the 
difference in lag time observed (Figure 3.2.6). If the H51A oligomers formed are 
more stable and less dynamic that those of the wild-type protein then they could be 
slower at converting into the amyloidogenic state necessary for fibril formation. 
Alternatively, the H51A oligomers observed here may be off-pathway oligomers 
thus slowing the rate of fibril formation by diverting H51A monomers to dead-end 
products.  
Together the H51A variant data suggests a role for the D-strand in amyloid fibril 
formation at pH 2.5. This supports previous data whereby the mutation of His51 to 
proline also decreased the rate of fibril formation (Chiba et al. 2003). It is possible, 
that the lack of charge at this residue is causing the differences in fibril formation 
kinetics observed; therefore, the role of charge residues throughout the β2m sequence 
in fibril formation was investigated further. 
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3.2.7 Effect of Lysine Mutations on β2m Fibril Formation 
Since lack of a charged residue in H51A resulted in a decrease in lag time and also 
decreased the dynamics of the oligomers present, the effect of charged residues, in 
general, on β2m fibril formation at pH 2.5 was investigated further. Six lysine 
residues were selected throughout the β2m sequence and substituted one by one to 
alanine (Figure 3.2.17). These lysine residues selected throughout the β2m sequence 
are all present in the loop regions of β2m and thus may be acting to prevent β2m 
aggregation (Richardson et al. 2002).  
The work on the lysine variants was carried out with Dr. Charlotte Scarff (University 
of Leeds). The choice of mutation and primer design for these lysine variants was 
carried out by myself (Materials and Methods Section 3.4.2.4). All the expression, 
purification, ThT kinetics, EM, and mass spectrometry on the lysine variants K58A, 
K75A, K91A were carried out by myself. The expression, purification, ThT kinetics, 
EM and mass spectrometry of the K6A, K19A and K41A variants were carried out 
by Dr. Charlotte Scarff (University of Leeds).  
 
Figure 3.2.17 - Native β2m structure (PDB file:2YXF) (Iwata et al. 2007) showing the position of the 
lysine variants used in this thesis. The mutated lysine residues are modelled as balls and sticks (blue).    
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All the lysine variants were expressed and purified as described in Section 3.2.1 and 
Materials and Methods 3.4.3. To determine whether these lysine variants are able to 
form amyloid fibrils, the variants were incubated individually in 100 mM ammonium 
formate pH 2.5 at 37 ºC, shaking at 600 rpm, and after approximately 48 h each 
sample was imaged by negative stain EM. The EM images show all variants formed 
long-straight fibrils (Figure 3.2.18).  
 
 
Figure 3.2.18 - Electron microscopy of fibrils formed in 100 mM ammonium formate pH 2.5, 37 ºC, 
600 rpm, by wild-type β2m and the β2m variants, K6A, K19A, K41A, K58A, K75A and K91A. The 
scale bar for the K58A, K75A and K91A variants represents 200 nm. EM of the variants K6A, K19A 
and K41A was performed by Dr. Charlotte Scarff (University of Leeds), the scale bar for these 
variants represents 100 nm.   
   
The kinetics of fibril formation for the lysine variants were also investigated using 
ThT fluorescence (Figure 3.2.19). If charged residues are important in amyloid fibril 
formation at pH 2.5, then differences in the fibril formation kinetics would be 
expected for these variants. An example of the ThT kinetic data for the lysine 
variants K58A, K75A and K91A is shown in Figure 3.2.19A. Strikingly, all the 
lysine variants analysed showed dramatic differences in their lag times suggesting 
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that charge is indeed important in amyloid fibril formation of β2m in 100 mM 
ammonium formate pH 2.5.   
 
 
Figure 3.2.19 - A) Fibril formation kinetics of lysine variants, K75A (green), K58A (purple), K91A 
(yellow) along with wild-type β2m (red). Five replicates are shown for each variant. Experiments 
were carried out using a plate reader, in 100 mM ammonium formate pH 2.5, 37 ºC, shaking at 600 
rpm. All data were normalised to the end point of the reactions. B) Comparison of the kinetics of fibril 
formation of the lysine variants K58A (purple), K75A (green), K91A (yellow), K6A (blue), K19A 
(blue), K41A (blue) with respect to wild-type (red). The fold change in lag time compared to wild-
type β2m is shown for comparison. The horizontal blue lines represent ± 1 standard deviation from 5 
repeats of the wild-type β2m proteins lag time. The experimental data performed by Dr. Charlotte 
Scarff (University of Leeds) are shown in blue. The error bars represent ± 1 standard deviation.     
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On further analysis of the EM image of K58A, small oligomers are present in 
addition to long-straight fibrils which are absent in all other EM images (Figure 3.2.3 
and 3.2.18). These could either be off-pathway oligomers or on-pathway oligomers 
that are simply slower at converting into mature amyloid fibrils consistent with the 
increased elongation rate observed. In addition, on further analysis of the EM images 
for K41A and K91A, the fibrils observed were shorter in length compared to all 
other fibrils formed from either the β2m variants or wild-type β2m (Figure 3.2.18). 
The increase in lag time observed in this case for the K41A and K91A variants may 
be due to the decrease in stability of the final amyloid fibrils causing the equilibrium 
between oligomers and amyloid fibrils to shift back towards the monomer/oligomer 
population. Additional experiments in which the stability of fibrils are measured, for 
example by guanidine denaturation experiments, are needed to confirm this 
hypothesis.    
All the lysine variants displayed here showed comparable oligomer populations and 
collision cross-sections to wild-type β2m as analysed by ESI-MS and ESI-IMS-MS 
in 100 mM ammonium formate pH 2.5 (data not shown). This suggests that these 
charged lysine residues are involved post-hexamer formation since no differences are 
observed up to this oligomer size in the ESI mass spectra, and also the initial 
oligomeric contacts have been suggested to be hydrophobic by ESI-CID-MS (Figure 
3.2.13). 
Overall, β2m amyloid formation is a complex mechanism in which oligomers join 
together to form higher-order fibril structures. In this thesis, important residues 
involved in β2m amyloid fibril formation have been highlighted. Although, mass 
spectrometry alone cannot be used to reveal a unique model to fit all the 
experimental data shown here, with additional experimental work the mechanism of 
amyloid fibril formation could be revealed.  
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3.3. Conclusions 
 
In this thesis, residues have been highlighted that upon mutation affect the lag time 
of fibril formation as monitored by ThT fluorescence (Figures 3.2.4 and 3.2.19). One 
mutation in particular on the D-strand of β2m, H51A, caused a significant two-fold 
increase in the lag time of fibril formation (Figures 3.2.4 and 3.2.6). Further analysis 
of the oligomeric intermediates of this variant by ESI-MS, revealed differences in 
the structural dynamics of the oligomers present throughout the lag phase (Figure 
3.2.16). This suggests that either there is a balance between on- and off-pathway 
intermediates slowing the rate of fibril formation, or that the more stable, less 
dynamic H51A oligomers are slower at converting to a conformation that is required 
for fibril formation. These structural differences were not evident from the ESI-IMS-
MS and ESI-CID-MS data alone with the β2m wild-type and H51A oligomeric 
species appearing structurally and thermodynamically identical using these methods 
of analysis (Figures 3.2.9, 3.2.11 and 3.2.13).     
 
Mutation of lysine residues throughout the β2m sequence had dramatic effects on the 
lag time of fibril formation (Figure 3.2.19). The K41A and K91A variants both 
increased the lag phase by up to 3.5-fold compared with the wild-type β2m (Figure 
3.2.19). This increase in lag time has been shown previously for another variant of 
β2m termed the triple variant whereby three residues on the E-strand were substituted 
to alanine (F62A, Y63A, Y67A) suggesting this aromatic region is also important in 
β2m fibril formation (Plattt et al. 2005; Platt et al. 2008; Routledge et al. 2009). 
Looking together at the residues important in fibrillogenesis, no trend is obvious 
between the location of the important residues and the lag time of fibrillogenesis 
(with residues Phe62, Tyr63, Tyr67 in strand E, His51 in strand D, Lys41 in strand C 
and Lys91 in the F-G loop showing the most dramatic effects). The picture is more 
complicated using these types of experiments, since the mutated residue itself may 
not be causing the effects observed; local or long range effects of the mutation could 
be changing the overall protein conformation altering its ability to form oligomeric 
interactions important in fibrillogenesis. Additional experiments are needed to 
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determine the precise role of these important residues in amyloid fibril formation and 
to unravel further details on the oligomeric intermediates. Further insight into the 
mechanism of amyloid fibril formation will aid the design of novel inhibitor to 
prevent this complex process.  
 
An alternative technique for studying protein conformation and dynamics is 
hydrogen deuterium exchange (HDX) (Percy et al. 2012). HDX on native proteins in 
solution can report on the whole structure and large scale as well as local 
conformational changes. Indeed, HDX experiments on β2m have revealed an 
increase in the conformational dynamics of β2m on its release from MHC 1 
(Hodkinson et al. 2009; Hodkinson et al. 2012). Protein digestion, with (for 
example) the protease pepsin, can be used prior to MS analysis to provide additional 
site-specific information on the location of exposed peptide bonds in the structures 
being probed. For example, the regions involved in the partially unfolding of the 
SH3 domain (a small, modular domain found in many proteins) have been identified 
by proteolytic digestion combined with HDX MS (Wales et al. 2006). These 
experiments are not ideal since problems with back exchange can occur, 
complicating experimental analysis. MS/MS can be used instead of protein digestion 
with proteases to reveal site-specific information on proteins and their complexes. 
CID fragmentation methods have been used to report on HDX within protein 
structure; however, problems can arise whereby deuterium atoms exchange sites 
during the fragmentation process, termed scrambling (Jorgensen et al. 2005). This 
problem has recently been overcome by the use of ETD/ECD instead of CID 
fragmentation (Pan et al. 2008; Rand et al. 2009). Indeed a very recent publication 
by Rand et al. (2012) has shown great promise for studying protein conformation by 
MS, whereby deuterated ammonia was introduced into the ionisation source with 
subsequent fragmentation in the trap and transfer region of the Synapt mass 
spectrometer (Introduction Section 1.4, Figure 1.6) revealing residue-specific 
information on the gas phase conformations of ubiquitin and cytochrome c (Rand et 
al. 2012).   
  
Oxidative labelling is another recently introduced technique used to label protein 
complexes for detection by ESI-MS (Konermann et al. 2010). Here, free hydroxy 
radicals are generated using a high energy laser. These OH
·
 radicals subsequently 
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react with exposed amino acids resulting in oxidation and an increase by 18 Da is 
observed on MS analysis. Oxidative labelling can be combined with proteolysis or 
CID/ECD/ETD fragmentation to determine site-specific labelling sites. Experiments 
by the Konermann group have shown the application of this technique to monitor the 
location of individual amino acids upon folding of membrane proteins from their 
denatured state (Pan et al. 2011; Pan et al. 2012). These labelling techniques are 
advantageous over HDX MS experiments since the labelling is irreversible and thus 
problems with back-exchange and scrambling are avoided. This technique offers 
great promise for determining oligomeric interfaces during ESI-IMS-MS analysis, 
since residues involved in the binding interface between the oligomers will be 
protected from labelling and thus could be identified. 
  
In a similar way, covalent labelling has shown great promise for the analysis of 
oligomeric intermediates during β2m fibril formation at neutral pH in the presence of 
Cu
2+
 (Mendoza et al. 2010; Mendoza et al. 2011). In these experiments, sulfoN-
hydroxysuccinimide acetate (NHSA), diethylpyrocarbonate (DEPC) and 2, 3-
butanedione (BD) were used to label lysines, histidine, amine and OH groups, and 
arginine side chains, respectively, and the protection/solvent exposure of these 
residues to labelling throughout the lag phase of fibril formation was used to 
determine which residues are buried/exposed in which oligomeric state of interest. 
Although from these data alone the precise structure of the amyloidogenic 
intermediates could not be predicted, the results obtained together with previous X-
ray crystallography data allowed a more accurate prediction of the dimer and 
tetramer oligomeric sturctures, thus allowing a model of the mechanism of formation 
of these oligomeric species to be established (Mendoza et al. 2010; Mendoza et al. 
2011).  
 
Together, this thesis chapter has shown how ESI-IMS-MS can be used to analyse 
oligomeric intermediates in amyloid fibril formation. Although the data presented do 
not predict a mechanism of amyloid formation conclusively, with the recent 
advances in the mass spectrometry field (as discussed here), more detailed structural 
information on the β2m oligomeric intermediates will be possible in the near future.    
152 
 
Amyloid 
3.4. Materials and Methods 
 
3.4.1 Reagents 
Molecular Biology Reagents 
The β2m pINKwil-type plasmid was constructed by Dr Neil Kad (formerly of 
University of Leeds) by inserting the wild-type human β2m gene sequence from 
plasmid pBJ192 (Reid et al. 1996) into a pET23a expression vector (Novagen). The 
plasmids encoding the β2m variants K19A, F22A, F30A, H51A, L54A, Y63A, 
L64A, L65A, V82A, H84A and R97A were supplied by Thomas Jahn, Katy 
Routledge and Timo Eichner (formerly of University of Leeds). Escherichia coli 
(E.coli) BL21 (DE3) pLysS cells were purchased from Promega Corporation 
(Southampton, UK).  
 
E.coli bacterial strains 
Strain Characteristics 
BL21(DE3)pLysS HsdS gal (λIts 857 ind1 Sam7 nin5 lacUV5-T7gene1) 
XL1-Blue 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac (F’ 
proAB lacl
q
ZM15 Tn10(Tet’)) 
Table 3.4.1 - E.coli bacterial strains used for extracting DNA for storage (XL1-Blue) and protein 
expression (BL21 (DE3) pLysS). 
 
 
Reagents for Bacterial Growth 
NZ Amine was purchased from Duchefia, Netherlands. Details of where all other 
molecular biology, protein expression and protein purification reagents were 
purchased are described in Chapter 2 (Pilus Materials and Methods 2.4). 
 
Reagents used for fibril formation assays 
Black 96 well plates were purchased from Corning Ltd, USA and clear sealing films 
from Thistle Scientifics, UK. Thioflavin T (ThT) was purchased from Sigma-Aldrich 
Corporation (Poole, Dorset, UK). 
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Electron Microscopy Materials 
Carbon/formvar-coated 300 mesh electron microscopy grids were purchased from 
the Electron Microscopy suite in the Faculty of Biological Sciences, University of 
Leeds. 2 % (w/v) solution of uranyl acetate was obtained from the Electron 
Microscopy suite in the Faculty of Biological Sciences, University of Leeds. 
 
Mass Spectrometry Reagents 
Ammonium formate was purchased from Sigma-Aldrich Corporation (Poole, Dorset, 
UK), and HCl from Fisher Scientific (Loughborough, UK).   
 
3.4.2 Molecular Biology 
3.4.2.1 Plasmid DNA preparation 
Plasmid DNA was isolated from 10 mL of fresh overnight liquid cultures of XL1-
Blue cells using a Qiagen plasmid Mini-prep kit according to the manufacturer’s 
instructions. To determine the concentration of DNA plasmid, an A260 of 1.0 was 
assumed equivalent to 50 µg/mL of double stranded DNA (Sambrook 1989). 
 
3.4.2.2 Transformation of plasmid DNA 
Plasmid DNA was transformed into XL1-Blue cells or BL21 (DE3) pLysS cells for 
DNA extraction or protein expression, respectively, according to the protocol 
mentioned previously (see Pilus Materials and Methods, Section 2.3). When the 
plasmid DNA was initially transformed into E.coli XL1-Blue cells after mutagenesis, 
NZY
+
 medium was used to grow the cells after heat shocking instead of LB medium. 
To make NZY
+
 medium, 10 g NZ Amine, 5 g yeast extract and 5 g NaCl were 
dissolved in a final volume of 1 L with >18 M water. The medium was then 
autoclaved at 120 C at 15 p.s.i for 20 min and before use, the following filter-
sterilised supplements (initial stock concentrations) were added (per litre): 12.5 ml 
1M MgSO4, 12.5 ml 1M MgCl2 and 20 ml 20 % (w/v) glucose. 
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3.4.2.3 β2m amino acid sequence 
The amino acid sequence of β2m is shown below along with the location of the β-
strands throughout the sequence. 
 
 
 
 
3.4.2.4 Stratagene QuikChange®  Mutagenesis 
Site-directed mutagenesis (QuikChange) was carried out to create the alanine 
variants K6A, K41A, K58A, K75A and K91A. QuikChange mutagenesis was carried 
out according to the manufacturer’s instructions, except that following mutagenesis, 
the DNA template was digested with 1 µL DpnI enzyme (specific for methylated 
DNA) for 16 h at 37 C, rather than the recommended 1 h, to improve mutation 
frequency. All variants were sequenced from the T7 promoter to ensure that the gene 
contained the desired mutation and no other. The primers used to create the β2m 
variants are shown in Table 3.4.2.  
 
Variant Primer Sequence (5 to 3) 
K6A tatacatatgattcaaagaactccagcaattcaggtttactcacgtcatc
ca K41A ccgacattgaagttgacttactggcgaatggagagagaattgaaaaag 
K91A tgtgactttgtcacagcccgcgatagttaagtgggatcga 
K75A ctgaattcacccccactgaagcagatgagtatgcctgcc 
K58A cattcagacttgtctttcagcgcggactggtctttctatctctt 
Table 3.4.2. Forward primers used for QuikChange site-directed mutagenesis.  
 
 
3.4.3 Expression and Purification of β2m   
3.4.3.1 Growth Media 
Luria-Bertani (LB) medium was purchased from Merck (Germany) and sterilised by 
autoclaving at 120 C at 15 p.s.i. for 20 mins. 15N labelled minimal media were made 
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by dissolving 10 g K2HPO4, 10 g KH2PO4, 7.5 g Na2HPO4, 9 g K2SO4, 1 g 
15
NH4Cl 
(or 1 g 
14
NH4Cl for unlabelled minimal media) in 1 L deionised (18 MΩ) water and 
autoclaving at 120 C at 15 p.s.i. for 20 mins. Once cool, filter sterilised 1M MgCl (2 
mL), 1 M CaCl2 (100 µL) and 20 % (w/v) glucose (20 mL) were added. Filter-
sterilised antibiotics were added to the LB/minimal media when appropriate. 
 
3.4.3.2 Pre-culture 
Pre-cultures were made by addition of 20 µL of a bacterial glycerol stock (containing 
Bl21 (DE3) pLysS cells transformed with the relevant plasmid) and ampicillin (100 
µg/mL) to 500 mL sterile LB media (Pilus Materials and Methods, Section 2.4).  The 
media was incubated overnight at 37 ºC overnight, shaking at 200 rpm and used 
immediately for large-scale protein over-expression. For 
15
N labelled protein 
expression, a pre-culture was made by addition of 20 µL bacterial glycerol stock to 
500 mL of sterile unlabelled minimal medium and the mixture incubated for 24 
hours at 37 ºC overnight, shaking at 200 rpm. This culture was then centrifuged at 
6,000 rpm, 4 ºC and then resuspended in 5 mL 
15
N labelled minimal media, 
ampicillin added to a final concentration of 100 µg/mL, and the culture used 
immediately for large-scale protein over-expression.  
 
3.4.3.3 Cytoplasmic protein expression 
Twelve 2 L flask each containing 1 L of LB media and 100 µg/mL ampicillin were 
pre-warmed overnight at 37 ºC.  30 mL of each pre-culture containing E.coli BL21 
(DE3) pLysS cells with the relevant plasmid transformed into it were added to each 
flask along with 1 mL of 100 mg/mL carbenicillin (stored at -20 ºC). For 
15
N 
labelled protein, 500 µL of pre-culture was added to each flask (typically five flasks 
containing 1 L of minimal media) containing 1 mL of 100 mg/mL carbenicillin. All 
cultures were incubated at 37 ºC, shaking at 200 rpm in an orbital shaking incubator, 
and the optical density (O.D) at 600 nm was measured at regular intervals. At an OD 
of 0.6, protein expression was induced by the addition of 1 mL of 1 M filter sterilised 
IPTG. After 16 hours, the cultures were harvested at 6,000 rpm (JLA 8.1 rotor, 
Beckman Coulter, High Wycombe, UK), 4 ºC.   
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3.4.3.4 Inclusion Body Isolation 
The cell pellet was resuspended in 100 mL lysis buffer containing 20 mM Tris-HCl 
pH 8.0, lysozyme (100 µg/mL), phenyl methyl sulponyl fluoride (PMSF) (50 
µg/mL) DNase (20 µg/mL), ethylenediaminetetraacetic acid disodium salt (EDTA) 
(1 mM) and incubated at room temperature for 30 mins. Cells were further lysed 
using a TS Series cell disruptor (Constant Systems Ltd, UK) at 20 kpsi. The cell 
lysate was then centrifuged at 12,000 rpm (JA 25.50 rotor, Beckman Coulter, High 
Wycombe, UK) for 1 h at 4 C. The supernatant was discarded and the cell pellet 
was resuspended in 100 mL 20 mM Tris-HCl pH 8.0. The cell pellet was again 
centrifuged (12,000 rpm, for 1 h at 4 C) and the pellet resuspended a further two 
times in 20 mM Tris-HCl pH 8.0, discarding the supernatant after each 
centrifugation step. The final cell pellet was solubilised in 150 mL 20 mM Tris-HCl 
pH 8.0 containing 8 M urea and incubated overnight on an orbital shaker at 70 rpm. 
Finally any insoluble material was discarded by centrifugation at 12,000 rpm (JA 
25.50 rotor, Beckman Coulter, High Wycombe, UK) for 1 h at 4 C.   
 
3.4.3.5 Refolding By Dialysis 
Protein in urea was dialysed against 5 L of 20 mM Tris-HCl pH 8.0 at 4 C using a 
3,500 Da molecular weight cut-off dialysis membrane. Any insoluble material was 
pelleted by centrifugation at 12,000 rpm (JA 25.50 rotor, Beckman Coulter, High 
Wycombe, UK) for 1h at 4 C and discarded before protein purification.  
 
 
3.4.3.6 Protein Purification 
Anion Exchange Chromatography 
The refolded β2m protein solution was initially purified by anion exchange 
chromatography using a XK26/100 column containing 100 mL HiTrap Q-Sepharose 
fast flow resin (GE Healthcare, Buckinghamshire, UK). All solutions were filtered 
using a 0.22 μm Steritop filter (Millipore, Massachusetts, USA) and degassed using 
a Buchi Vac V-500 vacuum pump (Buchhi Labortechnik AG, Switzerland) prior to 
passing through the column. The column was equilibrated with 10 column volumes 
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of 20 mM Tris-HCl pH 8.0 and the impure protein solution loaded onto the column 
at a flow rate of 1.5 mL/min using an ÄKTA prime purification system (GE 
Healthcare, Buckinghamshire, UK). Unbound protein was washed through the 
column with 5 column volumes of 20 mM Tris-HCl pH 8.0 at a flow rate of 3 
ml/min. Finally the protein was eluted with a linear gradient of 0-500 mM NaCl in 
20 mM Tris-HCl pH 8.0, over 700 mL, flow rate 3 mL/min. All steps were 
performed at room temperature. 
 
The pooled β2m fractions, as detected by spectrophotometry at A280 and confirmed 
by SDS-PAGE (Pilus Materials and Methods Section 2.4.11), were dialysed into 
H2O (18 MΩ) at 4 C, freeze-dried and stored at -20 ºC until further use. 
 
Size Exclusion Chromatography 
The freeze dried β2m was dissolved into 20 mM Tris-HCl pH 8.0 at a concentration 
of ~5mg/mL and filtered through a 0.22 μm Steritop filter (Millipore, Massachusetts, 
USA). 5 mL was then injected onto a HiLoad 26/60 Superdex 75 column (GE 
Healthcare, UK) equilibrated in 20 mM Tris-HCl pH 8.0 and controlled by an ÄKTA 
prime purification system. The protein was eluted at a flow rate of 3 mL/min. 
Typically monomeric β2m eluted after 200 mL with oligomeric forms eluting prior to 
this. Several (usually six) gel filtration runs were necessary to purify the whole batch 
of protein. Finally all fractions containing pure β2m protein, as confirmed by SDS-
PAGE, were combined and dialysed into H2O (18 MΩ) before freeze drying and 
storage at -20 ºC. The average yield of pure wild-type β2m for this procedure was 50 
mg/L of bacterial culture. β2m variant yields for this procedure vary considerably, 
from 5 mg/L to 50 mg/L of bacterial culture.         
 
3.4.4 Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS-
PAGE) 
Gel electrophoresis was routinely used to monitor over-expression and purification 
of recombinant proteins and to determine fibril yield (for example a yield of 50 mg/L 
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was obtained for wild type β2m). Tris-tricine buffered gels were used in all cases 
(Pilus Materials and Methods, Section 2.4.11).  
 
3.4.5 Characterisation of β2m   
3.4.5.1 Purity and Mass Determination 
Purified protein was determined to be monomeric after gel filtration and was shown 
to be pure by SDS-PAGE (Pilus Materials and Methods, Section 2.4). The exact 
molecular weight of purified protein was determined by electrospray ionisation mass 
spectrometry (ESI-MS) (Pilus Materials and Methods, Section 2.4.15.3) using CsI to 
calibrate the mass spectrometer (Pilus Materials and Methods, Section 2.4.15.1). The 
expected and experimentally determined molecular weights are shown in Table 
3.4.3.  
β2m variant 
Expected 
Molecular Weight (Da) 
Determined 
Molecular Weight (Da) 
Extinction 
Coefficient (M
-1
cm
-1
) 
wild-type 11860 11860 19940 
K6A 11803 11800 19940 
K19A 11803 11800 19940 
K41A 11803 11801 19940 
F30A 11784 11782 19940 
H51A 11794 11793 19940 
K58A 11803 11803 19940 
Y63A 11768 11771 18450 
L64A 11818 11818 19940 
K75A 11803 11804 19940 
V82A 11832 11833 19940 
H84A 11794 11795 19940 
K91A 11803 11801 19940 
R97A 11775 11775 19940 
Table 3.4.3 – A comparison between calculated molecular masses based on amino acid sequences and 
the measured molecular masses from nanoESI-MS analysis. The extinction coefficients used to 
calculate the protein concentration for each variant are also shown. 
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3.4.5.2 Extinction Co-efficient Determination 
The concentration of each β2m variant was calculated using the Beer-Lambert law by 
measuring the absorbance at 280 nm and using the theoretical extinction coefficients 
determined from the amino acid sequence (using Protparam online software) 
(Edelhoch 1967; Gill et al. 1989; Pace et al. 1995). The extinction coefficients used 
for the β2m variants are shown in Table 3.3.3.  
 
3.4.6 Electron Microscopy 
10 μl of fibrils in 100 mM ammonium formate pH 2.5 (i.e. reaction end products) 
were placed on freshly ionised formvar- and carbon-coated EM grids for 30 sec. The 
grids were then blotted with filter paper to remove excess solvent and the samples 
stained with 2 % (w/v) uranyl acetate for 30 sec. The grids were then blotted again 
and air-dried before analysis. All images were taken using a Philips CM10 electron 
microscope operating at 80 keV. 
 
3.4.7 Analytical Gel Filtration 
Freeze dried β2m was dissolved into 20 mM Tris-HCl pH 8.0 at a concentration of 
100 µM. 200 µL was then injected onto a Superdex™ 75 10/300 GL column (GE 
Healthcare, UK) equilibrated in 20 mM Tris-HCl pH 8.0 and controlled by an ÄKTA 
prime purification system. The protein was eluted at a flow rate of 0.5 mL/min and 
the elution volume of the monomeric wild-type β2m used for comparison with all 
other β2m variants.           
 
3.4.8 Fibril Growth Kinetics 
3.4.8.1 Fibril Kinetics using the Plate Reader 
β2m or one of its variants was dissolved in 100 mM ammonium formate pH 2.5, 10 
μM ThT (on ice) to a final protein concentration of 0.4 mg/mL (1 mL total volume). 
The protein concentration was determined by A280 using the specific extinction co-
efficient determined for each variant (Table 3.4.3) and 100 µL aliquots placed into a 
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black 96 well plate. The plate was sealed with a clear heat-activated sealing film 
(Thistle Scientifics) allowing measurements in situ without evaporation of the 
sample. The plate was incubated at 37 °C with orbital shaking at 600 rpm for 48 h in 
a Fluostar Optima plate reader (BMG Labtech GmbH, Offenburg, Germany). ThT 
fluorescence was measured by the top down mode using a 440 nm (±10 nm) filter for 
excitation and a 480 nm (±12 nm) filter for emission. The data were normalised in 
each case to the final ThT fluorescence reading. At the end-point of the reaction, 
samples were taken for negative stain electron microscopy (Section 3.4.6). 
 
3.4.8.2 Simultaneous Mass Spectrometry and Fibril Kinetics 
β2m or one of its variants was dissolved in 100 mM ammonium formate pH 2.5 (on 
ice) to a final protein concentration of 0.4 mg/mL. The protein concentration was 
determined by A280 using the specific extinction co-efficient determined for each 
variant (Table 3.4.3) and fibrillogenesis initiated by incubation at 37 °C, shaking at 
600 rpm (Thriller Thermoshaker Incubator, PEQLAB Ltd. UK) for up to 48 h. 50 μL 
samples were taken at regular intervals and diluted with 950 μL Thioflavin T (ThT) 
(20 μM) in 100 mM ammonium formate pH 2.5. ThT fluorescence was measured in 
a PTI Quantamaster C-61 spectrofluorimeter using an excitation wavelength of 444 
nm and emission at 480 nm with slit-widths of 4.5 nm. Simultaneous to the ThT 
reading, a 10 μL sample of the β2m variant in 100 mM ammonium formate pH 2.5 
was taken for analysis by mass spectrometry (Section 3.4.12). At the end-point of the 
reaction, samples were taken for negative stain electron microscopy (Section 3.4.6).   
 
3.4.9 Calculation for the Lag Time of Fibril Growth 
The observed growth traces showed different final ThT fluorescent signals for 
different β2m variants. For simplicity all data were normalised assuming a final ThT 
signal of 1.0 and the resulting curves used to determine the lag times of fibril 
formation. The lag time was obtained by fitting a tangent to the steepest part of the 
normalised ThT growth phase and the time at which the line intersected the baseline 
was taken as the lag time (Hortschansky et al. 2005).  
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Fold changes in lag time were calculated using Equation 3.4.1 where lagvariant is the 
average lag time of the β2m of interest and lagwiild-type is the lag time of wild-type 
β2m.     
 
                 Fold Change   lagvariant/lagwild-type                    Equation 3.4.1 
3.4.10 Mass Spectrometry 
3.4.10.1 Buffer Preparation 
Ammonium formate buffers were made at 100 mM in deionised (18 MΩ) water.  
The pH was adjusted to pH 2.5 by addition of HCl.  The ammonium formate buffer 
was stored at 4 ºC for a maximum of one week and filtered through a 200 nm-pore 
filter (minisart high-flow single-use sterile filter, Sartorius, Surrey, UK) before use. 
 
3.4.10.2 ESI-(IMS)-MS 
Ion mobility spectrometry-mass spectrometry (IMS-MS) experiments were 
performed on a Synapt HDMS, hybrid quadrupole-IMS-oaTOF (Waters Ltd., 
Manchester, UK) mass spectrometer interfaced with a NanoMate Triversa source 
(Advion Biosystems Inc. NY, USA). Positive nanoESI was used with a capillary 
voltage of 1.75 kV and a nitrogen nebulising gas pressure of 0.7 p.s.i. A cone voltage 
of 170 V and a backing pressure of 3.6 mbar were used to observe the β2m 
oligomers. The ion accelerating voltages into the trap and transfer T-wave were set at 
4 V and 40 V, respectively. The wave height was typically ramped from 2-25 V at 
300 ms
-1
.  
 
Drift times were corrected for both mass dependent and mass independent times as 
reported previously (Knapman et al. 2010) and the drift time cross-section function 
was calibrated as described (Smith et al. 2009). Briefly, equine cytochrome C, sperm 
whale myoglobin and bovine ubiquitin were dissolved at a concentration of 10 µM in 
a mixture of acetonitrile/H2O/acetic acid (50:40:10 v/v/v). The charge state ions for 
each protein were identified by their unique m/z and their measured drift times 
plotted against Ω’ (see Introduction Section 1.4, Equation 1.11) calculated from 
David Clemmer’s library of protein cross-sections determined by conventional IMS 
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(Liu et al. 1997; Shelimov et al. 1997; Valentine et al. 1997) (Figure 3.4.1, Table 
3.4.4). The data were then fitted to the y = Ax
B
 relationship to obtain the calibration 
curve (Figure 3.4.1). The values for A and B from the calibration curve were used to 
determine the collision cross-section of the protein charge state ions of interest from 
their drift time measurements. In all cases, the same IMS conditions were used for 
the protein of interest and the IMS calibrants.  
 
Charge 
State 
Ω (Å2) Ω' (x1021Å2 C-1 Da-1) 
Ubiquitin Cytochrome C Myoglobin Ubiquitin Cytochrome C Myoglobin 
4 
1004     8.277     
1059     8.731     
5 
1027     6.773     
1137     7.499     
1239     8.172     
6 
1041     5.721     
1220     6.705     
1525     8.382     
7 
1317     6.204     
1580     7.443     
8 
1442     5.944     
1622     6.686     
9 1649 2215   6.042 8.120   
10 1732 2226 2796 5.712 7.344 9.228 
11 1802 2303 2942 5.402 6.908 8.827 
12   2335 3044   6.420 8.372 
13   2391 3136   6.068 7.961 
14   2473 3143   5.828 7.409 
15   2579 3230   5.673 7.107 
16   2679 3313   5.524 6.834 
17   2723 3384   5.285 6.570 
18   2766 3489   5.070 6.397 
19   2800 3570   4.862 6.201 
20     3682     6.076 
21     3792     5.959 
22     3815     5.723 
 
Table 3.4.4 - Collision cross-sections (Ω) and charge and mass independent collision cross-sections 
(Ω’) for the proteins bovine ubiquitin, horse cytochrome c and sperm whale apomyoglobin. Cross-
sections are for protonated ions. Ω values were taken from David Clemmer’s library (Liu et al. 1997; 
Shelimov et al. 1997; Valentine et al. 1997). 
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Figure 3.4.1 – Typical example of measured drift times for the proteins, myoglobin (yellow), 
cytochrome C (blue) and ubiquitin (green) versus Ω’ (charge and mass independent collision cross-
section) used for IMS calibration. All calibrants were acquired under denaturing conditions.  The 
black line shows the calibration curve, fitted to the relationship y = Ax
B
. 
 
 
For all mass spectrometry experiments, the raw data were processed using MassLynx 
v.4.1 software (Waters Ltd., Manchester, UK) in combination with Driftscope v.3.0. 
 
 
3.4.10.3 CID Methods 
For CID-MS/MS experiments the m/z corresponding to the 9+ β2m dimer ions was 
selected in the quadrupole region of the Synapt HDMS mass spectrometer for 
fragmentation in the transfer collision cell. Increasing collision energy was applied to 
the transfer in 20 eV increments until the parent ion was completely dissociated into 
fragment ions. The dimer 9+ was separated by IMS-MS from the tetramer 18+ ions 
prior to the transfer region of the mass spectrometer (Section 3.4.10.2), and 
Driftscope v.3.0 used to extract all fragment ions corresponding only to the drift time 
of the dimer 9+. Fragmentation profiles describing the fragmentation pathway of the 
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dimer 9+ were generated. These display the fraction of ternary ion intensity (as a 
percentage of total ion intensity) versus normalised collision energy (NCE). 
 
 
                                       NCE  =    E . Arm . z                          Equation 3.4.2    
                                                       Arm + Cm 
 
where E is the collision energy, Arm is the mass of Argon, Cm is the mass of the 
complex and z the charge of the parent ion.  
 
The collision energy required to fragment 50 % of the dimer 9+ ions was reported 
for all β2m variants. CID-MS data were repeated twice and the error reported in 
terms of ±1 standard deviation.  
 
3.4.10.4 Subunit Exchange Experiments 
For subunit exchange experiments, 
15
N labelled wild-type β2m was mixed in a 1:1 
(w/w) ratio with 
14
N wild-type β2m or one of the β2m variants (40 µM 
15N β2m:40 
µM β2m variant) and ESI-MS acquired at regular time intervals using the NanoMate 
Triversa source. For subunit exchange measurements carried out at 50 % of the lag 
time of fibril growth, the lag time was estimated (using previously acquired data) and 
at the correct time point during fibril growth (Section 3.4.8.2 for fibril forming 
conditions) 100 µL of the β2m variant was mixed in a 1:1 ratio with 100 µL of 
15
N 
labelled wild-type β2m or 
15N labelled β2m variant (incubated on ice throughout the 
time course). Mass spectra were acquired immediately and at regular time intervals 
over the subsequent 4 h. All samples were incubated in the 96 well plate in the 
NanoMate Triversa source at 20 ºC throughout the subunit exchange time courses. 
The extent of subunit exchange was determined by comparing the area under the 
peaks corresponding to the 
14
N β2m variant and the 
15
N wild-type β2m/β2m variant 
with the mixed 
14N β2m variant:
15
N wild-type β2m/β2m variant subunit exchanged 
oligomers.  
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Membrane Proteins 
4.1. Introduction 
 
Integral membrane proteins play essential roles in many biological processes such as 
transport of solutes, signalling and energy transduction. Despite this, our 
fundamental knowledge of the structure of membrane proteins is limited. Membrane 
proteins are notoriously difficult to study; their expression and purification is 
challenging and problems occur when trying to preserve the structural activity and 
the stability of these proteins in vitro (Seddon et al. 2004).  
 
Increasing numbers of biochemical techniques are being used to study membrane 
proteins and their complexes in solution (Marassi et al. 1998; Garcia-Saez et al. 
2007; Carpenter et al. 2008; Raunser and Walz 2009). Mass spectrometry will be the 
primary analytical tool used for membrane protein analysis in this thesis. Although 
non-covalent ESI-MS of intact membrane proteins has only been established 
relatively recently (Barrera et al. 2011), mass spectrometry is a good technique to 
study membrane proteins since it can determine protein conformation (Wang et al. 
2010) and the subunit stoichiometry of biomolecular complexes (Barrera et al. 
2009), in addition to identifying any post-translational modifications present 
(Bechara et al. 2012). 
 
4.1.1 Mass Spectrometry of Membrane Proteins 
Membrane proteins are insoluble in volatile aqueous/organic solvents used typically 
in mass spectrometry analysis of proteins and their complexes. Membrane protein 
analysis by mass spectrometry has been challenging due to their hydrophobicity and 
thus to the large excess of detergent molecules needed to solubilise the membrane 
protein complexes in solution. Under soft ionisation conditions, membrane protein 
peaks may be swamped by multiple peaks arising from the detergent clusters in the 
m/z spectrum, making membrane protein analysis almost impossible. Initial ESI-MS 
analysis of the E.coli multidrug resistant transporter protein (EmrE) bound to the 
tetraphenylphosphonium cation (TPP
+
) in dodecylmaltoside (DDM) detergent, 
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showed broad peaks in the m/z spectrum corresponding to a heterogeneous 
distribution of DDM molecules binding to the protein-ligand complex (Figure 
4.1.1A) (Ilag et al. 2004; Tate 2006). These broad peaks made the exact molecular 
weight of the protein difficult to assign. The data showed great promise that 
membrane proteins complexed with detergent micelles could be preserved during the 
electrospray ionisation process and into the gas phase. Further analysis showed that 
on subjecting these broad peaks to collision induced dissociation, EmrE and TPP
+
 
were released from DDM and peaks detected corresponding to the TPP
+
 and the 6+ 
charge state ions of EmrE (Ilag et al. 2004) (Figure 4.1.1B).  
 
Figure 4.1.1 A) ESI-MS of EmrE in dodecylmaltoside (DDM) with tetraphenyl phosphonium (TPP
+
); 
B) CID-MS of ion isolated at 6500 ± 100 m/z (red). Peaks corresponding to the TPP
+
, EmrE (E) and 
DDM clusters products, released from the EmrE-TPP
+
-DDM complex, are highlighted in the m/z 
spectrum. This Figure was adapted from Ilag et al. (Ilag et al. 2004). 
 
 
This breakthrough from the Robinson group in ESI-MS of membrane protein 
complexes led to the investigation of larger multi-subunit membrane protein 
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complexes. The first membrane protein complex to be analysed by ESI-MS was 
BtuC2D2, a vitamin B12 importer containing two BtuC transmembrane subunits and 
two BtuD cytoplasmic subunits (Locher et al. 2002; Barrera et al. 2008). Upon 
increasing the activation energy applied to the BtuC2D2-detergent micelle complex in 
the gas phase, the intact tetramer was released from the micelle and the 
corresponding ions detected in the m/z spectrum (Barrera et al. 2008). ESI-IMS-MS 
was used to determine the collision cross-section of the BtuC2D2 complex ejected 
from the detergent micelle (Wang et al. 2010). On comparison of this collision cross-
section with that predicted based on the crystal structure, it was suggested that the 
high energy applied to release membrane proteins from detergent micelles in the gas 
phase did not affect membrane protein structure, with the gas phase cross-section 
measured mirroring that of the modelled cross-section for BtuC2D2 (Wang et al. 
2010). More recently, the use of ESI-MS has expanded to include more complex, 
large macromolecular machines, for example the V-type ATPases from Thermus 
thermophilus and Enterococcus hirae (Zhou et al. 2011). In this study not only was 
the subunit stoichiometry of the complex determined, but also a potential regulatory 
role of nucleotide binding on ATP hydrolysis and proton translocation revealed.  
 
Currently, the most common method to study intact membrane proteins by mass 
spectrometry involves initial solubilisation of the proteins in micelle-forming 
detergent molecules. Despite this breakthrough in membrane protein analysis, 
detergent micelles are not optimal for preserving membrane protein function due to 
their highly dynamic nature and thus protein unfolding and aggregation in detergent 
micelles are commonly observed (Garavito et al. 2001; Zhou et al. 2001). In 
addition, the spherical micelles do not provide a native-like environment, poorly 
mimicking the physical properties of the planar cellular membrane. Alternative 
membrane solubilisation techniques are therefore needed to be able to explore the 
dynamic nature and mode of functioning of membrane proteins (Seddon et al. 2004; 
Popot 2010).  
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4.1.2 Amphipols 
One alternative to detergent micelles for solubilising membrane proteins are 
amphipols (APols): amphipathic polymers containing both hydrophobic and 
hydrophilic groups. Amphipols were designed to bind non-covalently to the 
transmembrane region of membrane proteins in a quasi-irreversible manner (Popot 
2010; Popot et al. 2011). The amphipol A8-35, composed of octyl and carboxyl 
chains, was the first amphipol designed and synthesised to bind membrane proteins, 
and as a result is the most well studied amphipol to date (Figure 4.1.2A). At, and 
above, pH 7 most carboxylates in A8-35 are ionised in aqueous solution making the 
amphipol highly soluble in water. In aqueous solution, A8-35 self-assembles into a 
tetramer with an average particle size of 40 kDa as determined by small angle 
neutron scattering, NMR, analytical ultra-centrifugation, static and dynamic light 
scattering and size exclusion chromatography (Gohon et al. 2006).  
 
 
Figure 4.1.2 – Chemical structures of A) the amphipol, A8-35 where x = 29-34%, y = 25-28%, z =39-
44% and B) the homopolymeric, glucosylated, non-ionic amphipol (NAPol). Figure adapted from 
Popot et al. (Popot et al. 2011). 
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Unfortunately, due to the high dependence on the ionisation status of the 
carboxylates for A8-35 solubility, membrane proteins in complex with the amphipol 
A8-35 can only be studied under basic conditions. These experimental constraints 
led to the design of novel non-ionic amphipols called NAPols (Figure 4.1.2B) 
(Sharma et al. 2008). As such, NAPols can now be used to solubilise membrane 
proteins over a wide pH range (Sharma et al. 2008; Bazzacco et al. 2012). Due to the 
lack of commercially available NAPols, the amphipol A8-35 has been used to trap 
the membrane proteins used in this thesis. 
 
4.1.3 Folding Membrane Proteins into Amphipols 
Apart from a few exceptions (Popot et al. 2003), amphipols cannot be used to extract 
membrane proteins directly from cell membranes. To transfer membrane proteins 
into amphipols, membrane proteins are first extracted and purified in detergent using 
standard methods (Arnold et al. 2008). The folded detergent-membrane protein 
mixture is then supplemented with amphipol and briefly incubated, before detergent 
removal from the detergent-amphipol-membrane protein complex (Figure 4.1.3A). 
Detergent can be removed from the solution in two ways. Firstly, the solution can be 
diluted to below the critical micelle concentration (CMC) of the detergent. Below the 
CMC, detergent disperses into its monomeric form which can be removed from the 
solution by dialysis. This method was used successfully to trap the nicotinic 
acetylcholine receptor (nAChR) in the amphipol, A8-35, restoring the native-like 
allosteric properties of nAChR (Martinez et al. 2002). Alternatively, detergent can be 
removed by the addition of polystyrene beads (Bio-Beads SM2). Detergent can 
absorb onto the Bio-Beads which can then be removed readily by centrifugation 
(Zoonens et al. 2005). This method is advantageous over the previous method for 
removing detergent as the sample remains concentrated and no dilution of the sample 
is required prior to analysis.   
 
Membrane proteins can also be folded into amphipols straight from their denatured 
state (Figure 4.1.3B) (Pocanschi et al. 2006; Baneres et al. 2011). Two outer 
membrane β-barrel proteins, OmpA and FomA, were initially selected for analysis 
(Pocanschi et al. 2006). On dilution of the urea unfolded OmpA and FomA into 
urea-free buffer in the presence of the amphipol, A8-35, both proteins immediately 
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displayed β-sheet secondary structure (as analysed by circular dichroism), an 
electrophoretic mobility comparable to the native state (as analysed by cold SDS-
PAGE) and resistance to trypsin proteolysis, suggesting both proteins had folded 
completely into A8-35 (Pocanschi et al. 2006). The folding of membrane proteins 
into amphipols from their denatured state has been extended more recently to a 
variety of G protein coupled receptors (GPCRs), including LTB4 (Dahmane et al. 
2009), 5-HT4a a serotonin receptor (Dahmane et al. 2009), CB1 a cannabinoid 
receptor (Dahmane et al. 2009) and the ghrelin receptor GHSR-1a (Baneres et al. 
2011).  
 
 
Figure 4.1.3 - Trapping membrane proteins (MP) in amphipols (red curved line). A) Upon addition of 
amphipol to the MP-detergent complex, detergent (blue) can be removed either (i) by dilution to 
below the CMC of the detergent followed by dialysis or (ii) by addition of Bio-Beads (green); B) 
Membrane protein folding from its urea-denatured state into amphipols is achieved by dialysis or 
rapid dilution into urea-free buffer.  
 
Membrane protein folding into amphipols from their denatured state presents several 
advantages compared with transferring membrane proteins to amphipols from 
detergent. For well-studied membrane proteins, the detergent in which these 
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membrane proteins are stable is known. In most cases the membrane protein of 
interest has not been well characterised and the detergent type in which the 
membrane proteins is stable will take time to determine. The ability to purify 
membrane proteins in their denatured state and fold them directly into amphipols 
avoids these challenging steps of detergent optimisation and associated problems 
with membrane protein stability. The use of amphipols in this way, therefore, is 
thought to greatly simplify membrane protein sample preparation and is the method 
chosen in this thesis to trap membrane proteins for analysis by ESI-MS. 
 
The membrane protein:amphipol ratio is a key parameter that needs to be optimised 
for preparation of membrane protein samples. If the membrane protein:amphipol 
ratio is too low, problems occur with protein solubility leading to aggregation. 
Alternatively, if the membrane protein:amphipol ratio is too high, the high 
concentration of amphipol can increase the viscosity of the solution to a level that 
compromises membrane protein function. The optimal membrane protein:amphipol 
ratio was investigated initially using the prototypical small α-helical inner membrane 
protein, bacteriorhodopsin, where a 1:3 (w/w) ratio of bacteriorhodopsin to 
amphipol, A8-35 produced the largest yield of natively folded bacteriorhodopsin 
(Gohon et al. 2008). Trapping experinents on larger protein complexes normally 
require a higher membrane protein:amphipol ratio of 1:5 (w/w) such as in the case 
for the multi-subunit cytochrome bc1 membrane protein complex (Bechara et al. 
2012). 
 
4.1.4 Stability of Amphipol-trapped Membrane Proteins 
One of the major advantages of solubilising membrane proteins in amphipols is the 
increased stability the amphipol provides to the protein (Popot et al. 2003; Popot 
2010). Indeed, bacteriorhodopsin showed no evidence of denaturation over six 
months of storage at 4 ºC in amphipol compared with only a few days in the 
detergent, octylthioglucoside (Popot et al. 2011). Bacteriorhodopsin-A8-35 
complexes can even survive freeze/thaw cycles without protein denaturation (Gohon 
et al. 2008).  
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The increase in membrane protein stability in amphipols has led to the use of 
amphipols as vectors for the delivery of membrane proteins and transmembrane 
peptides in vivo. Indeed, recent data have shown that vaccines formulated with the 
major outer membrane protein from Chlamydia trachomatis (MOMP):amphipol 
complex can protect mice against the Chlamydia trachomatis infection better than 
vaccines containing MOMP:detergent complexes, and to a similar level to 
vaccination with the live organism itself (Tifrea et al. 2011). Amphipols may greatly 
aid future vaccine developments in addition to helping solubilise membrane 
proteins/peptides for other therapeutic applications (Popot et al. 2011).  
 
Over the last sixteen years, amphipols have been employed to study membrane 
protein complexes in conjunction with a variety of biochemical techniques including 
size exclusion chromatography (Gohon et al. 2008), electron microscopy (Cvetkov et 
al. 2011), analytical ultra-centrifugation (Gohon et al. 2008), fluorescence resonance 
energy transfer (Zoonens et al. 2007) and solution NMR (Zoonens et al. 2005; 
Catoire et al. 2009; Catoire et al. 2010). The application of amphipol-trapped 
membrane proteins to ESI-MS has not been developed. A recent publication 
(appearing after commencement of these studies) used MALDI-TOF MS determine 
the molecular mass of the amphipol-trapped membrane proteins, bacteriorhodopsin, 
OmpA, cytochrome b6f and cytochrome bc1 (Bechara et al. 2012). The use of 
MALDI rather than ESI meant that only molecular masses could be obtained, and no 
structural details of the membrane proteins in the gas phase could be reported. 
Additionally, the harsher conditions of MALDI compared with ESI caused the 
membrane protein complexes analysed to dissociate prior to MS analysis (Bechara et 
al. 2012).  
 
This thesis chapter focuses on the ESI-MS analysis of two bacterial outer membrane 
proteins. PagP and OmpT. Both PagP and OmpT are synthesised in the cytoplasm 
and translocated across the inner membrane via the Sec translocon (Bos et al. 2007) 
before they fold correctly into the outer membrane with help from periplasmic 
chaperones and the Bam complex (Mogensen et al. 2005; Knowles et al. 2009). 
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4.1.5 Lipid A Palmitoyl transferase, PagP 
PhoPQ-activated gene P (PagP) is an eight-stranded, 20 kDa, β-barrel protein with a 
small N-terminal α-helix (Hwang et al. 2002; Ahn et al. 2004). Once inserted into 
the outer membrane, PagP catalyses the transfer of a palmitate chain from 
phospholipids to lipid A, the hydrophobic anchor of the lipopolysaccharide, LPS. 
This helps reinforce the outer membrane protecting the bacterium from host immune 
defences (Bishop 2005). Lipid A acylation has shown resistance to cationic 
antimicrobial peptides in vivo (Guo et al. 1998). 
 
Figure 4.1.4 - Crystal Structure of PagP (PDB file: 1THQ) in lauryldimethylamine-oxide (Ahn et al. 
2004) A), and B) rotated 90º out of the plane of the paper. The residues contributing to the Cotton 
Effect in the far-UV CD spectrum, Tyr26 and Trp66, are highlighted. 
 
The structure of PagP in the detergent dodecylphosphocholine and 
lauryldimethylamine-oxide (Figure 4.1.5) has been determined by NMR (Hwang et 
al. 2002) and X-ray crystallography (Ahn et al. 2004), respectively. In both cases, 
PagP is tilted 25º compared to the membrane plane (Hwang et al. 2002; Ahn et al. 
2004) (Figure 4.1.4) allowing the clustering of the aromatic residues at the 
membrane interface regions (Schulz 2002). The folding of PagP into liposomes has 
also been studied extensively by cold SDS-PAGE, Fourier transform infrared 
spectroscopy, fluorescence and circular dichroism (Huysmans et al. 2007). These 
studies have indicated that the N-terminal α-helix is not essential for PagP folding 
but acts as a post-assembly clamp, stabilising the folded PagP after insertion into the 
outer membrane (Huysmans et al. 2007). 
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Figure 4.1.5 - Structure of the detergents dodecylmaltoside (DDM), octyl-β-D-glucopyranoside (OG), 
lauryldimethylamine-oxide (LDAO), Triton X-100, and lipids dodecylphosphocholine (DPC) and 1,2-
didodecanoyl-sn-glycero-3-phosphocholine (DLPC). 
 
 
 
In addition to performing functional studies on PagP (Bishop et al. 2000; Hwang et 
al. 2004; Huysmans et al. 2007), the correct natively folded PagP can also be 
characterised by a distinctive positive ellipticity band in the far-UV circular 
dichroism (CD) spectrum (Khan et al. 2007). This positive band at 232 nm, also 
known as a Cotton effect, arises from the Tyr26 and Trp66 residues (Figure 4.1.4)  
which pack closely together in the native PagP structure (Khan et al. 2007; Cuesta-
Seijo et al. 2010). Although PagP folding into detergent micelles and liposomes has 
been studied extensively, the folding of PagP into amphipols has yet to be 
established.  
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4.1.6 Outer Membrane Protease, OmpT 
The outer membrane protease, OmpT, is a ten-stranded, 34 kDa, β-barrel protein 
(Figure 4.1.5) that cleaves peptides between dibasic residues with arginine being 
preferential at the P1 and P1’ positions (McCarter et al. 2004). OmpT can protect 
against a range of antimicrobial peptides and thus plays a role in bacterial 
pathogenicity (Hritonenko et al. 2007). The crystal structure of OmpT in octyl-β-D-
glucopyranoside (Figure 4.1.5) shows that not all of OmpT is present in the 
transmembrane region, in fact long loops protruding out of the membrane are present 
which contain the enzyme’s active site (Figure 4.1.6) (Vandeputte-Rutten et al. 
2001). The folding of OmpT into detergent micelles has been studied by cold SDS-
PAGE and far-UV CD (Kramer et al. 2000). However, in detergent alone OmpT was 
not found to be functional (Kramer et al. 2000). Indeed, only on addition of 
lipopolysaccharide (LPS), the major component of the outer membrane in Gram-
negative bacteria, was OmpT functionally active as an outer membrane protease. The 
lack of activity in the absence of LPS is thought to be a safety mechanism to prevent 
the cleavage of cytosolic proteins during OmpT transport to the outer membrane 
(Kramer et al. 2002). 
    
Figure 4.1.6 - Crystal Structure of OmpT (PDB file: 1I78) in octyl-β-D-glucopyranoside (Vandeputte-
Rutten et al. 2001).  
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Although, a structurally similar outer membrane protease, OmpA, has been folded 
into the amphipol, A8-35 (Pocanschi et al. 2006), the folding of OmpT into 
amphipol has not yet been characterised.  
 
In this thesis, ESI-MS has been applied to the study of the β-barrel outer membrane 
proteins PagP and OmpT in complex with amphipols. Both PagP and OmpT were 
successfully folded into the amphipol, A8-35, and their stability and functional 
activity confirmed by cold SDS-PAGE, size exclusion chromatography, far-UV CD 
and fluorescence. The membrane protein-amphipol complexes, once formed, were 
subjected to ESI-IMS-MS and the collision cross-sectional areas of the proteins 
determined. Based on these results, the future application of ESI-IMS-MS to study 
other membrane protein complexes will be evaluated.  
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Membrane Proteins 
4.2. Results and Discussion 
 
The compatibility of amphipol-membrane protein complexes with ESI-MS was 
investigated through the study of two outer-membrane proteins OmpT and PagP. 
Although OmpT and PagP are relatively simple β-sheet bacterial outer membrane 
proteins, their interaction with amphipols has not been reported previously.   
 
4.2.1 Folding OmpT into A8-35 
 
The OmpT plasmid was kindly provided by Lindsay McMorran (University of 
Leeds). OmpT plasmid was expressed in BL21 (DE3) cells and OmpT isolated as 
inclusion bodies (Materials and Methods Section 4.4.3). Purification by size 
exclusion chromatography in 25 mM TrisHCl pH 8.0, 250 mM NaCl, 6 M guanidine 
hydrochloride showed a single peak eluting off the column corresponding to > 95 % 
pure monomeric OmpT (Figure 4.2.1A) which was additionally confirmed by SDS-
PAGE (Figure 4.2.1B). OmpT (yield ~15 mg/L bacterial culture) was dialysed into 
H2O and stored at -80 ºC as a white precipitate. 
 
One method commonly used to fold membrane proteins into amphipols involves 
initially solubilising the membrane protein of interest in detergent (Zoonens et al. 
2005) (Figure 4.1.3). OmpT has been folded routinely into a variety of different 
detergent micelles for biochemical analysis (White et al. 1995; Kramer et al. 2000; 
Vandeputte-Rutten et al. 2001). OmpT was therefore dissolved into Triton X-100, 
amphipol added in a 1:5 (w/w) ratio of membrane protein:A8-35, and the detergent 
then removed by the addition of Bio-Beads. Unfortunately, OmpT did not 
completely solubilise in Triton X-100 so less than 10 % protein was incorporated as 
a result into the amphipol (data not shown).  
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Figure 4.2.1 - A) Size exclusion chromatography trace (Superdex 75 column) of OmpT in 25 mM 
TrisHCl, 250 mM NaCl, 6 M guanidine hydrochloride pH 8.0; B) SDS-PAGE gel showing pure 
OmpT along with the molecular weight markers. 
 
 
An alternative, more straightforward method was investigated to fold membrane 
proteins into amphipols. Amphipols have been used previously to fold the 
structurally similar β-barrel bacterial outer membrane protein OmpA from 8 M urea 
(Pocanschi et al. 2006). In this method, OmpA was solubilised initially in 8 M urea 
and then diluted rapidly 20-fold into urea-free buffer containing the amphipol, A8-35 
(Figure 4.1.2A). In a similar way, to initiate OmpT folding, OmpT unfolded in 8 M 
urea, was mixed with the amphipol A8-35 in a 1:5 (w/w) ratio of OmpT:A8-35, and 
this mixture was dialysed immediately into 100 mM ammonium bicarbonate pH 8.0. 
Remarkably, using this method OmpT remained 100 % soluble in urea-free buffer, 
and no visible evidence of aggregation or precipitation was apparent. 
 
Cold sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) can 
be used to distinguish between folded and fully denatured forms of membrane 
proteins (Schnaitm 1973). Thus, cold SDS-PAGE was used to determine the folding 
yield of OmpT into the amphipol, A8-35. On dilution of OmpT into 8 M urea, a 
single band was observed on the SDS-PAGE gel corresponding to unfolded OmpT 
(Figure 4.2.2). In comparison, the A8-35-solubilised OmpT migrated faster than its 
urea unfolded conformation indicating OmpT had folded completely into A8-35 
(Figure 4.2.2). Additional heat denaturation of the OmpT:A8-35 complex again 
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unfolded OmpT causing it to migrate at a similar molecular weight to the urea 
unfolded OmpT sample. Altogether, the cold SDS-PAGE results indicate OmpT is 
more folded in amphipol compared with its denatured state; however, further 
analysis is required to determine whether the protein is correctly folded into its 
functionally active form in A8-35.  
 
 
Figure 4.2.2 – SDS-PAGE gel of OmpT unfolded in urea and OmpT in A8-35 with and without heat 
denaturation prior to loading on the gel. 
 
Tryptophan fluorescence can be used as an intrinsic probe of membrane protein 
folding (Moon et al. 2011). Membrane proteins unfolded in denaturant have a 
tryptophan emission spectrum whose λmax is blue-shifted compared with their folded 
counterpart, for example, in detergent micelles or lipid. Since the amino acid 
sequence of OmpT contains eight tryptophan residues (Materials and Methods 
Section 4.4.2), the fluorescence emission spectrum of the tryptophans in OmpT can 
be used to determine the extent of OmpT folding into amphipol. The fluorescence 
emission spectrum of OmpT in A8-35 is shown in Figure 4.2.3. The λmax for OmpT 
in A8-35 is 330 nm compared with 347 nm in the unfolded OmpT spectrum in urea. 
The average wavelength between 320 nm and 370 nm has been used to compare 
fluorescence emission spectra between OmpT folded species in liposomes (Lindsay 
McMorran, University of Leeds). This average wavelength value increases the 
sensitivity of the assay by avoiding variability in absolute intensities at a particular 
wavelength (due to pipetting errors associated with pippetting liposomes) through 
intensity normalisation (Material and Methods Section 4.4.6.5). To compare the 
folded OmpT:A8-35 spectrum to that of folded OmpT in liposomes, the average 
wavelength of OmpT in A8-35 and in 8 M urea was calculated. The average 
wavelength red-shifts from 345.2 nm to 341.6 nm on comparison of OmpT in A8-35 
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with OmpT in 8 M urea. This average wavelength of OmpT folded in A8-35 is 
comparable to that observed in 1,2-dilauroyl-sn-glycero-3-phosphocholine (DLPC) 
liposomes (Figure 4.1.5) at pH 8.0, in 3 M urea (342.6 nm) (Lindsay M. McMorran, 
University of Leeds, personal communication).  
 
 
Figure 4.2.3 – Fluorescence emission spectrum of OmpT:A8-35 complex (blue) compared with 
spectrum in 8M urea (red). 
 
Far-UV circular dichroism (CD) is a commonly used technique to determine protein 
secondary structure (Kelly et al. 2005). Far-UV CD was, therefore, used to 
determine whether β-sheet secondary structure is present in the OmpT:A8-35 
complex. The far-UV CD spectrum of the OmpT:A8-35 complex showed a 
characteristic negative maximum at 218 nm (Figure 4.2.4A), which indicates that 
OmpT has β-sheet structure in complex with A8-35 and is therefore most likely to 
have folded into its native state in the amphipol.  
 
The complementary technique of size exclusion chromatography (SEC) was used to 
study the stability and heterogeneity of the OmpT:A8-35 complex (Materials and 
Methods Section 4.4.6.6). A single, narrow peak was observed corresponding to the 
OmpT:A8-35 complex in solution (Figure 4.2.4B). The single OmpT:A8-35 species 
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elution volume corresponds to a higher molecular weight (~ 100 kDa) compared 
with that predicted based on the OmpT amino acid sequence (34 kDa). This may be 
due to the amphipol coating around the OmpT protein is increasing the Stokes radius 
of OmpT causing it to elute earlier off the gel filtration column. Nonetheless, the 
presence of a single OmpT:A8-35 peak shows only one folded OmpT:A8-35 species 
is present in solution.  
 
 
 
Figure 4.2.4 A) Far-UV CD spectrum of OmpT-A8-35 complex in 100 mM ammonium bicarbonate 
pH 8.0; B) SEC trace showing a single peak corresponding to the OmpT-A8-35 complex in 100 mM 
ammonium bicarbonate pH 8.0 is present in solution. The void volume (VO), total column volume 
(Vt), and the elution times for the standard proteins ferritin (440 kDa), bovine serum albumin (67 
kDa) and β-lactoglobulin (35 kDa) are shown. 
 
 
The SDS-PAGE, SEC, CD and fluorescence emission spectra all indicate that OmpT 
is folded into the amphipol, A8-35; however, none of these techniques alone proves 
OmpT is folded into its native, functionally active state. The functionality of refolded 
OmpT was examined, therefore, by use of a fluorescence based assay. Native OmpT 
readily cleaves an internally quenched fluorogenic peptide (Abz-Ala-Arg-Arg-Ala-
Tyr-(NO2)-NH2) in the presence of lipopolysaccharide (LPS) causing an increase in 
fluorescence at 430 nm. In the absence of LPS, no cleavage is observed (Kramer et 
al. 2002; Brandenburg et al. 2005). LPS is thought to activate OmpT allosterically 
via a subtle conformational change in the active site, and thus is thought to be a 
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safety mechanism to prevent cleavage of cytosolic proteins during trafficking to the 
LPS containing outer membrane (Kramer et al. 2002). OmpT:A8-35 complex was 
incubated at various concentrations with and without the presence of LPS and the 
specific OmpT enzyme activity measured based on the observed increase in 
fluorescence (Figure 4.2.5) (Materials and Methods Section 4.4.6.3). On increasing 
the concentration of the OmpT:A8-35 complex, the rate of cleavage of the 
fluorogenic peptide increased suggesting that OmpT is functional in the OmpT:A8-
35 complex. The specific activity for OmpT was found to be 0.70 µmoles/mg 
enzyme/min, comparable to that observed in DLPC liposomes, pH 8.0 containing 3 
M urea (0.75 µmoles/mg enzyme/min) (Lindsay M. McMorran, University of Leeds, 
personal communication). A small amount of activity is also observed in the absence 
of LPS (0.13 µmoles/mg enzyme/min) (Figure 4.2.5B); however, this is 6-fold 
reduced compared with the activity observed when LPS is present in solution 
showing that LPS is still required for efficient OmpT emzyme activity. The low 
activity of OmpT observed in the absence of LPS could be due to the presence of the 
amphipol causing a slight conformational change in OmpT resulting in the active site 
becoming more accessible for peptide cleavage. Together the SDS-PAGE, 
fluorescence emission, CD, SEC and the fluorescence activity data show OmpT 
readily folds into A8-35 to form a stable, native, functional OmpT:A8-35 complex.  
 
Figure 4.2.5 A) OmpT:A8-35 functional assay showing the fluorescence increase (relative 
fluorescence units) on cleavage of the peptide Abz-Ala-Arg-Arg-Ala-Tyr-(NO2)-NH2 on addition of 
0.05 µM (black), 0.10 µM (blue), 0.15 µM (green), 0.20 µM (yellow), 0.30 µM (red) OmpT-A8-35 
complex in the presence of LPS; B) OmpT:A8-35 functional assay without LPS present at an OmpT-
A8-35 concentration of 0.05 µM (black), 0.15 µM (green) and 0.30 µM (red). 
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One significant advantage of amphipol-trapped membrane proteins over solubilising 
membrane proteins in detergent micelles is the increased stability that the amphipols 
provide. Bacteriorhodopsin/amphipol complexes have been shown to be stable for up 
to 6 months at 4 ºC (Gohon et al. 2008); hence, the stability of OmpT in A8-35 was 
investigated. After two months of storage at 4 ºC, the OmpT:A8-35 complex was 
analysed by cold SDS-PAGE, CD, SEC and its activity further measured by the 
fluorescence based assay described above. Strikingly, no differences in the SDS-
PAGE, SEC and CD spectra were observed on comparison of freshly prepared 
OmpT:A8-35 samples with OmpT:A8-35 samples stored for 2 months in 100 mM 
ammonium bicarbonate buffer (Figure 4.2.6). Only a slight decrease in activity (less 
than 3-fold) was observed for the old sample compared with the newly folded 
OmpT:A8-35 complex.  
 
 
Figure 4.2.6 - OmpT:A8-35 complex stability upon storage at 4 °C for 2 months. A) Cold SDS-PAGE 
analysis showing folded OmpT remains folded in A8-35; B) Far-UV CD spectra showing OmpT:A8-
35 before (red) and after (black) incubation at 4 °C for 2 months; C) SEC of OmpT in 8M urea (blue), 
OmpT:A8-35 (red) and OmpT:A8-35 after 2 months (black). The void volume (VO) and total column 
volume (Vt) are shown; D) Activity assay for OmpT showing the fluorescence increase  (relative 
fluoresecence units) of peptide on addition of 0.05 µM (black) and 0.15 µM (green) of freshly 
prepared OmpT:A8-35 compared with 0.15 µM of OmpT:A8-35 complex after 2 months of 
incubation at 4 °C (blue).  
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OmpT has been shown here for the first time to fold completely into the amphipol, 
A8-35 resulting in a stable OmpT:A8-35 complex. OmpT:A8-35 complex was 
further characterised by ESI-MS. IMS-MS was used to provide information on the 
structure of OmpT in the OmpT:A8-35 complex in addition to its accurate molecular 
weight. Before developing a method in which to study the OmpT:A8-35 complex by 
ESI-IMS-MS analysis, the mass spectrum of the amphipol, A8-35 alone was 
investigated. 
 
 
4.2.2 ESI-IMS-MS Analysis of the Amphipol, A8-35 
  
Due to their heterogeneous nature, the study of amphipols by mass spectrometry is 
challenging. The ESI mass spectrum of the amphipol, A8-35, is shown in Figure 
4.2.6. Multiple peaks are observed that arise from the heterogeneous nature of the 
amphipol making the molecular weight of individual amphipol species alone very 
difficult to assign. Fragments of the amphipol with various combinations of the x, y 
and z species (highlighted in the amphipol structure) of the amphipol in Figure 4.2.7 
are observed, indicating the correct amphipol of interest is present in solution.  
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Figure 4.2.7 – ESI-MS analysis of amphipol, A8-35 alone over the entire m/z range (top) along with a 
zoomed in m/z spectrum between 800 and 1000 m/z where various A8-35 related peaks are 
highlighted (bottom). x, y and z correspond to the repeated regions of the amphipathic polymer, 
highlighted in the structure. 
 
 
Over recent years, ion mobility spectrometry-mass spectrometry (IMS-MS) has been 
utilised increasingly to separate polymeric mixtures, allowing complex spectra to be 
assigned more accurately (Aminlashgari et al. 2012). IMS-MS was, therefore, used 
to separate the multiple charge states of A8-35 to determine whether a more accurate 
molecular weight could be assigned. The ESI-IMS-MS drifscope plot shows 
multiply charged ions (1+, 2+, 3+, 4+, 5+) present in the mass spectrum highlighting 
the power of ion mobility in separating out this complex amphipol mixture in the gas 
phase. The higher charge state ions (4+ and 5+) have a higher m/z (between 1,500 
and 2,500) which correlate with the expected molecular weight for the amphipol (9-
10 kDa). Unfortunately the mass spectrum does not reflect accurately the molecular 
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weight range of the amphipol due to smaller species ionising preferentially during 
the ESI process compared with the higher m/z species present. 
 
 
 
Figure 4.2.8 – ESI-IMS-MS drifscope plot of the amphipol, A8-35 alone highlighting the 1+. 2+, 3+ 
and 4+ charge states. The insert shows the isotope distribution in the mass spectrum (m/z range 1449-
1451) for the extracted peaks highlighted from the driftscope plot (1+, 2+, 3+ and 4+ charge state 
ions). 
 
 
4.2.3 ESI-IMS-MS Analysis of OmpT:A8-35 Complex 
To detect membrane proteins by ESI-MS, the membrane protein of interest must be 
released from the detergent micelle or lipid in the gas phase (Barrera et al. 2011). At 
low energy ionisation conditions, the OmpT in complex with amphipol was 
undetectable by ESI-MS (data not shown). When the energy in the trap and transfer 
T-wave devices of the instrument were increased from 6 V and 4 V to 150 V and 100 
V, respectively (Materials and Methods Section 4.4.6.7), the membrane proteins 
could be released from the amphipol and ions corresponding to the multiply charged 
membrane proteins were detected (Figure 4.2.9A). The mass spectrum of OmpT 
shows a narrow charge state distribution corresponding to the 6+, 7+, 8+ and more 
196 
 
expanded 9+ ions with an experimentally determined MW of 33,462 ± 5 Da, within 
0.01 % of calculated based on the amino acid sequence (33,460 Da).  
 
IMS-MS was used additionally to determine if the OmpT is preserved in a native-
like structure on release from amphipol in the gas phase. By calibrating the arrival 
time distributions of protein ions of known structure, the collision cross-sectional 
areas (CCS) of unknown proteins can be determined. An ideal ion mobility cross-
section calibration involves using native protein calibrants of a similar molecular 
weight and size to the proteins of interest (Bush et al. 2010). The high energy 
conditions used in membrane protein analysis make the analysis of native calibrants 
impossible under the same ESI-IMS-MS conditions. In the future, it may be possible 
to calibrate membrane protein cross sections using previously analysed membrane 
proteins of known CCS areas in the gas phase. In the meantime, following previous 
analysis of membrane proteins’ collision cross-sectional area measurements (Wang 
et al. 2010), a denatured calibration (using cytochrome c, myoglobin and ubiquitin) 
was used for membrane protein analysis (Amyloid Materials and Methods Section 
3.4.10.2) as this is thought to equally reflect the state of the CCS areas of membrane 
proteins in the gas phase as the native calibration.  
 
The experimentally determined CCSs for the 6+, 7+ and 8+ charge state ions of 
OmpT are 2601, 2736, 2779 Å
2
, respectively (Figure 4.2.9C). The lowest charge 
state ion (6+) is consistent (within a 5 % error) with the theoretically determined 
cross-sectional area predicted from the crystal structures (2718 Å
2
) using the 
projected superposition approximation (PSA) method (Bleiholder et al. 2011). Small 
shoulder peaks are present at increasing arrival time distributions for all of the OmpT 
charge states (Figure 4.2.9B). These are likely due to small amounts of gas-phase 
unfolding of the OmpT due to the high energies needed to eject OmpT from the 
OmpT:A8-35 complex. An additional increase in collision cross-section is observed 
with the 9+ charge state compared with the 8+ charge state ion (Figure 4.2.9C). This 
is thought to be due to Coulombic repulsion that is observed typically with highly 
charged ions. Together, the IMS-MS data shows the ability of amphipols to preserve 
native-like membrane protein structure on transition into the gas phase. 
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Figure 4.2.9 A) ESI-IMS-MS driftscope plot of OmpT:A8-35 showing the 6+, 7+, 8+ and 9+ charge 
states; B) Arrival time distributions of the charge states corresponding to OmpT. The arrows indicate 
the drift times used in the collision cross-section calculations; C) Table of the collision cross-sectional 
area measurements for each OmpT charge state using the ion mobility denatured calibration. 
 
 
The combination of the biophysical assays on OmpT and mass spectral analysis 
show the amphipol, A8-35 is a useful tool for studying membrane proteins. The 
application of amphipols to study other membrane proteins of interest was 
investigated further to determine whether amphipols can be used as a generic tool for 
membrane protein analysis. Accordingly, another smaller bacterial outer membrane 
β-barrel protein, PagP, was chosen for analysis.  
 
 
4.2.4 Folding PagP into A8-35 
The smaller 20.2 kDa protein, PagP (Figure 4.1.4) transfers a palmitate chain from 
phospholipids to the lipid A moiety of LPS in the outer leaflet of the membrane, 
reinforcing the hydrocarbon core of the outer leaflet and protecting it from host 
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immune defences (Bishop 2005). The PagP plasmid was kindly provided by Lindsay 
McMorran (University of Leeds). PagP plasmid was expressed in BL21 (DE3) cells 
and PagP isolated as inclusion bodies (Materials and Methods Section 4.4.3). On 
PagP purification by metal affinity chromatography, a single peak eluted 
corresponding to PagP on increasing the concentration of imidazole to 250 mM in 25 
mM TrisHCl pH 8.0, 250 mM NaCl, 6 M guanidine hydrochloride (Figure 4.2.10A). 
PagP was found to be pure as analysed by SDS-PAGE (Figure 4.2.10B) and 
subsequently dialysed into H2O for storage as a white precipitate at -80 ºC (yield ~10 
mg/L bacterial culture). 
 
 
 
 
Figure 4.2.10 - A) Nickel affinity chromatography trace (HisTrap 5 mL column) of PagP in 25 mM 
TrisHCl, 250 mM NaCl, 6 M guanidine hydrochloride pH 8.0 on increasing imidazole concentration; 
B) SDS-PAGE gel showing pure PagP along with the molecular weight markers. 
 
 
PagP was folded into A8-35 in the same way as OmpT. Briefly, A8-35 was added to 
PagP unfolded in urea and PagP folding initiated by dialysis in urea-free 100 mM 
ammonium bicarbonate buffer at pH 8.0. Cold SDS-PAGE analysis was used to 
determine the extent of folding of PagP into A8-35 (Figure 4.2.11). Despite much 
effort, it was not possible to fold PagP completely into A8-35, with two bands 
visible on the cold SDS-PAGE gel corresponding to a mixture of folded and 
unfolded PagP species in amphipol.  
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Figure 4.2.11 – SDS-PAGE gel of PagP in A8-35 (1:5 w/w) with and without heat denaturation prior 
to loading on the gel. 
 
The ratio of amphipol to membrane protein can be optimised to increase the folding 
yield of membrane proteins in amphipols. For example, only partial refolding of 
bacteriorhodopsin (BR) into the amphipol, A8-35, was observed using a BR:A8-35 
ratio of 1:2 (w/w); however complete refolding was observed by size exclusion 
chromatography on increasing the BR:A8-35 ratio to 1:5 (w/w) (Pocanschi et al. 
2006). The w/w ratio of A8-35 was altered and its effect on PagP folding yield 
investigated (Figure 4.2.12). Increasing the PagP:A8-35 (w/w) ratio, increased the 
folding yield of PagP up to a maximum folding yield of ~50 % at a 1:5 (w/w) ratio of 
PagP to amphipol. A 1:5 (w/w) ratio was used for the data presented throughout the 
rest of this thesis. The rate of dialysis can also affect protein folding. Various step 
dialysis methods (for example from 8 M urea, to 7 M urea, 6 M urea and 5 M urea 
before the complete removal of urea) were carried out to slowly remove the urea 
from the amphipol-containing PagP sample, however no increase in PagP folding 
yield was observed (data not shown).  
 
 
 
 
 
Figure 4.2.12 – SDS PAGE of PagP:A8-35 complex with and without heat denaturation prior to 
loading the samples on the gel.  
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Size exclusion chromatography was also used to determine the extent of PagP 
folding into A8-35 (Figure 4.2.13) (Materials and Methods Section 4.4.6.6). On 
solubilising PagP in 100 mM ammonium bicarbonate buffer containing 8 M urea, a 
single peak was observed after the void volume of the column corresponding to 
unfolded PagP. In comparison, the SEC data for the PagP:A8-35 complex showed a 
broad peak eluting off the column. This broad peak corresponds to the folded and 
unfolded PagP:A8-35 species that were also observed on the cold SDS-PAGE gel 
(Figures 4.2.11 and 4.2.12). The lower folding yield of PagP compared with OmpT 
is thought to be due to the highly aggregation-prone nature of PagP (Huysmans et al. 
2007). Problems have been observed previously on folding PagP into liposomes with 
only complete folding into 1,2-dilauroyl-sn-glycero-3-phosphocholine (diC12:0PC) 
observed in the presence of 7 M urea (Huysmans et al. 2007).  
 
 
Figure 4.2.13 – Size exclusion chromatography of PagP unfolded in 8M urea (blue, top) and the 
PagP-A8-35 complex in 100 mM ammonium bicarbonate pH 8.0 (red, bottom). 
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Although, PagP was not completely folded into A8-35, far-UV CD was used to 
determine whether the folded PagP present contained β-sheet secondary structure. A 
characteristic negative maximum at 218 nm was observed, suggesting PagP had 
folded correctly into A8-35 (Figure 4.2.14). The positive molar ellipticity at 232 nm 
(shown in Figure 4.2.12A) commonly observed in the native PagP far-UV CD 
spectrum is absent (Khan et al. 2007). The band at 232 nm is due to a Cotton effect 
between residues Tyr26 and Trp66 which pack closely together in the native PagP 
structure (Figures 4.1.4, 4.2.14A). Slight structural perturbations in the PagP 
structure in the amphipol could be resulting in the loss of this Cotton band. Local 
structural modifications through mutation of residues in the active site of PagP has 
also shown the loss of the PagP Cotton band in the far-UV CD spectrum (Khan et al. 
2010). The absence of the Cotton band could also be due to the mixture of folded 
and unfolded PagP species in A8-35 masking the natively folded PagP signal.  
 
 
Figure 4.2.14 - Far-UV CD spectrum of A) PagP in the detergent cyclofos-7 (- - -) and 1,2-dilauroyl-
sn-glycero-3-phosphocholine liposomes (-) showing a negative maximum at 218 nm and a Cotton 
Band at 232 nm; B) PagP:A8-35 complex showing a characteristic negative maximum at 218 nm 
corresponding to β-sheet secondary structure. Figure 4.2.14A was adapted from Huysmans et. al. 
(Huysmans et al. 2007). 
 
Additional tryptophan fluorescence emission experiments were carried out to further 
investigate the folding of PagP into the amphipol, A8-35. PagP contains 12 
tryptophan residues, two in the N-terminal α-helix, eight in the transmembrane 
region of the β-barrel, and two in the extracellular loops (Figure 4.4.2). The 
tryptophans and tyrosines in unfolded PagP in 8 M urea and the PagP:A8-35 
complex in 100 mM ammonium bicarbonate pH 8.0 were excited at 280 nm and 
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their tryptophan emission spectra recorded between 300 and 380 nm (Figure 4.2.15). 
The data show that the λmax shifts from 348 nm to 330 nm on folding the PagP from 
8M urea into A8-35 (Figure 4.2.15) showing the 12 tryptophans in PagP are more 
buried from solvent in the PagP:A8-35 compared with the urea denatured state. The 
data are comparable with the λmax for the fluorescence emission spectra of PagP 
refolded into cyclofos-7 micelles or DLPC (Figure 4.1.5) liposomes (335 nm) 
(Huysmans et al. 2007), suggesting PagP has correctly folded into the amphipol. 
 
  
Figure 4.2.15 – Fluorescence emission spectrum of PagP:A8-35 complex (blue) compared with the 
urea unfolded PagP spectrum (red). 
 
Despite the absence of the Cotton band in the CD spectrum, a functional assay was 
used additionally to determine if PagP is folded to a native functionally active state 
in A8-35. An activity assay in which native PagP hydrolyses p-nitrophenylpalmitate 
(p-NPP) to p-nitrophenol (p-NP) was monitored by the change in UV absorbance at 
410 nm (Huysmans et al. 2007). As the concentration of PagP was increased, in the 
rate of p-NPP hydrolysis also increased and increasing amounts of the yellow p-NP 
were detected (Figure 4.2.16). Although not a strictly quantitative method, due to the 
poor solubility of the p-NPP substrate in the buffer used (Materials and Methods 
Section 4.4.6.4), the specific enzyme activity of the PagP:A8-35 complex was 
calculated to be 0.019 ± 0.006 nmol/min/µM, a value similar to that observed for 
PagP in detergent (0.068 ± 0.011 nmol/min/µM) (Huysmans et al. 2007) considering 
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the different buffers used and problems associated with p-NPP solubilisation in these 
buffers. 
 
 
Figure 4.2.16 – PagP:A8-35 functional assay showing the absorbance increase at 410 nm on 
hydrolysis of p-NPP at a PagP:A8-35 concentration of 20 µM (blue), 30 µM (green), 40 µM (red). 
 
Analysis of the OmpT:A8-35 complex showed that once formed the OmpT:A8-35 
complex was stable for up to 2 months at 4 ºC (Figure 4.2.6). The stability of the 
PagP:A8-35 complex formed was investigated, therefore, by cold SDS-PAGE, far-
UV CD and tryptophan fluorescence emission spectroscopy (Figure 4.2.17). 
Although PagP was not initially fully folded in the amphipol, A8-35, after two 
months of storage at 4 ºC, the PagP:A8-35 complex remained 50 % folded as 
analysed by cold SDS-PAGE (Figure 4.2.17A). The far-UV CD and tryptophan 
fluorescence emission spectra were also comparable between freshly prepared 
samples and samples stored at 4 ºC for 2 months Figure 4.2.17B,C). These data 
suggest that once folded into amphipol, PagP remains folded and stable in 100 mM 
ammonium bicarbonate buffer at pH 8.0. 
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Figure 4.2.17 - PagP:A8-35 complex stability upon storage at 4 °C for 2 months. A) SDS-PAGE 
analysis showing PagP remains ~50 % folded in A8-35; B) Far-UV CD spectra showing PagP:A8-35 
before (red) and after (black) incubation at 4 °C for 2 months; C) Fluorescence emission spectra of 
PagP in 8M urea (blue), PagP:A8-35 (red) and PagP:A8-35 after 2 months at 4 °C (black). The 
fluorescence intensity was reported in relative fluorescence units (RFU).  
 
 
4.2.5 ESI-IMS-MS Analysis of PagP:A8-35 Complex 
Together, the SDS-PAGE, far-UV CD, SEC and fluorescence emission spectra 
suggest that only ~ 50 % of PagP is folded into the amphipol, A8-35, in 100 mM 
ammonium bicarbonate pH 8.0. It is possible that ESI-IMS-MS can be used to 
analyse the conformation of the folded and unfolded PagP species in the gas phase, 
hence IMS-MS was carried out on the PagP:A8-35 complex mixture in 100 mM 
ammonium bicarbonate buffer. If the presence of amphipol can preserve membrane 
protein structure on transition into the gas phase (as shown with the OmpT:A8-35 
complex mass spectral data (Figure 4.2.9)), at least two species should be observed 
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in the mass spectrum of PagP:A8-35 corresponding to a folded and unfolded 
conformation of PagP. 
 
In comparison to ESI-MS experiments on the OmpT:A8-35 complex under low 
energy ionisation conditions (Materials and Methods Section 4.4.6.7), PagP in 
complex with A8-35 was undetectable by ESI-MS under low energy ionisation 
conditions (data not shown). When the trap and transfer T-wave devices were 
increased to 150 V and 100 V respectively, PagP was released from the amphipol 
and ions corresponding to the multiply charged membrane protein were detected 
(Figure 4.2.18). The ESI mass spectrum of PagP shows a narrow charge state 
distribution corresponding to the 5+, 6+, 7+ ions with an experimentally determined 
MW of 20,175 ± 1 Da, within 0.01 % of calculated based on the amino acid 
sequence (20,175 Da). Higher charge state ions (7+, 8+, 9+ and 10+) are also 
observed corresponding to a more unfolded PagP species, however, although present 
in the driftscope, these peaks are difficult to analyse due to their overlap with the 
high m/z amphipol peaks.  
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Figure 4.2.18 - A) ESI-IMS-MS driftscope plot of PagP:A8-35 complex. The charge states of the ions 
are highlighted. The white arrows represent the more compact PagP conformation and the red arrow 
the more expanded conformation. The mass spectrum of PagP is shown on the left-hand side; B) 
Table of the collision cross-sectional area measurements for each PagP charge state using the ion 
mobility denatured calibration. The collision cross-section for the more expanded PagP conformation 
is highlighted in red.   
 
 
The experimentally determined CCS for the lowest charge state ions (5+) of PagP 
(1790 Å
2
) are consistent with the values predicted from the crystal structure using 
the projected superposition approximation algorithm (Bleiholder et al. 2011) (1732 
Å
2
) within a 5 % error, highlighting the power of amphipols in preserving membrane 
protein structure on transition into the gas phase. IMS-MS also allowed an 
additional, more expanded, conformation of PagP to be separated from the amphipol, 
A8-35 in the gas phase (the 7+ charge state of which is highlighted in Figure 4.2.18). 
From the arrival time distribution, the CCS of this 7+ charge state ion (3131 Å
2
) is 
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70 % larger than the more compact 7+ charge state ion (1836 Å
2
). Since no 
additional expanded conformations of OmpT were observed in the IMS-MS 
driftscope plot for the OmpT:A8-35 complex analysed under identical mass 
spectrometry conditions (Figure 4.2.9), it is thought that the unfolded PagP species 
observed in the gas phase is also present in solution and is not an artefact of the ESI-
IMS-MS process. In addition, since there are two conformations present for the 7+ 
charge state, the more expanded conformer is not likely to be due to Coulombic 
repulsion, in contrast to that observed for the 9+ charge state in the OmpT driftscope 
(Figure 4.2.9).  
 
The observation of the unfolded PagP using the high energy ionisation conditions 
suggests the unfolded PagP protein is also surrounded by the amphipol and is being 
protected during the electrospray process into the gas-phase. The percentage of 
unfolded PagP remained constant during storage at 4 ºC for 2 months (Figure 
4.2.17A) with no visible evidence of precipitation observed. This suggests that the 
amphipols can not only be used to study proteins in their native state but may also 
have implications in trapped structural intermediates in the membrane protein 
folding pathway.  
 
The data presented show that PagP has been inserted into amphipol, A8-35. Solution 
biochemical data combined with ESI-IMS-MS indicate that PagP can fold into a 
stable PagP:A8-35 complex; however a 50 % folding yield is obtained. The data 
show the power of IMS-MS in separating folded and unfolded conformations of 
PagP in support of the in solution SDS-PAGE and SEC data indicating that 
amphipols can preserve membrane protein structure on transition into the gas phase. 
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4.3 Conclusions 
 
Membrane protein analysis by biochemical techniques is challenging due to the 
difficulties associated with membrane protein purification and retaining native, 
functionally active complexes in vitro. Over the last sixteen years, amphipols have 
been increasingly used as an alternative to detergents to analyse membrane protein 
complexes in solution (Popot et al. 2011). In this thesis, two β-barrel outer 
membrane proteins, PagP and OmpT, were studied. Both membrane proteins were 
inserted for the first time into the amphipol, A8-35. Analysis by SDS-PAGE, SEC, 
CD and fluorescence emission spectroscopy revealed that OmpT had folded 
completely into the amphipol with a functional activity comparable to that observed 
in liposomes. PagP, however, did not completely fold into A8-35 with approximately 
50 % remaining unfolded in solution. Further investigation is needed into alternative 
methods of folding membrane proteins into amphipols to optimise the folding yield 
of PagP into amphipol. Indeed, alternative amphipols, for example the non ionic 
amphipols (NAPols) (Bazzacco et al. 2012), have now been designed that may assist 
the folding of PagP into a more stable PagP:amphipol complex. 
 
The analysis of membrane proteins by mass spectrometry has previously been 
established by solubilisation of membrane proteins in detergent micelles (Barrera et 
al. 2008; Barrera et al. 2009; Wang et al. 2010; Barrera et al. 2011; Zhou et al. 
2011). This approach to membrane protein analysis has limitations due to problems 
associated prior to ESI-MS analysis with preserving protein structure, protein-protein 
and protein-ligand interactions in detergent solutions. Amphipols offer the ability to 
trap membrane proteins in detergent-free aqueous solutions, thus alleviating these 
limitations. Additionally, amphipols are particularly stable in aqueous solution 
containing low salt which are ideal conditions for mass spectral analysis. The ESI 
mass spectrum of the amphipol, A8-35 alone showed multiple peaks corresponding 
to the intact amphipol along with multiple fragment ions. The heterogeneity of this 
sample makes the exact molecular weight of amphipol impossible to determine 
accurately. Indeed MALDI-MS analysis of the same amphipol, A8-35 was not 
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detectable since it is thought the sample is too polydisperse for any individual 
species to be detected (Bechara et al. 2012).    
 
Mass spectrometric analysis of amphipol-trapped membrane proteins has only been 
established relatively recently (Bechara et al. 2012). In this work, four different 
membrane proteins were studied, OmpA (an 8-stranded β-barrel outer membrane 
protein from E.coli), bacteriorhodopsin (a 7 α-helical retinal-containing proton pump 
from the archaebacterium Halobacterium salinarum), cytochrome b6f (a superdimer 
from the green alga Chlamydomonas reinhardtii with 8 transmembrane subunits) and 
cyctochrome bc1 (a multisubunit superdimer from beef heart mitochondria). 
MALDI-TOF MS analysis allowed the detection of all the membrane proteins 
studied, with the membrane proteins being released from the amphipols during the 
MALDI ionisation process. This mass spectrometry data allows the molecular 
weight, and subunit stoichiometries of membrane protein complexes to be 
determined. This MALDI-MS data alone does not provide any structural information 
on the membrane proteins in the gas phase and additional experiments are needed to 
determine if the membrane proteins are indeed functional in the MALDI matrix prior 
to mass spectrometry analysis. In this thesis an ESI-IMS-MS method was used to 
determine the molecular weight of the membrane protein of interest and also to 
investigate the structural properties of the membrane proteins in complex with 
amphipols.    
 
Two different A8-35-trapped membrane proteins, OmpT and PagP were studied by 
ESI-IMS-MS. IMS-MS separated amphipol from the membrane proteins in the gas 
phase allowing ions to be detected corresponding to the membrane proteins alone. 
Additional collision cross-sectional area calculations showed that amphipols can 
preserve membrane protein structure on transition into the gas phase with 
experimental cross sections within 5 % of those obtained from theoretical values 
calculated based on the PDB structures. For example in the case with PagP, IMS-MS 
could separate multiple different proteins conformations in the complex with the 
amphipol, reflecting the in solution biochemical data.  
 
The application of A8-35 to two different β-barrel membrane proteins suggests that 
this procedure could be applicable to other more complex membrane proteins. The 
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insertion of membrane proteins into amphipols is becoming increasingly popular for 
membrane protein structure analysis. The α-helical inner membrane protein, 
bacteriorhodopsin (Pocanschi et al. 2006; Gohon et al. 2008), β-barrel outer 
membrane proteins OmpX (Catoire et al. 2010), OmpA (Pocanschi et al. 2006), 
FomA (Pocanschi et al. 2006), and membrane protein complexes including ligand 
bound to G-protein coupled receptors (GPCR) (Catoire et al. 2010) and the NADH 
bound ubiquinone oxidoreductase (Flotenmeyer et al. 2007), are just some of the 
membrane proteins that have been inserted into amphipols over the last few years. 
Although in this thesis only small β-barrel outer membrane proteins were selected 
for MS analysis, the MS analysis of higher-order multi-subunit membrane protein 
complexes in amphipols is sure to become increasingly popular, since the higher the 
mass to charge ratio of the membrane protein complex studied, the easier their 
separation from amphipol during IMS-MS analysis. 
 
Nanodiscs are an alternative way of solubilising membrane proteins in solution for 
study by mass spectrometry (Marty et al. 2012). Nanodiscs typically consist of a 
lipid bilayer surrounded by a stabilising scaffold protein to which a membrane 
protein can be inserted (Ritchie et al. 2009; Bayburt et al. 2010; Popot 2010). 
Although these membrane proteins inside the nanodiscs are thought to be in a more 
native-like environment, the preparation of nanodiscs containing membrane proteins 
is not straightforward. Several parameters need to be optimised, such as the lipid 
type, the lipid-protein ratio, in addition to the nanodisc forming conditions making it 
difficult to be a high throughput approach. Insertion of membrane proteins into 
amphipols, however, is relatively straightforward with only the protein:amphipol 
ratio needing optimisation. Although membrane proteins in nanodiscs are thought to 
have an increased stability compared with membrane proteins inserted into detergent 
or liposomes, the stability of membrane proteins in amphipols compared with 
nanodiscs is dramatically increased with the membrane protein:amphipol complexes. 
The PagP and OmpT that folded into the amphipol, A8-35 remained folded and 
functionally active during storage for two months at 4 ºC.  
 
As amphipols become more commercially available, the study of membrane proteins 
in amphipols will become increasingly utilised within the membrane protein field. 
The additional stability that amphipols offer makes these membrane protein-
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amphipol complexes highly favourable over methods that use detergent to solubilise 
the membrane proteins of interest. Since membrane proteins constitute 
approximately 30 % of the proteome and more than 50 % of all known drug targets, 
the study of membrane proteins by high throughput mass spectrometric techniques 
will become increasingly utilised amongst this challenging field of research.   
 
 
  
212 
 
Membrane Proteins 
4.4. Materials and Methods 
 
4.4.1 Reagents 
All reagents were purchased as previously described in Materials and Methods 
Sections 2.4 and 3.4 unless otherwise stated below. 
 
Protein Purification Reagents 
Triton X-100 was purchased from Calbiochem, UK. Guanidine hydrochloride 
(GuHCl) was purchased from Melford Laboratories, Suffolk, UK. 
 
Reagents for Enzyme Assays 
Abz-Ala-Arg-Arg-Ala-Tyr-(NO2)-NH2 was purchased from Cambridge Peptides, 
UK. Lipopolysaccharide (LPS) was purchased from Calbiochem, UK, p-nitrophenyl 
palmitate (pNNP) from Sigma-Aldrich Corporation, Dorset, UK and isopropanol 
from Fisher Scientific, UK. 
 
Amphipol  
The amphipol, A8-35, was purchased from Affymetrix UK Ltd. (High Wycombe, 
UK). 
 
Mass Spectrometry Reagents 
Ammonium bicarbonate was purchased from Sigma-Aldrich Corporation (Poole, 
Dorset, UK).   
 
4.4.2 Molecular Biology 
Transformation of plasmid DNA 
Plasmid DNA (kindly provided by Lindsay M. McMorran, University of Leeds) was 
transformed into BL21 (DE3) cells for protein expression according to the protocol 
mentioned previously (see Pilus Materials and Methods, Section 2.4.7). 
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OmpT Amino Acid Sequence 
RAKLLGIVLT TPIAISSFAS TETLSFTPDN INADISLGTL SGKTKERVYL 
AEEGGRKVSQ LDWKFNNAAI IKGAINWDLM PQISIGAAGW TTLGSRGGNM 
VDQDWMDSSN PGTWTDESRH PDTQLNYANE FDLNIKGWLL NEPNYRLGLM 
AGYQESRYSF TARGGSYIYS SEEGFRDDIG SFPNGERAIG YKQRFKMPYI 
GLTGSYRYED FELGGTFKYS GWVESSDNDE HYDPGKRITY RSKVKDQNYY 
SVAVNAGYYV TPNAKVYVEG AWNRVTNKKG NTSLYDHNNN TSDYSKNGAG 
IENYNFITTA GLKYTF 
 
Note: the N-terminal methionine is cleaved off during protein expression and hence 
not shown in this sequence. 
 
PagP Amino Acid Sequence 
MNADEWMTTF RENIAQTWQQ PEHYDLYIPA ITWHARFAYD KEKTDRYNER 
PWGGGFGLSR WDEKGNWHGL YAMAFKDSWN KWEPIAGYGW ESTWRPLADE 
NFHLGLGFTA GVTARDNWNY IPLPVLLPLA SVGYGPVTFQ MTYIPGTYNN 
GNVYFAWMRF QFLEHHHHHH 
 
Note: the C-terminus of PagP was His-tagged to aid protein purification 
 
 
4.4.3 Expression and Purification of Membrane Proteins   
4.4.3.1 Pre-culture 
Pre-cultures were mediated by addition of 20 µL bacterial glycerol stock to 500 mL 
sterile LB media (Pilus Materials and Methods, Section 2.4.8). The medium, 
containing 100 µg/mL ampicillin, was incubated overnight at 37 °C overnight, 
shaking at 200 rpm and used immediately for large-scale protein over-expression. 
 
4.4.3.2 Cytoplasmic Protein Expression 
Two 2 L flasks each containing 1 L of LB media were pre-warmed overnight at 37 
°C. 30 mL of pre-culture containing E.coli BL21 (DE3) cells with the relevant 
plasmid transformed into it were added to each flask along with 1 mL of 100 mg/mL 
carbenicillin (stored at -20 °C). The culture was incubated at 37 °C, shaking at 200 
rpm in an orbital shaking incubator, and the optical density (O.D) at 600 nm was 
measured at regular intervals. At an OD of 0.6, protein expression was induced by 
addition of 1 mL of 1 M filter sterilised IPTG. After 3 hours, the cultures were 
harvested at 6,000 rpm, 4 °C.   
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4.4.3.3 Inclusion Body Isolation 
The cell pellet was resuspended in 100 mL lysis buffer containing 50 mM Tris-HCl 
pH 8.0, phenyl methyl sulponyl fluoride (PMSF) (50 µg/mL), DNase (20 µg/mL), 
ethylenediaminetetraacetic acid disodium salt (EDTA) (5 mM) and incubated at 
room temperature for 30 min (lysozyme (100 µg/mL) was additionally added to the 
PagPhis prep). Cells were further lysed using a TS Series cell disruptor (Constant 
Systems Ltd, UK) at 20 kpsi. The cell lysate was then centrifuged at 20,000 rpm for 
30 min at 4 C. The supernatant was discarded and the cell pellet resuspended in 100 
mL 50 mM Tris-HCl pH 8.0. The cells were centrifuged (20,000 rpm, 30 min, 4 C) 
and resuspended in 50 mM Tris-HCl pH 8.0, 1 % (v/v) Triton X-100. The cells were 
then centrifuged (20,000 rpm, 30 min, 4 C) and resuspended in 50 mM Tris-HCl pH 
8.0 before the final centrifugation step (20,000 rpm, 30 min, 4 C). The final cell 
pellet was solubilised in 150 mL 25 mM Tris-HCl pH 8.0, 250 mM NaCl containing 
6 M guanidine hydrochloride and incubated for 2 hours on an orbital shaker at 70 
rpm, 4 C. Any insoluble material remaining was discarded by centrifugation at 
12,000 rpm for 1 h at 4 C.    
 
4.4.3.4 Metal Affinity Chromatography (PagP purification) 
PagP was purified using a Histrap (5 mL) column (GE Healthcare, 
Buckinghamshire, UK). All solutions were filtered using a 0.22 μm Steritop filter 
(Millipore, Massachusetts, USA) and degassed using a Buchi Vac V-500 vacuum 
pump (Buchhi Labortechnik AG, Switzerland) prior to passing through the column. 
The column was equilibrated with 5 column volumes of 25 mM Tris-HCl pH 8.0, 
250 mM NaCl, 6 M guanidine hydrochloride and the impure protein solution loaded 
onto the column at a flow rate of 2 mL/min using a peristaltic pump. The column 
containing the His-tagged protein was transferred to an ÄKTA prime (GE 
Healthcare, Buckinghamshire, UK) and washed with 5 column volumes of 25 mM 
Tris-HCl pH 8.0, 250 mM NaCl, 6 M guanidine hydrochloride, 25 mM immidazole 
at 4 ºC at a flow rate of 2 mL/min to remove any non-specifically bound proteins. 
Finally PagPhis was eluted using 25 mM Tris-HCl pH 8.0, 250 mM NaCl, 6 M 
guanidine hydrochloride, 500 mM immidazole. The fractions containing PagPhis (as 
detected by spectrophotometry at A280 and SDS-PAGE) were combined and dialysed 
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into H2O (18 MΩ) at 4 C. The PagP precipitate was pelleted by centrifugation and 
stored at -80 ºC until further use. 
 
4.4.3.5 Size Exclusion Chromatography (OmpT purification) 
OmpT inclusion bodies solubilised in 25 mM Tris-HCl pH 8.0, 250 mM NaCl, 6 M 
guanidine hydrochloride were filtered through a 0.22 μm Steritop filter (Millipore, 
Massachusetts, USA) and injected (5 mL per run) onto a HiLoad 26/60 Superdex 75 
column (GE Healthcare, Buckinghamshire, UK) equilibrated in 20 mM Tris-HCl pH 
8.0, 250 mM NaCl, 6 M guanidine hydrochloride and controlled by an ÄKTA prime. 
OmpT typically eluted after 100 mL using a flow rate of 3 mL/min. Several gel 
filtration runs were necessary to purify the whole batch of protein. Finally all 
fractions containing pure OmpT, as detected by spectrophotometry at A280 and SDS-
PAGE, were combined and dialysed into H2O (18 MΩ) before storage as a 
precipitate at -80 °C.  
 
4.4.4 Characterisation of Membrane Proteins   
Membrane Protein Purity  
The purity of PagP and OmpT were determined by a single peak on the a HiLoad 
26/60 Superdex 75 (GE Healthcare, Buckinghamshire, UK) gel filtration column in 
addition to a single band being observed at the correct molecular weight using SDS-
PAGE analysis (Pilus Materials and Methods, Section 2.4.11).  
 
Determination of Membrane Protein Concentration 
The concentration of PagP and OmpT for all experiments was calculated using the 
Beer-Lambert law by measuring the absorbance at 280 nm and using the theoretical 
extinction coefficients determined from the amino acid sequence (using Protparam 
online software)  (Edelhoch 1967; Gill et al. 1989; Pace et al. 1995). The extinction 
coefficients used for PagP and OmpT are 82390 and 78270 M
-1
cm
-1
 respectively.  
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4.4.5 Membrane Protein Folding into Ampipols 
PagP and OmpT were initially dissolved in 100 mM ammonium bicarbonate pH 8.0 
containing 8 M urea. A8-35 (purchased from Affymetrix Ltd., High Wycombe, UK) 
was then added at a protein to A8-35 ratio of 1:5 (w/w) and the solution dialysed into 
100 mM ammonium bicarbonate pH 8.0 at 4 °C for 24 h. A final membrane protein 
concentration of 1 mg/mL was used for all experiments and an A8-35 concentration 
of 5 mg/mL unless otherwise stated.  
 
4.4.6 Analysis of Membrane Protein-amphipol Complexes.  
4.4.6.1 Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS-
PAGE) 
Gel electrophoresis was routinely used to monitor over-expression and purification 
of recombinant proteins. Additionally cold SDS-PAGE was used to measure the 
protein folding yield into amphipol (Schnaitm 1973). Tris-tricine buffered gels were 
used in all cases (Pilus Materials and Methods, Section 2.4.11). For the cold SDS-
PAGE gels, the samples made up in loading buffer were not boiled prior to loading 
on the SDS-PAGE gel. 
 
4.4.6.2 Circular Dichroism 
 CD spectra of all proteins were recorded on a Chirascan
TM
 CD Spectrometer 
(Applied Photophysics, Surrey, UK) using a 0.1 mm cuvette. 8 scans from 200 to 
260 nm with a bandwidth of 1.0 nm, and a scan speed of 20 nm/min, were 
accumulated and averaged. Background spectra containing the amphipol alone were 
subtracted for all samples. The recorded CD spectra were normalised to obtain the 
mean residue molar ellipicity [Θ] (λ), in degcm2/dmol:  
 
 Θ  λ      
Θ λ 
     
 
where l is the path length of the cuvette (cm), Θ (λ) is the recorded ellipticity (deg), c 
is the concentration (moles/L) and n is the number of amino acid residues, 296 and 
170 for OmpT and PagP, respectively. 
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4.4.6.3 Activity Assays OmpT 
To measure OmpT protease activity, the change in fluorescence emission at 430 nm 
of the cleavable fluorogenic peptide (Abz-Ala-Arg-Arg-Ala-Tyr-(NO2)-NH2) was 
measured upon excitation at 325 nm (Kramer et al. 2000). The excitation and 
emission slit widths were set to 2 nm and the fluorescence measured over a 300 s 
reaction timescale using a Photon Technology International fluorimeter (Ford, West 
Sussex, UK). The temperature was regulated to 25 °C using a waterbath and a 1 cm 
path length cuvette was used throughout. Where necessary, lipopolysaccharide (LPS) 
was added to the OmpT:A8-35 solution at a concentration of 1 mg/mL, and in all 
cases the fluorogenic peptide was added immediately before analysis to a final 
concentration of 50 µM. Samples were mixed manually, resulting in a dead time of 
approximately 15 s. The average specific enzyme activity over a range of protein 
concentrations was reported in amount of substrate utilised/mg of enzyme/min. A 
control in which OmpT was unfolded in 8 M urea confirmed the activity was due to 
the natively folded OmpT:A8-35 complex. The fluorescence due to the buffer and 
A8-35 alone was subtracted from all spectra acquired.   
 
4.4.6.4 Activity Assays PagP 
The enzymatic assay for PagP was adapted from a previously described method 
(Huysmans et al. 2007). The hydrolysis of p-nitrophenyl palmitate (p-NNP) to p-
nitrophenol by PagP was monitored by the increase in absorbance at 410 nm. p-NPP 
(10 mM in isopropanol) was diluted into 100 mM ammonium bicarbonate pH 8.0 
containing various concentrations of PagP:A8-35 complex to a final substrate 
concentration of 1 mM and the rate of reaction monitored over 200 min. The 
increase in absorbance due to A8-35 addition alone was subtracted from all 
measurements. A control in which PagP was unfolded in 8 M urea was used to 
confirm the activity was due to the natively folded PagP:A8-35 complex. The 
average specific enzyme turnover over a range of protein concentrations was 
reported in nmol product/min/µM of PagP using an extinction coefficient of 3390 M
-
1 
cm
-1
 for p-nitrophenol.    
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4.4.6.5 Fluorescence Emission  
To measure the extent of membrane protein folding in amphipol, the tryptophan and 
tyrosine residues in PagP and OmpT (0.5 µM) were excited at 280 nm and the 
fluorescence emission spectrum measured between 300 – 400 nm using a Photon 
Technology International fluorimeter (Ford, West-Sussex, UK). The excitation and 
emission slit widths were set to 2 nm, the temperature was regulated to 25 °C using a 
waterbath, and a 1 cm path length cuvette was used throughout. PagP and OmpT 
spectra were recorded folded in A8-35 and unfolded in 8 M urea. The fluorescence 
emission due to the buffer and A8-35 alone was subtracted from all spectra acquired. 
The average wavelength (nm) was calculated as follows between 320 and 370 nm 
(Royer et al. 1993): 
    
      
    
 
 
where <λ> is the average wavelength, λi the wavelength and Ii the fluorescence 
intensity at λi. 
, 
 
4.4.6.6 Size Exclusion Chromatography 
Size exclusion chromatography was carried out using a Superdex 200 (10/300) 
column connected to an Äkta system. 200 µL of protein:A8-35 complex (or 
membrane protein alone) containing 0.2 mg protein was injected onto the column 
equilibrated in either 100 mM ammonium bicarbonate (folded) or 100 mM 
ammonium bicarbonate pH 8.0 containing 8 M urea (unfolded). The protein was 
eluted at a flow rate of 0.5 mL/min at room temperature. Elution profiles were 
followed by measuring the absorbance at 280 nm. The elution of PagP and OmpT 
was additionally confirmed by SDS-PAGE analysis.  
 
4.4.6.7 Mass Spectrometry 
Buffer Preparation 
Ammonium bicarbonate buffers were made at 100 mM in deionised (18 MΩ) water. 
The ammonium bicarbonate buffer was stored at 4 ºC for one week maximum. 
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ESI-(IMS)-MS analysis 
Experimental measurements were performed on a Synapt HDMS mass spectrometer 
(Waters Ltd., Manchester, UK) equipped with a NanoMate (Advion Biosystems Inc., 
Ithaca, NY, U.S.A) nanoESI autosampling device. Positive nano-ESI with a capillary 
voltage of 1.75 kV and a nitrogen nebulising gas pressure of 0.5 p.s.i. was used for 
all experiments. For the mass spectra acquired on the amphipol alone, a cone voltage 
of 70 V, source temperature 60 °C, bias 20 V, trap voltage 6 V and a transfer 
voltages of 4 V was applied.  
 
For data acquired on the membrane protein-amphipol complexes, a cone voltage of 
170 V was applied. The trap and transfer T-wave devices were additionally increased 
to 150 and 100 V respectively, the bias set to 100 V and the backing pressure to 4.7 
mbar. Ion mobility separation was performed for all samples by ramping the wave 
height from 4.5-28.5 V at a speed of 300 m/s. Drift times were corrected for mass 
dependent and mass independent times (Knapman et al. 2010) and the drift time 
cross-section function calibrated as reported previously (Smith et al. 2009) (See 
Amyloid Materials and Methods, Section 3.4.10.2). Computer-based cross-sectional 
area calculations were made from Protein Data Bank structures using the projection 
superposition approximation (PSA) method described previously (Bleiholder et al. 
2011). An aqueous solution of CsI was used for mass calibration. All data were 
acquired over the m/z range 500-8000 and the raw data processed by use of 
MassLynx v.4.1 and Driftscope v.3.0 (Waters Ltd., Manchester, UK).  
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Final Remarks 
 
The work contained in this thesis describes the application of mass spectrometry to 
the structural analysis of proteins and non-covalent protein complexes. Mass 
spectrometry was chosen due to its advantages over other, more established 
biochemical techniques. These features include low sample consumption, no 
theoretical upper mass limit, and the ability to distinguish between multiple species 
co-populated in solution on account of their molecular weight. Over the last 30 
years, with the development of electrospray ionization mass spectrometry (ESI-MS), 
protein analysis by mass spectrometry has excelled. As a result, mass spectrometry is 
now routinely used not only to determine the molecular weight of non-covalently 
bound protein complexes in solution, but also to determine post-translational 
modifications (Witze et al. 2007; Bechara et al. 2012), subunit stoichiometries (Loo 
1997; Barrera et al. 2009; Gordiyenko et al. 2010; Janganan et al. 2011), protein-
protein interaction interfaces (Dodds et al. 2011; Liu et al. 2011), kinetic reaction 
mechanisms (Konermann et al. 1997; Fandrich et al. 2000; Rose et al. 2008), 
protein-ligand binding affinities (Wortmann et al. 2008; Jonker et al. 2011; Kitova et 
al. 2012) and in general to unravel complex protein assembly mechanisms 
(Knapman et al. 2010; Smith et al. 2010; Morrissey et al. 2012).  
Mass spectrometry can be used as a tool to monitor biochemical reactions in real 
time. Mass spectrometry can also be used to follow protein folding on the 
millisecond timescale (Simmons et al. 2002; Pan et al. 2010; Stocks et al. 2010; Pan 
et al. 2011) and the complex assembly of protein subunits (Rose et al. 2008; Verger 
et al. 2008; Smith et al. 2010; Smith et al. 2011), for example in the assembly of the 
heterohexameric NtGimC chaperone complex (Fandrich et al. 2000). In this thesis 
mass spectrometry has been used to follow two contrasting assembly mechanisms; 
pilus biogenesis and amyloid fibril formation. During pilus assembly thousands of 
structurally similar protein subunits are assembled on the outer membrane of bacteria 
and mass spectrometry was used to study these protein subunits based on their 
molecular weights. In contrast, during amyloid assembly, thousands of identical 
subunits assemble with one another and it is only with the combination of ion 
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mobility spectrometry and mass spectrometry that this heterogeneous mixture of 
amyloidogenic oligomers was separated. 
In particular, ESI-MS has been used in this thesis to determine accurately second 
order rate constants of pilus biogenesis in real time. The key to this success was the 
accurate quantification of the chaperone-subunit complex over time by the addition 
of a structurally similar internal standard. The application of this method led to the 
identification of specific amino acids in the N-terminal extension of the pilin 
subunits which are important in determining the specificity of pilus biogenesis 
(Leney et al. 2011).  
ESI-IMS-MS was used to determine the relative populations of β2m oligomers 
during amyloid fibril formation. Comparison of WT β2m oligomers with oligomers 
derived from a series of mutants covering the entire β2m protein sequence revealed 
specific residues important in amyloidosis, highlighting the complexity of this fibril-
forming process. Further, detailed characterisation of the β2m mutant H51A revealed 
subtle differences in the subunit exchange dynamics of the oligomeric species 
involved in fibril formation, even though their gas phase stabilities, cross sectional 
areas, and eventual fibril morphology remained comparable. Together these results, 
in combination with those on pilus assembly, demonstrate the power of mass 
spectrometry to discern protein reaction mechanisms in complex biological systems. 
In addition to ESI-MS and ESI-IMS-MS analysis, tandem MS is a widely used 
technique to determine subunit stoichiometry (Barrera et al. 2009; Synowsky et al. 
2009; Gordiyenko et al. 2010) in addition to revealing information about the nature 
of protein-protein interactions in solution (Chung et al. 1999; Erba et al. 2010; 
Dodds et al. 2011). CID-MS/MS can also reveal differences in binding affinities 
between protein-protein complexes (Daniel et al. 2002; Erba et al. 2010). This thesis 
shows how CID-MS/MS can be used to determine differences in the gas phase 
stabilities of the chaperone-subunit-usher ternary complexes formed during pilus 
assembly. By truncation of the PapG subunit into its adhesion and pilin domains, the 
reason for the increased affinity of the PapG subunit above all other subunits for the 
outer membrane usher was revealed (Morrissey et al. 2012).   
CID MS/MS has also been suggested as a useful tool to understand more about the 
nature of protein-protein complexes, providing further insight as to whether their 
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binding interfaces are hydrophobic or electrostatic in nature. On subjecting dimer 
and trimer β2m oligomers to CID-MS/MS, the oligomers underwent symmetrical 
division producing equally charged dissociation products. This is unusual for CID-
MS/MS analysis of the dissociation products where asymmetric division is the 
proposed mechanism of dissociation (Sciuto et al. 2011). Although further data are 
needed, preliminary data suggest the lack of symmetrical division in the 
amyloidogenic intermediates is due to the interface being more hydrophobic rather 
than electrostatic in nature. Additional covalent labelling experiments for example 
oxidative labeling (Konermann et al. 2010) may reveal insights into the location of 
individual amino acid residues in the on-pathway oligomeric intermediates. 
More recent attention in native protein mass spectrometry has turned to membrane 
proteins, which only in the last few years has been found possible. Membrane 
protein analysis by mass spectrometry is challenging due to the insolubility of these 
species in aqueous and organic buffers. Recent advances by Carol Robinson and 
collegues have shown it is possible to transfer membrane proteins in detergent 
micelles intact into the gas phase (Ilag et al. 2004; Barrera et al. 2008). Detergent 
micelles are not optimal for membrane protein analysis and alternative solubilisation 
techniques are needed to maintain membrane proteins in their native, functional state 
for structural and functional analysis (Seddon et al. 2004; Popot 2010). The use of 
amphipols for the analysis of membrane proteins by mass spectrometry has been 
investigated in this thesis. The two bacterial outer membrane proteins, OmpT and 
PagP, were inserted into amphipols and successfully analysed by ESI-MS. These 
data show great promise for the future of membrane protein analysis using mass 
spectrometry with membrane proteins remaining stable in amphipol for analysis for 
up to two months compared to a few days in detergent micelles and with minimal 
sample preparation required. The question now remains as to whether amphipols can 
protect membrane protein complexes on transition into the gas phase. This will 
greatly increase the applicability of amphipols for membrane proteins mass 
spectrometry analysis.  
Altogether mass spectrometry holds great promise for becoming a routinely used 
analytical tool for analysis of protein structure. Advances in amino acid labeling 
techniques will allow single amino acid residues to be tracked throughout protein 
complex assembly, while developments in mass spectrometric imaging could 
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provide information simultaneously on the spatial arrangement of these biomolecules 
in the gas phase. In the meantime, the use of mass spectrometry in combination with 
other in solution biochemical techniques is the most powerful approach to elucidate 
complex biochemical mechanisms.   
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Appendix 1 
 
 
Derivation of equation for second-order rate constant 
 
 
XBA   
 
(A = [peptide], B = [chaperone-subunit], X = product) 
 
]][[
][
BAk
dt
Bd
  
 
0][ 0 X  - since no product initially 
 
[A] ≡ [A]t and [B] ≡ [B]t  
 
Expressing [A] and [B] in terms of [X] 
 
][][][ 0 XAA        
][][][ 0 XBB   
 
Therefore the rate equation in terms of [X] is 
 
dt
Xd
dt
Bd ][][
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dt
Xd
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Rearranging this in order to integrate it gives 
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dt
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This can be integrated using partial fractions 
 
Using z and y as constants, making this a sum of two simpler fractions 
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making a common denominator and multiplying out 
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substituting these back into the previous equation 
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Integrating this gives 
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Changing the sign inside the ln and combining 
 
kt
B
XB
BAA
XA
BA






 







 
 0
0
000
0
00 ][
])[]([
ln
)][]([
1
][
])[]([
ln
)][]([
1
 
237 
 
 
kt
XBA
BXA
BA









 ])[]([][
]])[[]([
ln
)][]([
1
00
00
00
 
 
 
tBAk
XBA
XAB
)][]([
])[]([][
])[]([][
ln 00
00
00 








 
 
 
tBAk
BA
AB
)][]([
][][
][][
ln 00
0
0 






 
 
 
 
 
Rearranging for [B] 
 
(remember B = chaperone-subunit measured experimentally) 
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Since 10
logk
 = k, the reaction is ten fold diluted before analysis, and accounting for 
the initial ratio of PapDPapE:PapDPapH intensity at the different initial PapDPapH 
and PapDPapE concentrations used.  The final equation for use in determining 
second order rate constants is as follows 
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where  [B]    = concentration of PapDPapX 
 [A]    = concentration of peptide 
 [B]0   = [B] before addition of peptide 
 [A]0   = [A] before addition of PapDPapX 
  k      = second order rate constant 
 x      = dilution factor before acquisition, and the DX:DH intensity ratio at 
t=0 
 
